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 In the United States, joint diseases affect more than 50 million people, a number 
that is expected to rise in the next few decades. Hallmarks of joint disease often involve 
degradation of articular cartilage tissue, which leads to patient disability and pain. 
Articular cartilage cannot heal very effectively on its own, and there is a limited 
understanding on which therapeutics would be most effective in disease treatment. 
Because of the inherent complexities of cartilage, it is often difficult to predict how 
therapeutics will be transported through the tissue, especially for larger molecules. 
 For proper development of effective therapeutic strategies, a better 
understanding of transport of larger therapeutics is needed. First, a review of molecular 
transport in cartilage is presented to better motivate this work (Chapter 1). There are 
many molecular and environmental factors that affect transport for larger solutes, such 
as hydrodynamic size and/or molecular weight (Chapter 2), charge (Chapter 3), and the 
presence of fluid flow within the tissue (convective transport) (Chapter 2 – 4). 
Additionally, the heterogeneities in composition within the tissue is important and can 
be used to predict cartilage transport (Chapter 5). Finally, this new macromolecular data 
informed the development of a predictive framework under which transport of solutes 
over a wide range of sizes can be accurately predicted (Chapter 6). 
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Main Figures 
Figure 1| Molecules used for arthritis therapy range from ~ 200 Da – 150 kDa and 0.35 
– 5 nm in hydrodynamic size. Some of the most common agents are: nonsteroidal anti-
inflammatory drugs (NSAIDs), corticosteroids, growth factors, and antibodies. All of 
these molecules need to reach chondrocytes, which are embedded in a dense, 
heterogeneous matrix that varies in composition with depth. This matrix is thought to 
have a hierarchy of pore sizes from ~ 6 nm between glycosaminoglycan (GAG) chains 
to ~ 50 – 100 nm between collagen fibrils21. Notably, larger solutes, such as antibodies, 
are about the same size as the smaller pores in cartilage. The breadth of sizes of potential 
therapeutics and heterogeneity of articular cartilage results in a highly complex 
molecular transport problem. 
 
Figure 2| Graphical depiction of experimental techniques used to determine solute 
diffusivity and partition coefficient. Fluorescence recovery after photobleaching 
(FRAP) (A) uses transient changes in local fluorescence to determine local solute 
diffusivities in the region of interest (AS: articular surface, MZ: middle zone, DZ: deep 
zone). In diffusion cell (B) experiments, cartilage is placed in between two baths, with 
one filled with the solute that is tagged by a fluorophore or radiolabel. By monitoring 
how much solute permeates through the sample into the other bath over time, solute 
diffusivity can be calculated. Solute desorption (C) allows a known amount of solute to 
fully exude from the sample in a set time, which enables calculation of partition 
coefficient and diffusivity. This technique is one of the most commonly used techniques 
to examine solute partition coefficient. Nuclear magnetic resonance and computed 
tomography (NMR/CT) (D) and fluorescence gradient (E) techniques rely on 
visualization of local solute signal within the cartilage sample, and can be used to 
determine either local or bulk diffusivities. 
 
Figure 3: Schematic of experimental procedure. The left shows the experimental setup 
of an individual well and the right shows a radial fluorescence profile of an individual 
sample. Cylindrical samples are bisected and that cut surface is imaged under the 
confocal microscope. Only the middle 50% of the sample is shown in the confocal 
image. 
 
Figure 4: Normalized fluorescence intensity vs radial depth from the sample edge for a 
representative middle portion of loaded and passive sample exposed to the antibody 
solution for 3 hours. The loaded sample was exposed to loading at 5% cyclic strain at 1 
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Hz. Solid lines denote a radial 1D diffusion curve derived from Fick’s 2nd law, while 
dotted lines denote experimental data. Diffusivities and goodness of fits from each 
sample are shown. 
 
Figure 5: Transport enhancement vs. strain amplitude at 1 Hz (A) and transport 
enhancement vs. loading frequency at 2.5% strain (B). Enhancement was found to be 
linearly correlated with strain amplitude (at 1 Hz) for both neonatal bovine tissue (slope: 
0.30) and mature equine tissue (slope: 0.24) (R2 > 0.93). The two correlations were 
forced to have an intercept of 1 and were not statistically different from one another (p 
= 0.11). All strain amplitudes were statistically different from a value of one (p < 0.05), 
except for 0.25% strain. The maximum enhancement was found to be at 1 Hz. All 
loading frequencies were statistically different from a value of one (p < 0.05), except 
for 0.25 Hz. 
 
Figure 6: Predicted fluid velocities for different strains at 1 Hz (A) and frequencies at 
2.5% cyclic strain (B) vs. radial depth into the tissue. Experimental local transport 
enhancement from neonatal cartilage experiments for different strains at 1 Hz (C) and 
frequencies at 2.5% strain (D). A normalized radius of 1 corresponds to the sample 
radial edge. Local diffusivity curves closely followed the curvature of fluid velocity 
profiles. The highest transport enhancement was found near the edge, near areas of 
highest fluid flow. Normalized radii of at least 0.925, 0.875, and 0.900 correspond to 
enhancements greater than 1 for 1.25% 2.5%, and 5.0%, respectively (p < 0.05, 
ANOVA). Normalized radii of at least 0.8750, 0.8750, and 0.9375 correspond to 
enhancements greater than 1 for 0.25 Hz, 1 Hz, and 2.6 Hz, respectively (p < 0.05, 
ANOVA). All fluid velocity profiles were obtained at steady state conditions (occurred 
within 10 minutes). 
 
Figure 7: Correlative plot of enhancement ratio and maximum fluid velocity for various 
loading conditions that were previously analyzed. The best fit line is forced to have an 
intercept of 1; the correlation was statistically significant (p < 0.001). Artifacts from lift-
off could have caused transport enhancements from higher loading amplitudes (5%) and 
frequencies (2.6 Hz) to have data points higher than expected. However, correlations 
between individual loading regimes were not significantly different from one another. 
 
Figure 8: Schematic of sample preparation and experimental setup (left and center) with 
the fluid flow induced by the platen being perpendicular to the deep zone (DZ) and the 
articular surface (AS). A 4-mm diameter sample 2-mm thick was bisected, then a slice 
was cut from each half to obtain a final sample dimension of 4x2x1.15 mm. 
Fluorescence image obtained from the Ab (150 kDa) solute using confocal microscopy 
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(right). Red box (~1000 μm wide, 500 μm tall) indicates the region of interest that was 
examined for this study. 
 
Figure 9: Representative normalized fluorescence curve for the Ab (150 kDa) solute 
under passive conditions (blue) compared against the 16-layer diffusion model (solid 
black) (left). For this sample, average coefficient of variance was 6.4%. All solutes had 
average coefficient of variances less than 12.5%. Loaded and passive samples had 
equally good fits overall for all solutes. Average normalized fluorescence curve for Ab 
(150 kDa) through the articular surface shown (right). Standard deviations are 
represented by the shaded region for n = 8. For this solute, distinct changes in concavity 
were observed and therefore profiles could be roughly broken into three distinct regions. 
The articular surface region is characterized by a sharp decrease in fluorescence for the 
first 100 μm or so, followed by the plateau region where the fluorescence is relatively 
constant, followed by the deep region where there is a more rapid drop off of 
fluorescence. 
 
Figure 10: Passive fluorescence profile comparison of the four differently sized solutes 
used. Error bars (standard deviation for n = 6-8) for all solutes are shown in shades 
surrounding average profiles. 
 
Figure 11: Passive fluorescence profile comparison of the four differently sized solutes 
used (left) along with the multi-layer diffusivities (right). Error bars denote standard 
deviations for all solutes (n = 7, 8, 7, 6 for DVD, Ab, Fab, scFv, respectively). 
Fluorescence curves for these solutes were visually similar up until 400 μm, where 
solute fluorescence diverged according to size. Overall, local diffusivities were 
heterogeneous throughout the depth of the tissue, and there were three distinct sections 
of these curves for each solute. On average, diffusivities for the DVD, Ab, Fab, and 
scFv, were 3.3, 3.4, 5.1, and 6.0 μm2/s from 0-100 μm, but size did not affect diffusivity 
significantly within this region (p > 0.05). Diffusivities increased to a maximum of 16.5, 
18.5, 20.5, and 23.4 μm2/s for the DVD, Ab, Fab, and scFv, respectively, between 225-
325 μm. Calculated diffusivities at 225 μm, 275 μm, and 325 μm were higher than all 
other diffusivities in the tissue, for all solutes (p < 0.05). Diffusivities then decreased to 
similar values found within the surface region in the 400-800 μm range (deep region), 
and had no significant dependence on size (p > 0.05). Values obtained from the 0-125 
μm range and 400-800 μm range were not different from each other, for any solute (p > 
0.05). 
 
Figure 12: All four solutes’ fluorescence profiles for passive and loaded conditions. 
Lighter shades of color indicate greater loading amplitude. All cyclic loading was 
 xvi 
conducted at 1 Hz for 3 hours. Most enhancement of the fluorescence profiles for all 
solutes can be found from 0 – 400 μm from the articular surface. Sample sizes: N = 7, 
8, 4, 6 for passive, 1.25%, 2.5%, and 5% for DVD solute, respectively. Sample sizes: N 
= 8, 7, 6, 5 for passive, 1.25%, 2.5%, and 5% for Ab solute, respectively. Sample sizes: 
N = 7, 6, 7, 7 for passive, 1.25%, 2.5%, and 5% for Fab solute, respectively. Sample 
sizes: N = 6, 8, 7, 8 for passive, 1.25%, 2.5%, and 5% for scFv solute, respectively. 
 
Figure 13: All four solutes’ depth-wise diffusivities for passive and loaded conditions. 
Lighter shades of color indicate greater loading amplitude. Error bars denote standard 
deviations with n = 4-8 for all solutes (see Figure 5 for specific sample size information). 
Loading increased diffusivities most from 0 – 400 μm from the articular surface, with 
highest diffusivity enhancement occurring between 225-325 μm (p < 0.05). For most 
solutes, no significant transport enhancement was experienced in the first 125 μm of the 
tissue, at any loading condition (p > 0.05). As expected, solutes undergoing higher 
cyclic amplitudes (i.e. 5%) received more transport enhancement than solutes 
undergoing less loading, from 125 μm to 325 μm (p < 0.05). In general, larger solutes 
benefited from loading more than smaller solutes, especially within the range 225-325 
μm (p < 0.05). Almost no loading based enhancement can be observed deeper than 425 
μm into the tissue. 
 
Figure 14: Cartilage cylinders were bisected and then sliced to obtain a final sample 
dimension of 4x2x1.15 mm (A). Samples were loaded in a way that caused fluid flow 
to be perpendicular to the articular surface (AS) and deep zone (DZ) (B). Representative 
image from confocal microscopy showing the fluorescence gradient perpendicular to 
the AS (C). The red box (~1000 μm wide, 500 μm tall) indicates the region of interest 
that was examined for this study. 
 
Figure 15: Average normalized fluorescence curve for all solutes (pI 4.7, 5.4, 5.9) 
through the articular surface. Standard deviations are represented by the shaded region 
for n = 5-7. Fluorescence values trended higher as pI increased within the region 100-
300 μm from the articular surface. 
 
Figure 16: Fluorescence curves for all solutes (passive condition) tested (left) and local 
diffusivities (right). Error bars denote standard deviations with n = 5-7 for all solutes. 
Overall, local diffusivities were heterogeneous throughout the depth of the tissue. On 
average, diffusivities for the pI 4.7, pI 5.4, and pI 5.9, were 3.8, 4.5, 4.6 μm2/s at 50 μm, 
but pI did not affect diffusivity significantly within this region (p > 0.05). Diffusivities 
increased to a maximum of 15.0, 16.9, and 19.0 μm2/s for the pI 4.7, pI 5.4, and pI 5.9 
solutes respectively, between 200-275 μm. Calculated diffusivities at 125 μm, 200 μm, 
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and 275 μm were higher than all other diffusivities in the tissue, for all solutes (*: p < 
0.05). Diffusivities for pI 5.9 were higher than that of pI 4.7, between 200-375 μm (p < 
0.05). Diffusivities then decreased to similar values found within the surface region in 
the 400-800 μm range, and had no significant dependence on pI (p > 0.05). Values 
obtained from 50 μm and 425-800 μm range were not different from each other, for any 
solute (p > 0.05). 
 
Figure 17: Fluorescence curves for pI 5.9 and 5% cyclic loading (left) and local 
diffusivities for all solutes at 5% cyclic loading (right). Error bars denote standard 
deviations with n = 5-7 for all solutes. Orange solid line denotes average passive 
diffusivity levels in the passive condition for all solutes. Cyclic loading at 5% cyclic 
strain and at 1 Hz increased fluorescence values between 150 and 400 μm. Solutes did 
not experience any significant differences in diffusivity values or trends at this loading 
amplitude (p > 0.05). Additionally, there were no differences between solute 
diffusivities at 1.25% or 2.5% (shown in supplement). However, maximal transport 
enhancement increased for all solutes with increasing loading amplitude, as expected. 
 
Figure 18: During sample preparation (A), cartilage explants were randomly assigned 
to three groups: 2 mg/ml collagenase, 200 μg/ml trypsin, or healthy controls. With the 
bottom third of all samples submerged in PBS, drops (~10 μl) of collagenase or trypsin 
were added to the articular surface of samples. After rinsing with protease inhibitors, 
samples were cut to obtain slices measuring 4x2x1.15 mm. Degraded and healthy slices 
were then exposed to a fluorescent antibody solution (B) so that diffusion would occur 
perpendicularly to the articular surface. After 3 hours of exposure, samples diffusion 
was examined with confocal microscopy. Compositional analysis was also performed 
with Fourier transform infrared spectroscopy (FTIR), second harmonic generation 
(SHG) imaging, biochemistry, and histology. Bulk aggrecan and collagen content were 
calculated with biochemistry techniques, and was normalized to dry weight for each 
group (N̅) (mg/mg). Using the average relative composition from FTIR and SHG (R̅), 
relative concentrations were scaled point by point by the ratio of N̅ and R̅. 
 
Figure 19: Fluorescence images allow calculation of fluorescence profiles for all three 
groups and determination of how degradation affects local solute diffusivities (left). 
Transport analyses showing the fluorescence curves of all experimental conditions 
(middle) and their respective local diffusivities throughout the depth of the cartilage 
(right). Samples with the surfaces degraded by either enzyme (collagenase or trypsin) 
exhibited higher fluorescence compared to the healthy controls within the first 400 μm 
from the articular surface. Degradation with either trypsin or collagenase led to higher 
diffusivities compared to healthy within the first 350 μm (*: p < 0.05, repeated-measures 
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two-way ANOVA), and all groups were statistically similar at depths more than 400 μm 
(with an average of 4 μm 2/s). Collagenase-treated samples exhibited the highest local 
diffusivities (70 μm2/s at 250 μm), compared to the trypsin-treated (40 μm2/s at 250 
μm) or healthy samples (20 μm2/s at 250 μm), and highest diffusivities at the surface (0 
μm) of the tissue (45 μm2/s), compared to the trypsin (10 μm2/s) or healthy (4 μm2/s) 
groups (p < 0.05). Error bars (both shaded and standard) denote standard deviations with 
n = 4 - 8. 
 
Figure 20: Safranin-O histology images (left) demonstrate how trypsin and collagenase 
degrade the proteoglycans near the surface zone of the cartilage. Absorbance spectra 
from FTIR analysis for the degraded samples compared to normal healthy controls 
(middle) at a depth of 100 μm. Collagenase and trypsin both drastically changed the 
absorbance spectra by altering the carbohydrate peak height near (1140 – 985 cm-1), 
suggesting collagenase caused greater loss of proteoglycans (including aggrecan) 
compared to trypsin. Local aggrecan composition (right) was obtained by calculating 
the depth-dependent aggrecan fitting coefficient by decomposing FTIR absorbance data 
152. This coefficient was scaled to the average dry-weight aggrecan concentration 
obtained from biochemical analysis for each group (21 – 23%) (see Supplementary 
Figure 1). Degradation with collagenase or trypsin led to significant decreases (up to 
40%) in aggrecan content, within the first 210 and 420 μm, respectively (p < 0.05). 
Aggrecan content was statistically similar past 420 μm. 
 
Figure 21: SHG images demonstrate how these enzymes affect the distribution of 
organized collagen in the tissue (left) and normalized SHG intensity profiles (middle). 
As anticipated, organized collagen concentrations in trypsin-treated samples did not 
differ significantly from healthy controls (right), but collagenase-treated samples 
exhibited significantly lower organized collagen concentrations within the first 50 μm 
from the articular surface (p < 0.05).  
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Figure 22: Correlations comparing local diffusivities from the transport analysis to the 
local composition obtained from FTIR and SHG for healthy (A), trypsin-treated (B), 
and collagenase-treated (C) groups. Lighter shaded data designate points near the 
articular surface of samples (within 0 – 200 μm). Overall, concentrations of collagen 
and aggrecan were negatively correlated with local diffusivity in all groups. The slopes 
of the diffusivity/composition correlations for local aggrecan and collagen content are -
78 and -47 for healthy samples, -153 and -138 for trypsin-treated samples, and -293 and 
-285 for collagenase-treated samples, respectively. Aggrecan and collagen content were 
more strongly correlated with diffusivity in the degraded groups (trypsin: R2 = 0.45, 
0.74; collagenase: R2 = 0.86, 0.75), compared to the healthy group (R2 = 0.31, 0.46). 
Additionally, aggrecan and collagen correlations for collagenase-treated samples 
exhibited steeper diffusivity/concentration relationships compared to correlations from 
the healthy group (p < 0.05, ANCOVA). In contrast to both healthy and trypsin-treated 
samples, points near the articular surface of collagenase-treated samples fell closely to 
the overall regression lines, highlighting the prohibitive nature that collagen alignment 
has on macromolecular transport. 
 
Figure 23: Variability in diffusivity is largely predicted by solute molecular weight or 
hydrodynamic radius. Pooled solute diffusivity data from 31 individual papers, plotted 
as a function of solute molecular weight (MW) (left) and hydrodynamic radius (right). 
Data includes spherical (filled points) and “linear” (open points) solutes. All “linear” 
solute data points were obtained from diffusion studies using variously sized dextran or 
chondroitin sulfate molecules. All other solutes were classified as spherical. Values for 
hydrodynamic radii were obtained directly from the cited literature; if this was not cited, 
an empirical relationship (rs = 0.0332MW
0.463) (87), was used to estimate 
hydrodynamic radius. Spherical solute diffusivity in cartilage was found to be very 
strongly correlated (black) to both molecular weight and hydrodynamic radius, 
obtaining an R2 = 0.81 for both solute metrics. Best fits for linear solutes (gray) were 
weak (R2 < 0.3), and deviated from spherical solutes, indicating that linear solutes 
diffuse differently in cartilage tissue. On average, linear solutes had higher diffusivities 
than spherical solutes of similar size, which may be due to the ability of linear solutes 
to change conformation as they move through the matrix. 
 
Figure 24: The relationship between solute diffusivity and size does not depend on 
measurement technique, tissue species, tissue age, or tissue storage method. Pooled 
solute diffusivity data compared against different experimental techniques (left), tissue 
species/age (middle), and tissue storage condition (right). Data was grouped into 5 
different experimental techniques: computed tomography/nuclear magnetic resonance 
spectroscopy (CT/NMR), diffusion cell, solute desorption, fluorescence recovery after 
photobleaching (FRAP), and fluorescence gradient (left). Linear solutes (open points) 
 xx 
were also included for completeness in graph A, but only spherical solutes were 
included in the best-fit curves (black). Tissue was also separated into tissue types: adult 
human, mature bovine and equine, and immature bovine cartilage (middle). Finally, data 
was also separated based on tissue storage condition before experimentation: either 
fresh or frozen (right). Across all data groupings for spherical solutes, the relationship 
between diffusivity and size did not differ between groups or from the relationship 
formed from the pooled data (ANCOVA, using log-transformed data, p > 0.05). This 
strongly supports that diffusivity can be accurately predicted in cartilage regardless of 
the parameters used in individual experiments. 
 
Figure 25: Mechanistic transport models are inconsistent in predicting solute diffusivity 
in cartilage. Transport models for solute diffusivity (left) and partition coefficient (right) 
were compared to aggregate literature data. Diffusivities for all spherical solutes were 
compared to three prominent models (left): Renkin, Brinkman, and Clague and Phillips 
(65,72,75). Across this spherical solute data, root mean square (RMS) error [μm2/s], 
coefficient of variance (COV), and R2 are presented (based on untransformed data). 
Both the Brinkman and Renkin models did not fit pooled data adequately, assuming an 
effective pore radius of 7 nm and a Darcy permeability of 1.0 nm2. The pooled data was 
well-fit to the Clague and Phillips relation assuming a total volume fraction of 0.25 and 
an effective fiber radius of 4 nm. However, a simple power-law relationship was found 
to best-fit the data. Right: The Ogston model was used to predict partition coefficients 
of spherical solutes assuming a volume fraction and effective fiber radius of aggrecan 
to be 0.08 and 0.475 nm, respectively. Overall, for neutrally-charged, spherical solutes, 
the Ogston model was predictive of solute partition coefficient. Partition coefficients 
for linear solutes (open points), such as dextran, deviated significantly from spherical 
solutes. 
Supplementary Figures: 
Figure S1: Passive samples were exposed to the conjugated antibody solution on their 
cylindrical surface for various amounts of time. Diffusivities were measured in the 
radial direction; diffusivities asymptotically approached a steady state value after two 
hours. Due to the experimental setup, there was lag time between cessation of loading 
and imaging of samples, where additional internal diffusion was taking place. This 
internal diffusion produced artificially high diffusivities if the length of experiments 
was not much larger than this lag time (~15 minutes). As a result, experiments needed 
to be longer than 2 hours to avoid imaging artifacts falsely inflating diffusivity values 
before the 2-hour time point. Therefore, all data within the manuscript are from 
experiments that were at least 3 hours in length. 
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Figure S2: Each fluorescence profile for loaded and unloaded samples were broken 
down into discrete layers (25 μm bands from 0 – 300 μm from the radial edge, 200 um 
bands thereafter). A radial multi-layer 1D diffusion model was used to calculate local 
diffusivities. Layers above were made larger for clarity purposes. 
 
Figure S3: Additionally, a separate group of samples was tested without platens or strain 
offset to assess passive axial diffusion through the exposed articular surface. 
Fluorescence profile analysis was carried out perpendicular to the articular surface to 
obtain a single diffusivity in the axial direction. These diffusivities were compared to 
radial diffusivities for samples that were also in the free-swelling condition. Passive 
diffusivity into the articular surface was found to be significantly higher (35-50%) 
compared to diffusivity in the radial direction for all species types (p < 0.05). The 
antibody had the lowest radial diffusivity in mature equine cartilage (1.9 x 10-8 cm2/s), 
and the highest in neonatal bovine tissue (4.4 x 10-8 cm2/s). Neonatal bovine tissue had 
higher diffusivities compared to the other two groups (p < 0.05). 
 
Figure S4: All four solutes’ fluorescence profiles for passive and loaded conditions. 
Cyclic loading was conducted for 3 hours at 1 Hz and 1.25% cyclic loading amplitude. 
Mean values are shown for each solute, with shaded regions denoting standard 
deviations. 
 
Figure S5: All four solutes’ fluorescence profiles for passive and loaded conditions. 
Cyclic loading was conducted for 3 hours at 1 Hz and 2.5% cyclic loading amplitude. 
Mean values are shown for each solute, with shaded regions denoting standard 
deviations. 
 
Figure S6: All four solutes’ fluorescence profiles for passive and loaded conditions. 
Cyclic loading was conducted for 3 hours at 1 Hz and 5% cyclic loading amplitude. 
Mean values are shown for each solute, with shaded regions denoting standard 
deviations. 
 
Figure S 7: All three solutes’ depth-wise diffusivities for 1.25% (left) and 2.5% (right) 
cyclic loading. Orange solid line denotes average passive diffusivity levels in the 
passive condition for all solutes. Error bars denote standard deviations with n = 5-7 for 
all solutes. Higher loading amplitude lead to higher effective diffusivities, as expected. 
However, there were no differences in diffusivity between solutes at any loading 
amplitude. 
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Figure S 8: Fluorescence profiles for pI 4.7 solute in passive and cyclic loading 
conditions. Loading was conducted for 3 hours at 1 Hz and at 1.25%, 2.5%, and 5% 
cyclic loading amplitudes. Mean values are shown for each solute, with shaded regions 
denoting standard deviations for n = 4-8. 
 
Figure S 9: Fluorescence profiles for pI 5.4 solute in passive and cyclic loading 
conditions. Loading was conducted for 3 hours at 1 Hz and at 1.25%, 2.5%, and 5% 
cyclic loading amplitudes. Mean values are shown for each solute, with shaded regions 
denoting standard deviations for n = 4-8. 
 
Figure S 10: Fluorescence profiles for pI 5.9 solute in passive and cyclic loading 
conditions. Loading was conducted for 3 hours at 1 Hz and at 1.25%, 2.5%, and 5% 
cyclic loading amplitudes. Mean values are shown for each solute, with shaded regions 
denoting standard deviations for n = 4-8. 
 
Figure S 11: Chemiluminescence vs. pI for the three solutes used in this study. 
Isoelectric point was determined by the maximum chemiluminescence value obtained 
from electrophoresis. 
 
Figure S12: Graphical depiction of the linear decomposition method to obtain local 
cartilage composition for a healthy sample at 100 μm from the articular surface. 
Measured articular cartilage spectra from FTIR were best fit to the addition of a collagen 
spectra, an aggrecan spectra, and a baseline that accounts for instrument-specific 
deviations and drift that can occur with different environmental conditions [53]. This 
linear decomposition method was used to determine local aggrecan content of all 
samples by scaling the coefficient, c2, to the average dry weight aggrecan content 
obtained from biochemical analysis for each group (~ 21 – 23%). Error between 
measured spectra and best fit spectra were consistently less than 15%, for all samples 
and depths. 
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Figure S13: Comparison of local collagen content calculated from FTIR (left) and SHG 
(right). Both methods give similar trends in collagen content as a function of depth. 
However, data calculated from FTIR decomposition did not exhibit significant 
differences between groups at any depth. Meanwhile, collagenase-treated data from 
SHG exhibited significantly lower organized collagen concentrations within the first 50 
μm from the articular surface (p < 0.05). Thus, SHG is more sensitive to the changes 
that collagenase imposes on the matrix for this degradation protocol. Likely, longer 
exposure times to collagenase would have resulted in differences between groups for 
the FTIR analysis as well. 
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PREFACE 
Articular cartilage is a remarkable tissue that lines the ends of long bones, providing a 
smooth, low-friction surface in synovial joints. This type of cartilage, which is avascular 
and aneural, relies on the diffusion and transport of nutrients and other factors from 
synovial fluid to maintain its health. Therefore, disruption of cartilage homeostasis, as 
with occurrence of joint injury or excessive systemic inflammation, often results in 
irreversible tissue damage (arthritis). Currently, arthritis is the leading cause of 
disability in the US, affecting more than 46 million people, with estimated direct costs 
of $87 billion per year. The two most common forms of the disease are osteoarthritis 
(OA), which is known to be initiated by multiple biological, genetic, and mechanical 
factors, and rheumatoid arthritis (RA), an autoimmune disorder that targets tissues in 
synovial joints. Overall, treatments for these diseases vary in effectiveness. Treatments 
for OA include steroid injections to reduce pain or injections of viscous polymers to 
reduce joint friction, but these unfortunately only have limited short-term success. 
Eventually, most people affected with severe OA need to receive joint replacements, 
which is a costly and painful procedure for the patient. Because of the lack of long-term 
options, there has been a great interest to develop new OA therapies. 
 
Inhibition of inflammatory pathways has been promising as a therapeutic strategy for 
arthritis treatment, as inflammation plays a key role in both OA and RA. To date, this 
strategy has been significantly more successful in treating rheumatoid arthritis. Several 
strategies for inhibiting inflammation, including antibody-based strategies, such as 
Humira®, have proven very effective at abating both the symptoms of RA and associated 
 xxx 
 
joint degeneration. As such, there is much interest in determining whether such 
antibody-based approaches would also be effective in preventing cartilage degeneration 
in OA. Because of the inherent complexities of cartilage, transport of these large 
molecules is often hard to predict and is not currently fully characterized. Furthermore, 
these antibody molecules are similar in size to the native pore size of the tissue, which 
may lead to severely hindered transport properties. Thus, the purpose of this research is 
to fully describe antibody transport in articular cartilage, to aid development of new 
arthritis therapeutic strategies. Additionally, this research also synthesizes this new 
antibody transport data with existing data for smaller molecules, to formulate a 
predictive framework from which to predict transport of a wide variety of therapeutics 
targeting cartilage. We will begin with assessing what is currently known about 
molecular transport in cartilage, including all relevant background information for the 
reader, and end with a comprehensive synthesis of data collected from these studies with 
historical data.
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CHAPTER 1 
Molecular Transport in Articular Cartilage: What Have We Learned in the Past 50 
Years?1 
Abstract 
 Developing therapeutic molecules to target chondrocytes and inflammatory 
factors within arthritic cartilage is an active area of investigation. The extensive work 
conducted over the past half century enables accurate prediction and reliable 
optimization of transport of a wide variety of molecules into cartilage. In this review, 
we summarize the factors that can be used to tune transport kinetics of therapeutics. 
Overall, the most crucial factor when designing new therapeutic molecules is solute 
size. Diffusivity and partition coefficient both decrease with solute size as indicated by 
molecular weight or hydrodynamic radius. Surprisingly, despite an effective pore size 
of about 6 nm, even very large molecules (~ 16 nm) can diffuse through the cartilage 
matrix. Additionally, altering solute charge/shape or applying physiologic loading to 
cartilage can be used to predictably improve solute transport. This knowledge can be 
used to accurately predict and improve transport of solutes in adult human cartilage and 
enable the development of arthritis therapeutics with the most desirable transport 
kinetics. 
 
 
1C. DiDomenico, M. Lintz, and L. J. Bonassar, “Molecular transport in cartilage: 
What has a half century taught us?,” Nat. Rev. Rheumatol., In press. 
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Introduction 
Treatment of osteoarthritis (OA) necessitates transport of therapeutic molecules into 
cartilage1–3 to reach the numerous degradative enzymes and cytokines produced by 
chondrocytes4–7. The use of large therapeutic molecules, such as antibodies (150 kDa), 
has been very successful in other arthritic diseases, such as rheumatoid arthritis (RA), 
where  large quantities of degradative cytokines are produced in the synovium7–11. 
Because of the vascularized nature of the synovium, efficacious anti-inflammatory 
drugs that are administered intravenously can quell cytokine production and halt RA 
disease progression10. However, sufficient transport of these drugs into cartilage is 
difficult, because of its highly anisotropic, dense, and avascular nature12. Thus, 
understanding how molecular transport occurs within cartilage is critical to the 
successful development and implementation of future OA therapies. 
 
Current therapies for arthritis include intra-articular injection of steroids and oral 
administration of non-steroidal anti-inflammatory drugs (NSAIDs)1,12–14, which are 
both about 500 Da and 0.5 nm in hydrodynamic size (FIG. 1). These drugs have limited 
long-term efficacy for treatment of OA13–17 and there has been interest to investigate the 
administration of larger therapeutics1,3,18–20, which include growth factors and 
antibodies that range from 7 – 200 kDa and 1 – 6 nm in hydrodynamic radii. Regardless 
of their size, all of these solutes need to penetrate the dense cartilage in the joint to exert 
therapeutic effects on chondrocytes2,3. While smaller molecules are assumed to fully 
penetrate the tissue quickly, the transport mechanics of larger molecules are much less 
clear, because of the highly complex nature of cartilage. 
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Figure 1| Molecules used for arthritis therapy range from ~ 200 Da – 150 kDa and 
0.35 – 5 nm in hydrodynamic size. Some of the most common agents are: nonsteroidal 
anti-inflammatory drugs (NSAIDs), corticosteroids, growth factors, and antibodies. All 
of these molecules need to reach chondrocytes, which are embedded in a dense, 
heterogeneous matrix that varies in composition with depth. This matrix is thought to 
have a hierarchy of pore sizes from ~ 6 nm between glycosaminoglycan (GAG) chains 
to ~ 50 – 100 nm between collagen fibrils21. Notably, larger solutes, such as antibodies, 
are about the same size as the smaller pores in cartilage. The breadth of sizes of potential 
therapeutics and heterogeneity of articular cartilage results in a highly complex 
molecular transport problem. 
 
Cartilage is a unique, complex tissue that is predominantly water (~75%), with two main 
solid components, type II collagen and aggrecan, a highly negatively charged 
macromolecule22,23. The fibrillar collagen II changes from highly aligned along the 
surface layers of the cartilage, to a more perpendicular alignment deeper in the tissue24. 
The concentration of aggrecan and collagen II also increase as a function of depth from 
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the articular surface22,23,25, which causes the local fixed charge density (FCD) of the 
tissue to increase as well22,23. Together, these solid matrix components contribute to a 
heterogeneous, highly dense, negatively charged tissue, with an effective pore size of ~ 
6 nm21,22, which is similar to that of some proposed therapeutics (FIG. 1). Because of 
the poroelastic mechanical response of cartilage26–28, fluid flow induced from 
mechanical loading helps expel waste products and transports nutrients (salt, glucose, 
etc.) and larger (> 10 kDa) growth factors into the tissue from the synovial fluid25,29–32. 
Thus, transport of molecules in this tissue is subject to many different factors, and it is 
important to understand how smaller nutrients, as well as very large potential 
therapeutic molecules, are affected by these heterogeneities.  
 
In this review, we firstly describe the experimental techniques that have been used to 
examine molecular transport in articular cartilage. We then describe several major 
factors that can be utilized to help predict and improve transport. We end by discussing 
how in vivo conditions influence molecular transport in cartilage and potential 
implications for the design of therapeutics. 
 
Techniques for examining transport 
The primary means for studying transport in cartilage are in vitro experimental 
techniques (summarized below and in FIG. 2). Some studies have focused on 
understanding bulk-tissue transport mechanics, while others quantified mechanics that 
vary spatially within the sample. Both are important for the complete understanding of 
transport within cartilage. Ultimately, these experimental techniques mainly focus on 
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quantifying two metrics: diffusivity and solute partition coefficient. Diffusivity (D) is a 
metric that quantifies solute mobility (movement speed) in the tissue, whereas the 
partition coefficient (K) measures the equilibrium concentration of the solute in the 
cartilage compared to the concentration in the surrounding bath (i.e. synovial fluid). 
These metrics reveal important transport information that can be used to inform 
therapeutic design. 
 
Figure 2| Graphical depiction of experimental techniques used to determine solute 
diffusivity and partition coefficient. Fluorescence recovery after photobleaching 
(FRAP) (A) uses transient changes in local fluorescence to determine local solute 
diffusivities in the region of interest (AS: articular surface, MZ: middle zone, DZ: deep 
zone). In diffusion cell (B) experiments, cartilage is placed in between two baths, with 
one filled with the solute that is tagged by a fluorophore or radiolabel. By monitoring 
how much solute permeates through the sample into the other bath over time, solute 
diffusivity can be calculated. Solute desorption (C) allows a known amount of solute to 
fully exude from the sample in a set time, which enables calculation of partition 
coefficient and diffusivity. This technique is one of the most commonly used techniques 
to examine solute partition coefficient. Nuclear magnetic resonance and computed 
tomography (NMR/CT) (D) and fluorescence gradient (E) techniques rely on 
visualization of local solute signal within the cartilage sample, and can be used to 
determine either local or bulk diffusivities.  
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Nuclear magnetic resonance spectroscopy and computed tomography 
Nuclear magnetic resonance (NMR) spectroscopy can be used to quantify and track 
solute movement in cartilage. In this method, cartilage is exposed to large magnetic 
fields and the relaxation spectra of desired NMR-active solutes are measured (FIG. 2). 
Solute concentrations can be calculated by examining the relative intensity of the local 
NMR spectra obtained from the sample. Additionally, temporal changes of the obtained 
NMR spectra elucidate how fast a solute is moving within the cartilage and can be used 
to predict solute diffusivities33–35. NMR spectra are very well known and predictable for 
small solutes, but interpretation of these spectra becomes more challenging with 
increasing molecular complexity. However, small contrast agents have been attached to 
larger solutes to visualize macromolecular transport in cartilage35. 
 
Computed tomography (CT) is a way to visualize contrast agent penetration into 
cartilage by utilizing the ability of such agents to absorb X-ray radiation. CT scans rely 
on reconstructions of data taken from many different angles to produce 3D images of a 
region of interest36. The experimental setup for using CT to measure solute transport is 
similar to that used for NMR spectroscopy (FIG. 2), where the sample is subjected to 
X-ray exposure from many angles while a side of the cartilage sample is exposed to the 
contrast agent bath. As the solute penetrates the sample, X-ray absorption changes, 
which allows the calculation of concentration and hence diffusivity. Since this method 
causes significant X-ray exposure, CT imaging has only been used to measure cartilage 
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transport ex vivo36–40. This method can be used for calculating bulk or local transport 
mechanics. 
 
Solute absorption/desorption 
This method focuses on quantifying a volume of solute that diffuses into and/or out of 
a cartilage sample ex vivo, and does not attempt to track solute movement within the 
sample itself. Solutes can be labeled with a variety of molecules (predominantly 
fluorophores or radiolabels) to identify and track their movement with appropriate 
detection techniques. In solute absorption experiments, samples are exposed to the 
solute bath for a set amount of time, usually until equilibrium21,25,32,41–46. Since the initial 
concentration of the bath and time exposed are known, one can deduce how much 
infiltrated the sample and therefore calculate bulk diffusivities and partition coefficients. 
This is often followed by allowing the solute in the sample to “desorb” into another bath 
(FIG. 2) so that an additional metric of diffusivity can be obtained32,45,54–57,46–53. 
Additionally, samples can be cyclically loaded during either the absorption or 
desorption steps to elucidate the effect of convection on a solute29,40,42,48,58–60. Most 
times, diffusivities from absorbance tests and desorption tests are similar, but comparing 
these two metrics can discern if the solute is binding to the cartilage matrix. This method 
can also be used to test diffusivities in different layers of cartilage, if the sample is sliced 
into discrete sections as a function of depth. However, slicing the cartilage in this way 
may damage the collagen network and therefore skew diffusivity measurements45. 
 
Diffusion cell 
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Diffusion cells measure the rate at which solutes diffuse through cartilage tissue. In this 
method, experimental setups include an upstream bath and a downstream bath, with 
cartilage acting as a permeable membrane between the two31,32,46,54–57,61 (FIG. 2). The 
solute of interest is added to one of the baths, which are usually stirred to promote well-
mixed boundary conditions on both sides of the cartilage. Solutes can be labeled with 
either fluorophores or radiolabels to identify and track their movement. Because of their 
nature, diffusion cells only can measure diffusivity of a solute through the cartilage 
tissue, and cannot be used to accurately calculate partition coefficients. Thus, this 
method is often paired with solute desorption techniques to obtain both metrics. As with 
solute desorption, diffusion cells can also be used to test diffusivities in different layers 
of cartilage. 
 
Fluorescence gradient 
Transport in samples can also be measured by quantifying solute fluorescence within 
the sample itself58,61–64. After solute exposure (which may not be to equilibrium) in a 
bath, samples are bisected to measure a spatial fluorescence gradient in the cartilage 
sample using appropriate microscopic techniques62 (FIG. 2). This fluorescence gradient 
is commonly fit to a 1D diffusion model to calculate bulk solute diffusivities62,65. This 
technique can also be used to measure local diffusivities, which can help quantify how 
solutes move through different regions of the tissue65. Changes in local sample 
fluorescence can also be examined after mechanical loading to quantify convective 
transport58,62. If samples have equilibrated, local fluorescence can be analyzed to 
distinguish if the solute partition coefficient varies as a function of position within the 
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cartilage. Or simply, average sample fluorescence can be related to solute concentration 
to quantify a bulk partition coefficient29. However, in contrast to solute 
absorption/desorption methods, one must be careful to avoid cartilage autofluorescence 
and background signal from matrix constituents, as well as other transient imaging 
artifacts62,65.  
 
Fluorescence recovery after photobleaching 
Fluorescence recovery after photobleaching (FRAP) enables calculation of local 
transport metrics for fluorescently tagged solutes. Most commonly, this technique 
involves exposing the tissue to a solute until equilibrium. Then, the sample is imaged 
using a confocal microscope where high intensity laser light photobleaches a small area 
on the sample63,64,66,67 (FIG. 2). Over time, the fluorescence at the photobleached area 
(usually circular) recovers due to diffusion of the fluorescently tagged solute. Based on 
the time of recovery, diffusivities can be obtained for discrete regions of the cartilage. 
Determination of any direction-dependent diffusion can be examined by comparing 
times for fluorescence recovery along two perpendicular axes of the circular 
photobleached area64. Ultimately, FRAP is a very accurate way to obtain local 
diffusivities of a solute. However, because of the local nature of FRAP, obtaining large-
scale bulk diffusivities is not usually feasible. 
Factors that affect transport 
Because of the complex nature of cartilage, there are several factors that can drastically 
affect solute transport kinetics. These include solute size, solute charge and shape, 
cartilage composition, and application of mechanical loading to the tissue. The 
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extensive work conducted over the past half century enables accurate prediction and 
reliable optimization of transport of a wide variety of molecules that vary in size from 
7 Da to 500 kDa and 0.1 nm to 16 nm. This knowledge allows researchers to design 
therapeutics that are best able to penetrate and be retained within the cartilage matrix.  
 
Transport depends on solute size 
The framework in which we understand molecular transport in cartilage involves the 
movement of molecules of varying size through the network of pores in the tissue. We 
would expect solute size to have a significant impact on transport because of the 
tortuosity of the pores within cartilage as well as a small effective tissue pore size57. 
Based on theories of transport in porous media68–71, it is expected that diffusivity 
decreases for larger solutes. In particular, diffusivity should drop dramatically as solutes 
approach the size of the pores in the tissue. Examining the significant cohort of data that 
this field has generated over the past 50 years25,29,45–47,49–55,31,57,60–63,65,67,72–74,32,75,34,35,37–
40 demonstrates this inverse relationship between diffusivity and solute size across a 
broad range of solute radii (0.1 – 16 nm) and molecular weights (10 Da – 500 kDa) 
(Table 1). This cohort of data also shows that the relationship between molecular size 
and diffusivity is robust for all the measurement techniques described above. Further, 
such effects are similar across a variety of tissue species (human, bovine, equine) and 
developmental stages (neonatal to adult). Notably, linear molecules with flexible 
molecular structures (i.e. dextrans), which are commonly used as surrogates for 
macromolecules, exhibit higher diffusivities compared to similarly-sized spherical 
molecules (Table 1). 
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As with diffusivity, molecular size would be expected to influence the partition 
coefficient of solutes in cartilage32,68,76. Based on literature data, partition coefficients 
for both spherical and linear solutes decrease rapidly with solute hydrodynamic radius 
(rs) (Table 1). However, linear solutes consistently have higher partition coefficients 
than similarly-sized spherical solutes. With respect to partition coefficients and 
diffusivities, the disparity between spherical and linear solute data suggests that linear 
solutes exhibit fundamentally different transport mechanics in cartilage77. 
Table 1: Summary of solutes that have been used to examine transport in cartilage 
(data from references:25,29,45–47,49–55,31,57,60–63,65,67,72–74,32,75,34,35,37–40). 
Spherical 
Solutes 
Molecular 
Weight (Da) 
Hydrodynamic 
Radius (nm) 
Diffusivity 
(μm2/s) 
Partition 
Coefficient 
Small ions and 
sugars 
7 – 350 0.08 – 0.5 1200 – 180 1 – 0.9 
Peptides 140 – 760 0.3 – 0.7 500 – 120 ~ 0.75 
Radiocontrast 
agents 
500 – 1,500 0.6 – 1 200 – 90 ~ 0.5 
Growth factors 
and smaller 
proteins 
7,600 – 
80,000 
2 – 4.5 26 – 12 ~ 0.1 
Antibodies 
25,000 – 
200,000 
2.5 – 7.6 16 – 2 0.05 – 0.01 
Linear Solutes 
Molecular 
Weight (Da) 
Hydrodynamic 
Radius (nm) 
Diffusivity 
(μm2/s) 
Partition 
Coefficient 
Dextrans 
3,000 – 
500,000 
1.75 – 16 400 – 8 1.75 – 0.02 
Chondroitin 
sulfate 
~ 20,000 ~ 3.25 ~ 90 ~ 0.25 
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Based on common formulations used to predict transport in porous media68,70,71, 
diffusion of molecules greater than the effective pore size of the tissue should not be 
possible. However, there is evidence that even extremely large (> 200 kDa, rs > 7 nm) 
molecules diffuse through the dense cartilage matrix63,65. Such data is likely surprising, 
especially since the effective pore size of healthy articular cartilage is estimated to be 
about 6 nm 22. These data suggest that there is a hierarchal system of pores within 
cartilage. Because inter-GAG spacing is about 5 nm, this implies that these large 
molecules move around aggrecan molecules and through spaces between collagen 
fibrils, which are about 50 – 100 nm in size21,78 (FIG. 1). Such observations raise the 
possibility of even larger therapeutics being relevant to arthritis therapy. 
 
Spatially-dependent transport mechanics 
Above, we confirmed that solute size is highly dependent on both diffusivity and 
partition coefficient in cartilage tissue. While these relationships are very useful, it is 
important to note that not all solutes exhibit uniform diffusivities throughout the 
heterogeneous tissue, especially larger solutes.  
 
In general, small uncharged solutes (< 1 kDa, rs: 0.2 – 0.5 nm), such as glucose and urea, 
generally exhibit uniform diffusion kinetics throughout the tissue because their size is 
significantly smaller than the effective pore size within the tissue22. However, the local 
transport properties of larger molecules (> 3 kDa) are much more complicated. Leddy 
et al63 studied the effects of dextran size (3 kDa – 500 kDa) on local transport kinetics 
in cartilage by means of FRAP. The smallest (3 kDa, rs ~ 1.75 nm) and largest (500 kDa, 
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rs ~ 15.3 nm) dextrans had highest diffusivities in the surface zone and statistically 
similar diffusivities elsewhere. The 40 kDa (rs ~ 5.7 nm) and 70 kDa (rs ~ 7.4 nm) 
dextrans had the opposite trends; they had lowest diffusivities in the surface region and 
highest diffusivities in the middle and deep regions. This is consistent with another 
study65, where local diffusivities of various antibodies were highest just past the surface 
zone, within 150 μm – 350 μm, for solutes sized 25 (rs ~ 2.35 nm), 50 (rs ~ 3.25 nm), 
150 (rs ~ 5.45 nm), and 200 kDa (rs ~ 7.59 nm). These data support that sufficiently 
small and very large molecules diffuse fastest through the surface zone of the cartilage, 
whereas molecules between these molecular weights will diffuse fastest just past the 
articular surface. This reinforces that size-based thresholds exist within cartilage that 
can drastically affect diffusive behavior. 
 
Additionally, larger molecules can exhibit significantly different diffusive behaviors in 
terms of diffusional anisotropy. Leddy et al64 found that diffusivity along the primary 
collagen fiber orientation of a 500 kDa dextran molecule was about 1.5 times greater 
than perpendicular to the fiber direction. There was no such anisotropy apparent in the 
other zones of the cartilage or for a 3 kDa dextran. Thus, larger solutes are more readily 
affected by changes in composition and orientation of the collagen within the tissue.  
 
Solute size summary 
There is a strong inverse relationship between transport and solute size across a large 
range of solute radii (0.1 – 16 nm) and molecular weights (10 Da – 500 kDa) (Table 1). 
Ultimately, increasing solute size has a large negative impact on both diffusivity and 
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partition coefficient. In terms of local transport mechanics, large (> 3 kDa, rs > 1.75 nm) 
solutes are more likely to exhibit heterogeneous diffusion through the thickness of the 
tissue and are more likely to be diffusively hindered by the collagenous surface region 
of the cartilage. These data can inform the development of successful arthritis 
therapeutics. 
 
Increasing solute charge aids transport 
Cartilage tissue has a very strong net negative charge that increases near the underlying 
subchondral bone22,23. Because the negative charges within cartilage are fixed, the tissue 
acts as a selective membrane that obeys Donnan equilibrium79. Thus, solute charge 
sometimes has a large effect on transport throughout the tissue because of electrostatic 
interactions with the matrix. Solute charge is usually quantified using isoelectric 
focusing which determines the isoelectric point of a molecule (pI), the pH at which the 
molecule has no charge. 
 
A significant amount of research has been conducted on the transport of charged 
molecules in cartilage. Maroudas et al21 has shown that small cations, such as Na+ and 
K+, have partition coefficients 2 – 4 times higher, on average, than negatively charged 
ions, such as Cl- (K ~ 0.6). Partition coefficients of cations generally increase with 
higher tissue GAG content, while partition coefficients of anions generally decrease32. 
Consistently, Byun et al55 found that that the partition coefficient of a positively charged 
peptide inhibitor (~ 500 Da, pI ~11) was between 2 and 5. When GAGs were removed 
from the tissue with enzymatic degradation in this study, partition coefficients dropped 
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to about 1. On the other hand, diffusivity is not significantly dependent on solute charge 
for small charged molecules. 
 
Even large (> 10 kDa) positively charged molecules can utilize electrostatic interactions 
to increase partitioning into cartilage. Bajpayee et al61 has shown that neutrally charged 
(pI: 7) 66 kDa avidin had a partition coefficient of 0.5 and positively charged, 66 kDa 
avidin (pI: 10.5 and net charge: +20) had a partition coefficient of 6. However, these 
equally sized solutes had similar diffusivities, suggesting that solute charge does not 
play a significant role in macromolecular solute mobility. Additionally, retention of the 
positive avidin in cartilage was superior (> 40%) compared to the neutrally charged 
version. 
 
Notably, solute charge was shown to alter local diffusion mechanics for antibody 
molecules (150 kDa) within 125 – 300 μm from the articular surface of the cartilage75. 
In this region, a 5.9 pI antibody exhibited a 20% increase in diffusivity compared to that 
of a pI 4.7 molecule. This research supports that solute charge also influences local 
transport mechanics, which might not be apparent in bulk diffusivity measurements. 
 
Charge summary 
Increasing positive solute charge is associated with higher local diffusivities, and higher 
partition coefficients. Positively charged solutes also are retained in the cartilage tissue 
for longer periods of time. Thus, relying on reversible binding of positively charged 
solutes can be used to increase effectiveness of future drug therapies. These effects are 
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ultimately linked to strong electrostatic interactions between the solute and the 
negatively charged cartilage matrix.  
 
Solute shape changes transport behavior 
Larger molecules can exhibit different shapes that can affect mobility in porous tissues. 
Solutes such as glucose and antibodies, are generally spherical in shape80. Some solutes, 
such as dextran, consist of long sugar chains that contribute to a more linear (and 
intrinsically more flexible) molecular structure80. This flexibility allows these solutes to 
change their conformation as they diffuse through a porous medium to an ellipsoidal 
conformation (i.e. a random coil) or a flexible chain conformation (reptational 
behavior)80,81. To date, very few studies have investigated the effects of solute shape in 
cartilage, but there are several models that describe diffusion in other porous media77,82–
87. These models predict the diffusivity of the linear molecule based its size relative to 
the pores of the media through which it is diffusing81,88.  
 
Several studies have directly compared transport of linear and spherical molecules in 
porous media. Using FRAP, Pluen et al82 demonstrated that flexible macromolecules 
(DNA chains) better diffused through agarose gels compared to similarly-sized rigid 
molecules (polymer beads). Across the literature, flexible molecules exhibited 20 – 30% 
greater diffusivity than their spherical molecule counterparts in various gels82,89. This is 
likely because flexible molecules can change conformation while moving through the 
tortuous pore network, while their generally rigid, spherical counterparts cannot. This 
behavior also explains why partition coefficients of these molecules are generally higher 
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than spherical solutes90,91. Although these studies were done in gels, the trends are 
accurate for cartilage as well (Table 1). Ultimately, linear molecules are likely not good 
predictors of transport characteristics of similarly-sized proteins or small molecules. 
 
Cartilage composition alters transport 
Several studies have demonstrated that the local and bulk composition of cartilage 
(which can change with animal species and age) can affect solute transport46,51,62–65,92. 
In one study, Evans et al 92 investigated several such relationships by correlating solute 
diffusivities to several cartilage tissue properties. GAG weight fraction was negatively 
correlated with solute diffusivities of various 500 Da fluorophores and 10 kDa dextran. 
Additionally, these diffusivities were positively correlated to fluid volume fraction. 
Another accurate predictor of solute diffusivity is tissue permeability32, a metric that is 
closely tied to the above tissue properties. Such a relationship between permeability and 
diffusivity exists because both depend on friction inside the tissue pores as well as the 
cartilage tortuosity32.  
 
The relationship between composition and solute diffusivity becomes more complicated 
when considering local diffusion mechanics. Because cartilage has a depth dependent 
permeability and water content25, intuition suggests that solutes should diffuse fastest 
near the surface and slowest deeper towards the subchondral bone. This trend is 
generally true, but some very large solutes have lowest diffusivities near the surface63,65. 
This deviation is likely caused from hindrance of these large molecules diffusing 
perpendicularly to the highly aligned collagen in this zone64. Additionally, some larger 
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(> 1 kDa) solutes exhibit depth-dependent32 partition coefficients which are 
proportional to tissue permeability21,46. Ultimately, the heterogeneity of cartilage 
influences local diffusion and partitioning of larger solutes (> 1 kDa) to a greater degree 
than smaller ones.  
 
Diseased or damaged tissue can drastically affect tissue properties and therefore have 
significant effects imposed on transport50,93,94. Torzilli et al45 demonstrated the effects 
of degrading GAGs on the diffusivities of three uncharged solutes of different molecular 
sizes (glucose, inulin, and dextran). After degradation, diffusivities of both inulin and 
dextran increased by about 2-fold, but there was no such change in diffusivity for the 
smaller glucose molecule. It is thought that removing GAGs from the tissue increases 
diffusivities of these larger molecules because it drastically increases the effective pore 
size of the tissue. These results further support that the composition of the cartilage has 
a greater effect on larger molecules.  
 
Cartilage composition summary 
The heterogeneities of cartilage can drastically affect solute transport properties. 
Ultimately, transport is fastest where the matrix density and FCD of the tissue is lowest 
(i.e. near the surface). However, larger solutes can deviate from these expected relations 
and are more readily influenced by these heterogeneities. Further study into the 
relationship between compositional heterogeneities and transport can enable therapies 
that are targeted to specific regions of the cartilage structure. 
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Physiologic loading increases transport 
Convection of solutes occurs via fluid flows that are induced by cyclic mechanical 
loading or sliding95, which can enhance transport of some solutes. These flows induce 
frictional interactions between the solvent, solute, and matrix96,97. How far fluid moves 
inside of cartilage during a loading cycle and overall fluid velocity depends heavily on 
the loading frequency and loading amplitude applied, because of the poroelastic nature 
of cartilage22. In general, increasing loading amplitude and frequency increases fluid 
velocity but decreases fluid penetration depth22,62. Both factors influence local and bulk 
transport kinetics within cartilage29,62,65,98. In some cases, the calculation of the Peclet 
number can quantify what impact convective and diffusive contributions have in an 
experimental system with applied loading58. 
 
Many studies have investigated the effects of various loading conditions (0.01 Hz - 3 
Hz, 0.1 - 10% amplitude) on solute transport29,42,100–104,48,58,59,62,65,73,98,99. Ultimately, 
transport contributions from convection for smaller solutes (< 1 kDa, 1 nm) are 
relatively small (< 50%), because diffusion of these molecules occurs quickly. For 
instance, Evans et al58,98 investigated the effects of cyclic loading on a relatively small 
(~ 400 Da) glucose-like molecule over a range of amplitudes and frequencies (5 – 50%, 
0.0006 – 0.1 Hz). They demonstrated that loading with 10% or 20% cyclic amplitude at 
0.1 Hz augmented desorption kinetics (< 50%), but other loading conditions produced 
minimal effects.  
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Convection has been shown to have a much greater effect (> 100%) on solutes that are 
large (> 1 kDa)29,31,48,62,65,73,98. For instance, loading cartilage disks at 10% cyclic strain 
at 0.2 Hz led to dramatic enhancement of partition coefficients of variously-sized 
molecules (400 Da – 70 kDa)29. These enhancements were greater in larger molecules 
than in smaller ones (i.e. 9 for 70 kDa dextran, 2.5 for 3 kDa dextran, but no 
enhancement for fluorescein). In another study, convective contributions from cyclic 
loading for a 150 kDa antibody were found to be maximal at 1 Hz and 5% cyclic strain, 
for a variety of cartilage tissue obtained from different animal species62. In this study, 
bulk solute transport in the radial direction in loaded samples was 2-3 times higher than 
transport in passive samples. Additionally, areas of local transport enhancement were 
highest near the sample periphery (and near the articular surface65), where fluid velocity 
was highest. These data support the idea that obtaining the best combination of fluid 
velocity and fluid penetration depth is important to maximizing solute transport 
enhancement62.  
 
On the other hand, static compression without a cyclic component, has been shown to 
decrease both diffusivities and partition coefficients of solutes, regardless of solute size 
or molecular weight46,47,92. Additionally, both transport metrics are inversely related to 
the amount of static compression applied to the sample46,47,92. Static compression 
effectively increases the density of cartilage and decreases effective pore size, leading 
to slower transport mechanics, especially for larger solutes.  
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Convective transport summary 
Cyclic mechanical loading of cartilage leads to a significant enhancement (up to 10-
fold) of solute transport at physiologic strain amplitudes (1 – 10%) and frequencies (0.1 
– 1 Hz). These enhancements from convection and mechanical loading are greater for 
larger solutes. However, static compression of cartilage leads to a slowing of transport 
kinetics. These data support that joint movement is very important for sufficient 
penetration of arthritis therapeutics in vivo. 
Solute transport considerations in vivo 
The solute, cartilage, and external transport factors discussed thus far have been shown 
to translate accurately to more clinically relevant preclinical and animal models44,105–
110. Magnetic resonance imaging (MRI) techniques have also been used in several 
prominent human and animal models involving transport of nutrients and growth factors 
within the joint space34,37,111,112. However, when solutes are introduced to the joint space 
in vivo, several new transport factors come into play. Two of the most critically 
important factors in vivo are solute residence time within the joint space and solute 
retention within the cartilage. This section aims to briefly summarize how solute-
specific variables affect these factors. 
 
The joint ultrastructure allows the body to effectively replace the synovial fluid that 
lubricates and hydrates the cartilage tissue several times per day, which is important for 
joint health113. The joint space is surrounded by the highly vascularized synovial 
membrane, which includes wide intercellular gaps, no basement membrane, and a 
highly efficient lymphatic drainage system113. Additionally, inflammation of the 
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synovium in OA and RA increases the permeability of this membrane113. Thus, in most 
instances, the synovial membrane is extremely permeable to most solutes. Because of 
this inherent permeability, it is difficult to maintain clinically relevant and efficacious 
concentrations of therapeutics in the joint space for extended periods of time1,113. 
 
Concentrations of therapeutic solutes within the joint space have residence times 
ranging from 1-48 hours, depending on several key factors, the most important of which 
is solute size1,114,115. Corticosteroids and orally administered anti-inflammatory drugs 
(< 700 Da) that are clinically used to treat pain and inflammation in arthritic joints have 
been estimated to have a mean joint residence time of around 1-3 hours1,2,115. Larger 
molecules, such as albumin (66 kDa) and hyaluronic acid (> 1 MDa) have joint 
residence times of about 11 and 24 hours, respectively2. Even though these larger 
molecules have higher residence times in the joint, larger molecules typically have 
lower concentration ratios between blood serum and synovial fluid, necessitating intra-
articular injections to obtain clinically-relevant concentration levels1. Furthermore, 
larger solutes unfortunately have much slower transport kinetics in cartilage, which 
makes obtaining efficacious amounts of the drug within the tissue difficult. 
 
There are several ways to increase solute residence times. One way is to develop highly 
positively-charged solutes that would either irreversibly or reversibly bind to the 
cartilage matrix113. Another strategy is to incorporate the drug within microspheres of 
sufficient size (often several μm in diameter)1,116. These microspheres act as drug 
carriers and slowly release the drug into the joint space as they are degraded by 
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naturally-occurring enzymes. Research supports that microspheres or solutes larger than 
200 nm cannot easily be removed from the joint space and therefore have very long 
residence times (≥ 48 hours)113,116,117. However, even the biggest microspheres are 
eventually phagocytosed and removed by native macrophages in the synovial fluid. 
 
As cartilage tissue degrades, as in many joint diseases, the composition and structure of 
the tissue changes118,119. These changes include removal of GAGs and an eventual 
disruption of the collagen orientation at the articular surface119,120. These changes have 
implications for transport of therapeutics. It is likely, especially with larger therapeutics, 
that these cartilage changes will cause faster transport mechanics and enable a higher 
concentration of solutes within the cartilage tissue45,121. However, this increased tissue 
permeability may lead to shorter solute retention times within the tissue, which may 
negatively affect therapeutic efficacy. Given these challenges, there are competing 
interests when developing arthritic therapeutics. Thus, it is likely that researchers will 
need to consider many factors when designing and applying new therapies so that 
penetration into the cartilage tissue and retention within the joint space are optimized. 
Future directions 
Many decades of work in this field has led to a much greater understanding of transport 
in cartilage. However, several significant questions remain. Why more flexible, linear 
molecules diffuse through cartilage tissue at a higher rate compared to more spherical 
molecules is unclear. Despite having large frictional forces exerted on them by pore 
walls, it is possible that linear molecules make up for this by being able to diffuse into 
smaller pores than more rigid molecules. While further understanding the diffusion 
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mechanics of linear solutes in cartilage would be helpful, it is important to understand 
that the diffusivities measured for such molecules are poor predictors of comparably-
sized proteins. 
 
Even solutes larger than the effective pore size of cartilage can diffuse through the entire 
depth of the tissue. This raises some interesting opportunities for macromolecular 
therapeutic design. For instance, nanoparticles (rs ≥ 3 nm) have been used to deliver 
customizable effects to cancer cells122, but these particles have never been used to target 
cartilage chondrocytes directly. Likewise, delivery of antibodies using microspheres 
and delivery of large (rs ~ 25 nm) viral vectors to modify diseased chondrocytes remains 
unstudied for arthritis therapy1,116. Even though these macromolecules would diffuse 
slowly through cartilage, they could be modified to maximize joint residence times, 
which could make their development more feasible.  
 
Currently, few studies45,50,93,94 address solute transport in light of cartilage degradation 
or damage. There is also relatively little known64,65,67,123 on how local composition 
affects local solute transport in both healthy and degraded cartilage tissue. We argue 
that developing a robust relationship or transport model for predicting solute 
diffusivities as a function of cartilage composition (both locally, and bulk) would be 
very helpful and hold great clinical significance. If combined with non-invasive imaging 
techniques (i.e. MRI) to estimate cartilage composition, this transport relationship could 
enable patient-specific tailoring of therapeutics, and likely lead to increased treatment 
success. 
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Conclusion 
Even though cartilage tissue is avascular, transport of solutes through this porous tissue 
is multi-faceted. The intrinsic heterogeneities of the tissue, such as collagen orientation 
and composition, drive solute transport mechanics that can be spatially-dependent and 
change significantly with solute properties. When joint homeostasis is disrupted, either 
by injury or genetic factors, this can often lead to long-term degradation of the joint 
space. Use of cartilage-targeted therapeutics to help restore joint homeostasis is under 
investigation, and understanding how such molecules diffuse into cartilage is critical for 
successful implementation. Ultimately, solute size is an excellent predictor of transport, 
and even solutes larger than the effective pore size can diffuse into the tissue. 
Additionally, altering solute shape or charge, and applying physiologic loading 
conditions to cartilage can be used to predictably augment transport of therapeutics into 
cartilage. This knowledge further enables researchers and clinicians to optimize kinetics 
of arthritis therapeutics into articular cartilage. 
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CHAPTER 2 
Cyclic Mechanical Loading Enhances Transport of Antibodies into Articular 
Cartilage2 
Abstract 
The goal of this study was to characterize antibody penetration through cartilage tissue under 
mechanical loading. Mechanical stimulation aids in the penetration of some proteins, but this 
effect has not been characterized molecules such as antibodies (> 100 kDa), which may hold 
some clinical value for treating osteoarthritis. For each experiment, fresh articular cartilage 
plugs were obtained and exposed to fluorescently labeled antibodies while under cyclic 
mechanical load in unconfined compression for several hours. Penetration of these antibodies 
was quantified using confocal microscopy and finite element simulations were conducted to 
predict fluid flow patterns within loaded samples. Transport enhancement followed a linear 
trend with strain amplitude (0.25% to 5%) and a non-linear trend with frequency (0.25-2.60 Hz), 
with maximum enhancement found to be at 5% cyclic strain and 1 Hz, respectively. Regions of 
highest enhancement of transport within the tissue were associated with the regions of highest 
interstitial fluid velocity, as predicted from finite element simulations. Overall, cyclic 
compression enhanced antibody transport by 2 to 3-fold. To our knowledge, this is the first study 
to test how mechanical stimulation affects the diffusion of antibodies in cartilage and suggest 
further study into other important factors regarding macromolecular transport. 
 
 
2C. DiDomenico, Z. X. Wang, and L. J. Bonassar, “Cyclic Mechanical Loading 
Enhances Transport of Antibodies into Articular Cartilage,” J. Biomech. Eng., vol. 
139, no. 1, pp. 11012-11012–7, 2016. 
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Introduction 
Both rheumatoid arthritis (RA) and osteoarthritis (OA) are thought to be initiated by the 
release of inflammatory cytokines that degrade and inflame the joint tissues 1,2. 
Inhibition of these inflammatory pathways has been of great interest as a therapeutic 
strategy for disease treatment for RA. Antibody based strategies inhibiting tumor 
necrosis factor-α (TNF-α), have proven especially effective at reducing both the 
symptoms of RA and associated joint degeneration. Interestingly, TNF-α is also known 
to play a role in OA 3, and there is interest in determining whether such RA antibody-
based approaches would also be effective in treating OA. 
 
Pathophysiologically, RA and OA are very different. Primary contributors of 
inflammation and degradation are found in different joint tissues in both diseases. In 
RA, the synoviocytes in the well-vascularized synovial lining surrounding the joint 
capsule are the main contributors to the release of inflammatory cytokines that infiltrate 
the synovial fluid, cartilage, and surrounding bone 4,5. Consequently, intravenous 
injection of antibodies easily reaches the source of inflammation and greatly reduces 
the activity of inflammatory factors, significantly decreasing future degradation and 
joint pain. However, in OA, chondrocytes located in the avascular articular cartilage 
produce a significant amount of these inflammatory cytokines, and are thus are a more 
challenging target for therapy 2,3. Therapeutics, especially smaller ones, injected directly 
into the joint have relatively short intra-articular half-lives (ranging from 1 hour for 
aspirin [180 Da] to several hours for albumin [66 kDa]), which may be another 
important consideration for future OA therapy 6–8.  
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A main factor limiting the potential utility of antibody-based approaches for OA 
treatment is the limited ability of such large molecules (molecular weight [MW] > 100 
kDa) to penetrate the dense avascular cartilage extracellular matrix, with pore sizes as 
low as 10 nm 9. Other factors, such as the high fixed charge density of the tissue may 
also limit macromolecular transport through phenomena such charge-meditated 
partitioning and binding 10.  However, it has been shown that convective fluid flows, 
such as those induced by mechanical loading, can enhance transport of macromolecules 
into cartilage, including relatively large molecules such as TIMP-1 (MW: 23 kDa), 
albumin (MW: 66 kDa), IGF-I (MW: 7.6 kDa), and transferrin (MW: 80 kDa) 11–14. 
These studies have demonstrated that the magnitude of convective enhancement of 
transport increases with the size of the solute of interest, giving credence to the idea that 
such methods could be used to enhance the transport of very large, complex molecules 
such as antibodies. This loading-based enhancement has also been shown that physical 
activity can enhance the uptake of smaller molecules such as MRI contrast agents into 
cartilage 15. However, it has never been explored whether loading-induced compressive 
flows can enhance the transport of antibodies into cartilage.  
 
Therefore, the goal of this study is to investigate the use of cyclic mechanical loading 
to enhance the transport of antibodies into cartilage tissue. Specifically, we investigate 
how transport due to cyclic compression changes with frequency and amplitude of 
loading and the extent to which regions of enhanced transport in the tissue correlate with 
regions of enhanced fluid flow.  
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Methods 
Cartilage Harvest and Preparation 
For each experiment, fresh, full-thickness cylindrical articular cartilage plugs (n = 12-
24) were harvested using biopsy punches under sterile conditions from one of three 
tissue sources to be compared: patellofemoral groove (PFG) of 1-3 day old bovids (~25 
experiments from ~20 different animals) (Gold Medal Packing, Rome, NY); PFG 
cartilage from skeletally mature equines (6 experiments from 2 different animals) 
(Cornell Veterinary School, Ithaca, NY); or hock joint cartilage from skeletally mature 
bovids (2 experiment from 1 animal) (Articular Engineering, Northbrook, IL). For all 
sources, samples were randomly distributed to experimental groups based on location 
within the joint to prevent tissue composition variation skewing experimental results. 
For all tissue, all plugs had the articular surface intact and were sliced to be nominally 
1.15 mm thick and 4 mm diameter, except for the mature bovine cartilage (0.5 mm 
thick). Superficial, middle, and deep zones were represented in all samples tested. These 
plugs were randomly assigned to two different groups (loaded and passive) and were 
placed into individual wells in 24-well plates with the articular surface facing upwards. 
An impermeable platen array was placed on top of each well plate, applying a 15% axial 
strain to all samples, to keep samples in place and to combat the effects of swelling and 
limit diffusion in the axial direction. For each well, 350 μl of fluorescently labeled 
(Alexa Fluor 633) goat-anti-mouse antibodies (MW: 150 kDa) (Life Technologies, 
Grand Island, NY) at a concentration of ~1 μM (50 μg/ml) in PBS (Corning, NY) was 
added. With this setup, only the outside cylindrical (radial) surface was exposed to the 
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antibody solution. Both mature and immature animals were chosen so that one could 
determine if experimental trends differed between young and mature tissue. 
 
Mechanical Compression 
Each group was placed into a 37°C incubator where the loaded group underwent 
unconfined cyclic axial compression with a custom-built, displacement-controlled 
bioreactor that maintained sterile conditions, as described previously 16. On top of the 
15% axial offset, singular sinusoidal strain amplitudes (0.25%, 1.25%, 2.5%, or 5.0%) 
were applied to the loaded samples at a singular frequency (0.25 Hz, 0.5 Hz, 1 Hz, 1.7 
Hz, or 2.6 Hz) for 3-4 hours. The passive group served as a control, with only a 15% 
offset strain. Through preliminary experiments, diffusive resistance from any stagnant 
film layer that may have formed on the passive group samples during testing was 
insignificant, which is consistent with literature regarding samples of similar size 17. 
 
Transport Analysis 
After loading, all plugs were bisected axially and the cut surface on one half was 
assessed on an inverted confocal microscope stage (LSM 510, Zeiss, Oberkochen, 
Germany) to characterize the radial antibody penetration (Figure 1). Laser power (λ: 
635 nm, ~15 mW) was set so that the total fluorescence intensity of the 8-bit image was 
roughly Gaussian and so that no pixels were saturated (pixel dwell time: ~0.5 ms). The 
pinhole was set to obtain a representative 30 μm thickness for each sample with a spatial 
resolution of 1.35 μm/pixel. A 10x objective with a numerical aperture of 0.3 (Zeiss, 
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Oberkochen, Germany) and a working distance of about 3 mm was used for all samples. 
A total of 12 tiles were taken to fully capture the sample under these imaging conditions. 
 
 
Figure 3: Schematic of experimental procedure. The left shows the experimental setup 
of an individual well and the right shows a radial fluorescence profile of an individual 
sample. Cylindrical samples are bisected and that cut surface is imaged under the 
confocal microscope. Only the middle 50% of the sample is shown in the confocal 
image. 
 
Radial penetration was defined as diffusion perpendicular to the circumferential surface 
of the plug that was in contact with the antibody bath. Experiments focused on radial 
penetration because permeability is more homogeneous in that direction (when 
compared to through the articular surface) and this allowed better control of the loading 
conditions 18. However, using the procedure described below, passive axial penetration 
through the articular surface was examined to understand the directional dependence of 
diffusion through cartilage in different species in the free-swelling condition. 
 
This experiment was modeled as 1D radial diffusion, under the assumption that 
antibodies only penetrated radially into the sample’s exposed cylindrical surface. 
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Background fluorescence was calculated from a 1000 μm2 area sufficiently far away 
from the sample and subtracted from the sample fluorescence. Although minimal at this 
wavelength and laser power, autofluorescence of each sample was calculated from a 
1000 μm2 area in the middle of the sample (where no solute was found on the time scale 
of the experiment) and subtracted from the total sample fluorescence. For all samples, 
column-wise pixel averages of the sample image data were obtained. These summations 
were constrained to the middle 50% of the sample to avoid edge effects from the bottom 
and top of the sample. Limiting to the middle of the sample also helped avoid any 
transport artifacts if the loading platen did not maintain contact with the sample 
throughout the loading cycle. Then, average fluorescence intensity profiles, from both 
radial edges of the cut surface to the center, were fitted to a radial 1D diffusion 
membrane absorption model derived from Fick’s 2nd law 19: 
 
where C is the solute concentration in the tissue, C0
 and C1
 are the initial concentrations 
of the tissue and bath, respectively, D is the solute diffusivity, t is the time exposed to 
the solute, a is the distance from the radial edge of the sample to the middle of the plug, 
Jm is the Bessel function of order zero or one, αn is the nth root of the Bessel function of 
order zero or one, and r is the distance from the radial edge of the sample. In these 
experiments, C0 was assumed to be 0 and C1 was the concentration of the bath. The 
solute fluorescence/concentration relationship was found by taking different dilutions 
of the solute and observing them under a confocal microscope (LSM 510, Zeiss, 
Oberkochen, Germany). The fluorescence of the antibody was found to be linearly 
𝐶 − 𝐶0
𝐶1− 𝐶0
= 1 −
2
𝑎
∑
𝑒(−𝐷𝛼𝑛
2𝑡)𝐽0(𝑟𝛼𝑛)
𝛼𝑛𝐽1(𝑎𝛼𝑛)
∞
𝑛=1           (1) 
 47 
 
correlated (R2 > 0.95) to solute concentration in the range of dilute concentrations (1-2 
μM) used for these experiments (data not shown), and thus fluorescence values was 
substituted for concentration values into Eq. 1, without affecting the initially unknown 
variable of interest, D. After normalizing the fluorescence curves to the maximum value, 
the above equation was fit to the fluorescence profile data and diffusivities that resulted 
in the lowest root-mean-squared (RMS) error for the entire curve fit were used for each 
sample. The diffusivities from each radial edge of a sample were averaged together to 
obtain the final measurement. 
 
Because it took approximately 15-30 minutes to remove and image all of the samples, 
a test was conducted to verify that experiments were long enough to negate any potential 
artifacts of additional sample diffusion during sample preparation and imaging. It was 
determined that passive diffusivities (Dp) were insensitive to bath exposure time for 
experiments that lasted longer than 2 hours (Figure S1) and as such, all further studies 
focused on times greater than 2 hours.  
 
Eq. 1 is a simplification of the solution to the advection-diffusion equation, and all 
convective effects are captured by the variable Deff, the “effective” diffusivity 20–22. 
Because direct sample pairing was not possible for this study, for every experiment, 
each effective diffusivity was divided by the average experimental Dp, then further 
averaged 23 to obtain an average “transport enhancement” for every loaded sample 
(defined as Deff/Dp). 
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Local Diffusivity Analysis 
Once an average diffusivity was obtained for a sample, fluorescence profile data were 
broken down into discrete “layers” (25 μm segments from 0-300 μm from the radial 
edge; 200 μm segments thereafter, for a total of 20 layers). Using a RMS error 
minimization procedure for each layer (assuming continuity between layers, and 
implementing boundary conditions and geometry used from Eq. 1), fluorescence data 
within that particular layer was analyzed with a transient radial 1D multi-layer diffusion 
model adapted from Carr et al 24, enabling the calculation of local diffusivities within a 
sample (either Dp or Deff) at t = 3-4 hours (Figure S2). Collectively, these calculations 
enabled the determination of radial diffusivity functions, and radially dependent 
diffusivities of loaded samples (Deff(r)) were compared across experiments to passive 
controls (Dp(r)) to obtain information about how transport enhancement of the solute 
changed throughout the radial depth of the tissue.  
 
FE Modeling 
Finite element modeling was performed to obtain predictions of the fluid flow patterns 
throughout cartilage plug under cyclic loading using a biphasic model in FEBio 25. 
Assuming a neo-Hookean solid (solid volume fraction = 0.2, modulus = 0.7 MPa, 
Poisson ratio = 0.2) with Holmes-Mow permeability (P0 = 1 x 10
-14 m4/Ns, M = 1.5, α 
= 2) throughout the entire plug (made of ~100 rectangular prism elements), maximum 
fluid velocity profiles in the radial direction were obtained for various bouts of loading 
of the plug (diameter=4 mm, thickness=1.15 mm) in unconfined compression 26. At 
steady state conditions (achieved on the order of 10 minutes), velocity profiles were 
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obtained for 5%, 2.5%, and 1.25% sinusoidal amplitude at 1 Hz, as well as 2.5% 
sinusoidal amplitude at 0.25 Hz and 2.6 Hz.  In all cases, waveforms were superimposed 
on a 15% static compression with constant exterior fluid pressure 26. Although 
previously shown for other loading conditions 27, this model was used to investigate 
how fluid velocity changed as a function of radial depth for the loading conditions used 
in this study. The results of these models were then compared to experimental 
measurements of the radial profile of local transport enhancement. 
 
Solute Characterization 
Before experiments were conducted, size exclusion chromatography (SEC) (Agilent 
1200 HPLC, GE Healthcare, Pittsburgh, PA, US) was used to determine that the 
conjugated goat-anti-mouse antibodies were not aggregating in solution on the time 
scale of the experiments (> 91% monomer). Additionally, high performance liquid 
chromatography with fluorescence detection (HPLC-FLD) (Agilent 1200 HPLC, GE 
Healthcare, Pittsburgh, PA, US) confirmed that there were non-detectable amounts of 
free conjugate (Alexa Fluor 633 label) in the conjugated antibody solution before 
experiments were conducted.  
 
Statistical Analysis 
For each strain amplitude and applied frequency, a one-way ANOVA was performed to 
determine the effect of mechanical loading, with subsequent Tukey post-hoc tests for 
pairwise comparisons. This method was also performed to determine where samples 
exhibited local transport enhancement and differences between radial and axial 
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diffusivities and species. Additionally, the effect of loading amplitude on transport 
enhancement and the relationship between fluid velocity and transport enhancement 
were assessed by linear regression analysis. An ANCOVA determined any differences 
between transport enhancement correlations for different cartilage species as well as 
differences between correlations for different loading conditions. 
 
Results 
The one-dimensional Fickian diffusion relationship fit well to both the loaded and 
passive radial fluorescence curves (R2 > 0.95, coefficient of variance < 15%) (Figure 
2). Low residual error between this model and data from loaded sample indicated that 
convective and diffusive contributions can be combined into an “effective diffusivity,” 
(Deff) a term used previously in other studies 
20–22. For example, in neonatal bovine 
tissue, 5% dynamic strain at 1 Hz for 3 hours resulted in Deff = 10 x 10
-8 cm2/s, a 2.4-
fold increase over passive diffusion. Under free-swelling conditions, axial penetration 
of antibodies (through the articular surface) was higher than radial penetration for all 
species (Figure S3). 
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Figure 4: Normalized fluorescence intensity vs radial depth from the sample edge for a 
representative middle portion of loaded and passive sample exposed to the antibody 
solution for 3 hours. The loaded sample was exposed to loading at 5% cyclic strain at 1 
Hz. Solid lines denote a radial 1D diffusion curve derived from Fick’s 2nd law, while 
dotted lines denote experimental data. Diffusivities and goodness of fits from each 
sample are shown. 
 
Increasing the strain amplitude of the applied loading at 1 Hz significantly increased 
radial antibody transport into cartilage, with enhancement up to 2.4 at 5% strain (Figure 
3).  For passive samples, Dp ranged from 2.8 to 6.0 × 10
-8 cm2/s, while Deff for 1 Hz (≥ 
1.25% strain) loaded samples ranged from 6.8 to 15.4 × 10-8 cm2/s. The convective 
transport enhancement (at 1 Hz) were linearly related to strain amplitude for both mature 
equine and neonatal bovine tissue (R2 > 0.92, p < 0.05) and these correlations were 
determined not to be statistically different from one another (p = 0.11). Due to tissue 
thinness, adult bovine tissue was not tested under loading. 
 
 
 52 
 
 
Figure 5: Transport enhancement vs. strain amplitude at 1 Hz (A) and transport 
enhancement vs. loading frequency at 2.5% strain (B). Enhancement was found to be 
linearly correlated with strain amplitude (at 1 Hz) for both neonatal bovine tissue (slope: 
0.30) and mature equine tissue (slope: 0.24) (R2 > 0.93). The two correlations were 
forced to have an intercept of 1 and were not statistically different from one another (p 
= 0.11). All strain amplitudes were statistically different from a value of one (p < 0.05), 
except for 0.25% strain. The maximum enhancement was found to be at 1 Hz. All 
loading frequencies were statistically different from a value of one (p < 0.05), except 
for 0.25 Hz. 
 
The relationship between transport enhancement and applied loading frequency showed 
a non-linear trend at a strain amplitude of 2.5% (Figure 3). Transport enhancements 
were significantly higher than 1 (p < 0.05), except for the loading frequency of 0.25 Hz, 
which showed no enhancement. The maximum transport enhancement was 1.9 at 1 Hz. 
The average transport enhancement at the highest frequency tested (2.6 Hz) was 1.2. 
 
To understand the relationship between fluid flow and local transport enhancement, 
simulations were performed to map the radial profiles of fluid flow during compression 
and further data analysis was performed to map the regions of transport enhancement in 
 
 
A B 
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cartilage samples. Fluid flow predictions from FE simulations of samples loaded at 1 
Hz showed regions of high fluid flow near the radial edges of samples, where the 
normalized radius (r/r0) is close to 1 (Figure 4). Increasing strain amplitude increased 
the predicted maximal fluid velocity at the radial edge of cartilage samples from ~3.5 
µm/s at 1.25% to ~7 µm/s at 5%. For simulations of all amplitudes, fluid exchange was 
confined to the outer 15% of the sample. Simulations also showed that changing the 
frequency at 2.5% strain increased fluid maximum fluid velocity from <2 µm/s at 0.25 
Hz to ~7 µm/s at 2.6 Hz. Changing the frequency of stimulation also had a great effect 
on the region of the tissue in which fluid exchange occurred.  At 2.6 Hz, fluid maximal 
fluid velocity dropped to 0 within 10% of the radius of the tissue, compared to 30% 
penetration at 0.25 Hz loading. 
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Figure 6: Predicted fluid velocities for different strains at 1 Hz (A) and frequencies at 
2.5% cyclic strain (B) vs. radial depth into the tissue. Experimental local transport 
enhancement from neonatal cartilage experiments for different strains at 1 Hz (C) and 
frequencies at 2.5% strain (D). A normalized radius of 1 corresponds to the sample 
radial edge. Local diffusivity curves closely followed the curvature of fluid velocity 
profiles. The highest transport enhancement was found near the edge, near areas of 
highest fluid flow. Normalized radii of at least 0.925, 0.875, and 0.900 correspond to 
enhancements greater than 1 for 1.25% 2.5%, and 5.0%, respectively (p < 0.05, 
ANOVA). Normalized radii of at least 0.8750, 0.8750, and 0.9375 correspond to 
enhancements greater than 1 for 0.25 Hz, 1 Hz, and 2.6 Hz, respectively (p < 0.05, 
ANOVA). All fluid velocity profiles were obtained at steady state conditions (occurred 
within 10 minutes).  
 
Fitting Eq. 1 to discrete regions of the fluorescence curves of loaded and unloaded 
samples enabled the calculation of Dp(r), Deff(r), and (Deff/Dp)(r) (Figure 4). Local 
diffusion curve fits had and average R2 > 80% and an average coefficient of variance of 
< 20%. This analysis revealed that transport enhancement was also confined to a narrow 
region of the tissue near the radial edge, with spatial patterns of enhancement varying 
with amplitude and frequency of loading.  For loading at 1 Hz, transport enhancement 
at the radial edge was as high as ~8 at 5% amplitude and ~4 at 1.25% amplitude, and in 
all cases there was no enhancement (i.e. Deff/Dp = 1) 15% in from the radial edge of the 
tissue.  For loading at 2.5% amplitude, transport enhancement at the radial edge was as 
high as 9 at 2.6 Hz and 2.5 at 0.25 Hz.  At 2.6 Hz, the region of transport enhancement 
penetrated about 8% from the radial edge, while at 0.25 Hz, Deff/Dp remained as high at 
1.15 at 25% from the radial edge. 
 
Discrete radial regions of highest enhancement and fluid flow from neonatal 
experiments were found near the sample radial edge (Figure 4). The regions of tissue 
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with highest enhancement transport (i.e. r/r0 > 0.9) were the same as those with highest 
predicted fluid velocity. Linear regression found a positive relationship between 
transport enhancement and maximum fluid velocities predicted by the FE models (R2 = 
0.85, p < 0.001) (Figure 5). 
 
Figure 7: Correlative plot of enhancement ratio and maximum fluid velocity for various 
loading conditions that were previously analyzed. The best fit line is forced to have an 
intercept of 1; the correlation was statistically significant (p < 0.001). Artifacts from lift-
off could have caused transport enhancements from higher loading amplitudes (5%) and 
frequencies (2.6 Hz) to have data points higher than expected. However, correlations 
between individual loading regimes were not significantly different from one another.  
Discussion 
The objective of this study was to investigate the role of mechanical loading on the 
transport of antibodies into articular cartilage in vitro 28. This study showed that cyclic 
mechanical loading enhanced antibody transport up to 2.4-fold for the whole sample 
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and up to 8-fold locally in regions of high fluid flow near the radial edge. This 2.4-fold 
enhancement led to loaded samples having approximately 200 μm deeper penetration 
when the fluorescence (and thus, concentration) was half of the maximum for a given 
loaded and passive sample. Additionally, at a radial depth of 500 μm, loaded samples 
had approximately two to three-fold greater concentration of antibodies compared to 
passive samples. Given the molecular weight (MW: 150 kDa) and hydrodynamic radius 
(~5.29 nm 29) of the antibody used, the obtained average passive diffusivity (~4 × 10-8 
cm2/s) is consistent with literature values and with the idea that diffusivity is inversely 
proportional to solute molecular weight and size 10,29,30. Additionally, it has been shown 
that mechanically aided transport with similar loading for molecules such as IGF-I 
(MW: 7.6 kDa) had enhanced transport by a factor of two over passive controls 13, which 
is consistent with the level of enhancement noted here.  
 
The novel technique used in these experiments enabled the determination of both local 
and global diffusivities of a fluorescent antibody within articular cartilage. This method 
allows more information to be drawn from a solute of interest, and does not rely on the 
system reaching equilibrium, such as in other studies 31,32. To date, local diffusivities of 
solutes in cartilage have not been examined extensively and could be important to 
understand how some solutes move through complex, heterogeneous physiological 
tissues, such as cartilage and tendon.  
 
To determine whether similar transport enhancement trends were exhibited in both 
mature and neonatal tissue, data from mature equine were compared to neonatal bovine 
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cartilage. Mature equine cartilage (which was found to have comparable properties to 
human tissue for both permeability and aggregate modulus 33,34) followed the same 
enhancement trends as the neonatal cartilage when exposed to different loading 
amplitudes (Figure 3). For all species, diffusion through the articular surface was 35-
50% higher than radial penetration under free-swelling conditions (Figure S3). 
Collectively, these data suggest that while the magnitude of diffusion is different 
between mature and neonatal tissue, enhancement of transport due to loading and 
directional dependence of transport are quite similar. As such, neonatal bovine tissue 
appears to be a valuable model system for studying transport in vitro. 
 
Previous studies suggest convective enhancement of nutrients plays a role in cell 
metabolism in regions of high fluid flow 12,26. To determine whether fluid flow is an 
important contributor to the enhancement of transport of this antibody, we compared 
the spatial pattern of enhancement to patterns of fluid flow predicted by FE models 26,35. 
These models have established that as the frequency or amplitude of loading increases, 
the maximum fluid velocity at the radial edge increases (Figure 4). However, increasing 
strain amplitude has a smaller effect on fluid penetration depth than increasing loading 
frequency. These fluid flow and fluid penetration relationships with loading are 
representative of the poroelastic tissue response of cartilage 36–38. Both a high fluid flow 
(to initially convect the solute into the tissue) and deep fluid penetration (to push solute 
inward) are needed for high levels of loading-based enhancement throughout the tissue. 
It was found that loading the samples at 1 Hz achieved both high fluid flow at the edges 
and deep fluid penetration (Figure 4), likely leading to the highest overall transport 
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enhancement (Figure 3) and the linear increase in enhancement for amplitudes at 1 Hz 
(Figure 3), which is consistent with other studies 39. Overall, it was found that the 
regions of highest transport enhancement (and thus effective diffusivities) were found 
near the radial edge of the plug, in regions of fluid flow predicted by FE models (Figure 
4). Additionally, local fluid velocities correlated positively (R2 = 0.81) with local 
enhancement (and thus effective diffusivities) (Figure 5). This relationship strongly 
links fluid flow with increased solute transport in cartilage, and seems to indicate a 
proportionality between fluid flow and local solute transport. However, this relationship 
and FE model does not explain mechanistically how fluid flow contributes to increased 
transport, but it does help give a basic understanding on how fluid flow affects local 
diffusivity measurements within the sample and that faster fluid flow correlates to 
increased local transport. Indeed, previous work has shown that frictional drag between 
the solid matrix and interstitial fluid help explain more of mechanistic understanding on 
how loading induces increased transport of solutes 40.  
 
Besides increased fluid flow near the sample edges, there could be other phenomenon 
occurring that enhance transport of various solutes and prevent molecules from being 
expelled from outward fluid flow during loading. It is possible that the collapse of pores 
during the downstroke of loading entraps large molecules and keeps them inside the 
cartilage matrix to be convected deeper into the tissue on subsequent cycles 41. 
Compressing the tissue to a higher degree (i.e. 5%, instead of 2.5%) could cause 
increased compression of these pores, leading to higher amounts of temporary 
entrapment and/or entanglement of these large molecules within the tissue (thus 
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increasing transport) 41. This phenomenon could explain why mechanical loading 
enhances transport of larger molecules more so than smaller ones 11,32,42,43. Likely, there 
is an interplay with all aforementioned phenomenon that result in increased penetration 
of the antibody used with loading.  
 
Given these positive results, there are some remaining questions and limitations. Due to 
the poroelastic response of cartilage, platen separation during its upstroke most likely 
occurred at most loading conditions, leading to harmonic distortion of the load applied 
to the cartilage 13,44. To avoid any fluid flow artifacts that were created by this platen 
separation, image analysis took place in the middle portion of the samples, sufficiently 
far away from the articular surface. Additionally, loading conditions in vivo are 
significantly different compared to conditions in these experiments. Solute penetration 
would occur perpendicular to the articular surface, instead of radially through the deeper 
zones of the tissue. However, it was found that diffusivity into the articular surface was 
higher than that in the radial direction (Figure S3), which was likely attributed to the 
increased permeability in that layer of the tissue compared to the deeper zones noted in 
this study 45. As a result, using diffusivity in the radial direction in the deeper zone of 
the tissue would likely be an underestimation of how much solute would penetrate the 
cartilage in vivo through the articular surface. Additionally, compaction of the 
superficial zone of cartilage in vivo may negatively affect diffusion through the tissue, 
which was not addressed in this study. Even though samples within loaded and passive 
groups were initially compressed by 15%, which could cause decreased diffusivities of 
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solute 46,47, this will not affect the relationship between passive and loaded conditions, 
which was the predominant message of this study. 
 
Ultimately, loading increased antibody transport in only a couple of hours. Since in vivo 
intra-articular half-lives of similarly sized solutes are about 6-10 hours 6, exercising the 
joint could have a significant impact on antibody diffusion into the cartilage matrix 
within this time frame, as has been shown with smaller solutes 15. Additionally, OA 
cartilage would exhibit some form of proteoglycan loss near the articular surface, 
resulting in higher permeabilities than the healthy cartilage used in these experiments 
48. This increased permeability of OA cartilage would most likely help the penetration 
and utility of OA antibody treatments as well. Interestingly, maximal enhancement was 
found at 1 Hz, which corresponds well with to the frequency of the walking gait cycle, 
which is consistent with previous studies noting enhancement of molecular transport as 
a result of extended periods of walking 15. Notably, partition coefficients of large 
molecules such as antibodies in cartilage are quite low (e.g. 0.01) 10, and the current 
study only measured relative (not absolute) concentrations of antibody within the tissue. 
Similarly, recent clinical trials of antibodies that block IL-1 have met with limited 
success, possibly due to limited penetration of these molecules within cartilage 49. As a 
result, it remains to be seen whether the 2 to 3-fold enhancement noted in this study 
would result in therapeutic concentrations of antibodies in cartilage.  
 
Overall, this study showed that antibodies can penetrate the dense healthy cartilage 
matrix and mechanical loading enhanced antibody transport to a large degree. Transport 
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enhancement of the antibody used was linearly correlated with applied strain amplitude 
and had a non-linear relationship with applied loading frequency. Regions of highest 
enhancement of transport were associated with the regions of highest interstitial fluid 
velocity, as predicted from FE simulations. These data suggest that the enhancement 
from dynamic compression is largely due to enhanced convective flows at the radial 
edges of the tissue. To our knowledge, this is the first study to test how mechanical 
stimulation affects the diffusion of antibodies in cartilage and suggest further study into 
other important factors regarding macromolecular transport.  
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Supplementary Materials: 
 
 
Figure S1: Passive samples were exposed to the conjugated antibody solution on their 
cylindrical surface for various amounts of time. Diffusivities were measured in the 
radial direction; diffusivities asymptotically approached a steady state value after two 
hours. Due to the experimental setup, there was lag time between cessation of loading 
and imaging of samples, where additional internal diffusion was taking place. This 
internal diffusion produced artificially high diffusivities if the length of experiments 
was not much larger than this lag time (~15 minutes). As a result, experiments needed 
to be longer than 2 hours to avoid imaging artifacts falsely inflating diffusivity values 
before the 2-hour time point. Therefore, all data within the manuscript are from 
experiments that were at least 3 hours in length. 
 
  
n = 6 ± SD 
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Figure S2: Each fluorescence profile for loaded and unloaded samples were broken 
down into discrete layers (25 μm bands from 0 – 300 μm from the radial edge, 200 um 
bands thereafter). A radial multi-layer 1D diffusion model was used to calculate local 
diffusivities. Layers above were made larger for clarity purposes. 
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Figure S3: Additionally, a separate group of samples was tested without platens or strain 
offset to assess passive axial diffusion through the exposed articular surface. 
Fluorescence profile analysis was carried out perpendicular to the articular surface to 
obtain a single diffusivity in the axial direction. These diffusivities were compared to 
radial diffusivities for samples that were also in the free-swelling condition. Passive 
diffusivity into the articular surface was found to be significantly higher (35-50%) 
compared to diffusivity in the radial direction for all species types (p < 0.05). The 
antibody had the lowest radial diffusivity in mature equine cartilage (1.9 x 10-8 cm2/s), 
and the highest in neonatal bovine tissue (4.4 x 10-8 cm2/s). Neonatal bovine tissue had 
higher diffusivities compared to the other two groups (p < 0.05). 
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CHAPTER 3 
The Effect of Antibody Size and Mechanical Loading on Solute Diffusion Through 
the Articular Surface of Cartilage3 
Abstract 
 Because of the heterogeneous nature of articular cartilage tissue, penetration of potential 
therapeutic molecules for osteoarthritis (OA) through the articular surface is complex, with 
many factors that affect transport of these solutes within the tissue. Therefore, the goal of this 
study is to investigate how the size of antibody variants, as well as application of cyclic 
mechanical loading, affect solute transport within healthy cartilage tissue. Penetration of 
fluorescently-tagged solutes was quantified using confocal microscopy. For all solutes tested, 
fluorescence curves were obtained through the articular surface. On average, diffusivities for 
the solutes of sizes 200 kDa, 150 kDa, 50 kDa, and 25 kDa were 3.3, 3.4, 5.1, and 6.0 μm2/s 
from 0-100 μm from the articular surface. Diffusivities went up to a maximum of 16.5, 18.5, 
20.5, and 23.4 μm2/s for the 200 kDa, 150 kDa, 50 kDa, and 25 kDa molecules, respectively, 
from 225-325 μm from the surface. Overall, the effect of loading was very significant, with 
maximal transport enhancement for each solute ranging from 2.2 to 3.4-fold near 275 μm. 
Ultimately, solutes of this size do not diffuse uniformly, nor are convected uniformly, through 
the depth of the cartilage tissue. This research potentially holds great clinical significance to 
discover ways of further optimizing transport into cartilage and lead to effective antibody-based 
treatments for OA. 
 
3C. DiDomenico, A. Goodearl, A. Yarilina, V. Sun, S. Mitra, A. S. Sterman, and L. J. 
Bonassar, “The Effect of Antibody Size and Mechanical Loading on Solute Diffusion through 
the Articular Surface of Cartilage Chris D. DiDomenico,” J. Biomech. Eng., vol. 14853, no. 
607, pp. 1–34, Jul. 2017. 
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Introduction 
The progression of osteoarthritis (OA) is known to be influenced by the release of 
inflammatory cytokines that cause widespread joint degeneration 1. As a result, 
inhibition of inflammatory cytokines and mediators has been a matter of great interest 
for development of arthritis therapies. Other effective inhibitory treatments for various 
diseases utilize antibodies or antibody fragments to bind to the target of interest and stop 
its effects. For example, antibody based strategies inhibiting tumor necrosis factor-α 
(TNF-α) have been effective in stopping joint degeneration in rheumatoid arthritis (RA), 
and are some of the highest grossing drugs (Humira, Enbrel, Remicade etc.) on the 
market 2–4. Because of the systemic nature of RA, subcutaneous injection of therapeutic 
antibodies is able to quell the production of inflammatory factors and reduce joint 
degradation and systemic symptoms. TNF-α and interleukin-1 (IL-1α and β) are also 
known to play a part in OA, but using antibody based therapy for OA remains a 
challenge for several reasons 5–7. In OA, a significant amount of degradative and 
inflammatory cytokines, including TNF-α and IL-1, are localized to the chondrocytes 
within the avascular cartilage tissue. As such, access of large molecules like antibodies 
to target cytokines is difficult, especially since synovial clearance times for drugs are 
on the order of hours 2,5–10. Additionally, because of the heterogeneous nature of 
cartilage tissue, penetration of drugs through the articular surface is complex and there 
are many factors that affect transport of these large therapeutic molecules within the 
cartilage matrix. 
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The structure and composition of cartilage is paramount to understanding how 
molecular transport occurs through the articular surface. Overall, articular cartilage has 
an avascular extracellular matrix that by wet weight, is mostly water (75%), 
glycosaminoglycans (10-12%), and collagen type-II (13-15%) 11,12. 
Glycosaminoglycans (GAGs) are responsible for a very small tissue pore size (~10 nm) 
13 and also contribute a high fixed charge density of the tissue 11,12. Importantly, 
concentrations of both GAGs and collagen type-II generally increase as a function of 
depth from the articular surface and cause decreasing tissue pore size and increasing 
fixed charged density 11,12,14. Collagen fiber orientation changes from being parallel and 
densely packed at the surface to more perpendicular further into the tissue 15. 
Additionally, near the articular surface, there are other proteins, such as decorin and 
biglycan, that could influence solute interactions 12. Collectively, the depth-dependence 
of cartilage structure and composition, combined with known effects of solute size on 
transport through porous media 16–18, may give rise to a complex molecular transport 
problem. Research suggests that there could be some distinct size-related solute 
diffusion behavior for the different “zones” of cartilage for dextrans 19. Understanding 
how the composition of cartilage as a function of depth affects diffusion of large (25-
200 kDa) therapeutic antibody molecules could shed light on how to better design these 
molecules to penetrate cartilage more readily and ultimately be more effective in 
preventing future joint degeneration.  
 
Transport of large macromolecules through cartilage is also known to be affected by 
mechanical loading. Multiple studies report that mechanical loading causes increased 
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fluid flow within cartilage and leads to increased molecular transport for relatively large 
molecules such as insulin-like growth factor I (IGF-I) (MW: 7.6 kDa), tissue inhibitor 
of metalloproteinase 1 (TIMP-1) (MW: 23 kDa), transforming growth factor-β (TGF-
β) (MW: 25 kDa), and albumin (MW: 66 kDa) 20–23. Mechanical loading has been 
identified as an important influence in enhancement of penetration of antibodies radially 
through the deeper zones of the tissue 24. Also, axial penetration of solutes through the 
articular surface is highly relevant to the transport of intra-articular therapeutics but little 
is known about how the depth dependent nature of cartilage affects this phenomenon. 
Further, understanding this loading enhancement for large molecules, as well as 
antibodies, could be beneficial in developing exercise regimens for arthritis patients that 
utilize optimal loading conditions for penetration of the solute of interest 25. 
 
Therefore, the goal of this study is to investigate how various antibodies variants of 
different size (antibodies and antibody fragments) penetrate perpendicular to the 
articular surface. Additionally, the effects of cyclic loading at different amplitudes at 1 
Hz will be investigated to study how convective flows perpendicular to the articular 
surface affect transport into cartilage.   
 
Methods 
Cartilage Harvest and Preparation 
For each experiment, fresh, full-thickness (2 mm) articular cartilage plugs (4 mm 
diameter) were harvested using biopsy punches under sterile conditions from the 
patellofemoral groove (PFG) of 1-3 day old bovids (~10 experiments from ~20 different 
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animals) (Gold Medal Packing, Rome, NY). These plugs were bisected axially, and one 
2x4x1.15 mm slice of tissue was obtained from each bisected half, for a total of 20-24 
slices for each experiment (Figure 1). All slices represented full-thickness (nominally 2 
mm thick) cartilage with the articular surface, middle zone, and deep zone intact. All 
slices were randomly distributed to experimental groups based on location within the 
joint to prevent variation in tissue composition skewing experimental results. These 
slices were randomly assigned to two different groups (loaded and passive) and were 
placed into individual wells in 24-well plates. Samples were placed in wells such that 
one of the cut surfaces (2x4 mm surface) was flat on the bottom of the well and the 
articular surface and deep zones were exposed to media on the lateral faces (Figure 1). 
An impermeable platen array was placed on top of each well plate, compressing all 
sample thicknesses approximately 15%, from 1.15 mm to 1.0 mm. This arrangement 
kept the samples in place and reduced the effects of swelling and limited diffusion 
perpendicular to the cut surfaces of the samples. For each well, 350 μl of one of 4 
fluorescently labeled (Alexa Fluor 633) antibody variants (AbbVie Inc, Worcester, MA) 
were added at a concentration of ~1-5 μM in PBS (Corning, NY). These antibody 
variants were the following: a 200 kDa dual variable domain (DVD) antibody, a 150 
kDa whole antibody (Ab), a 50 kDa fragment antigen-bonding (Fab) fragment, and a 25 
kDa single-chain variable fragment (scFv). All variants were derived from the same 150 
kDa whole antibody. With this setup, the solute of interest could freely diffuse 
perpendicular to the articular surface and the deep zone, but only diffusion through the 
articular surface was analyzed.  
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Figure 8: Schematic of sample preparation and experimental setup (left and center) with 
the fluid flow induced by the platen being perpendicular to the deep zone (DZ) and the 
articular surface (AS). A 4-mm diameter sample 2-mm thick was bisected, then a slice 
was cut from each half to obtain a final sample dimension of 4x2x1.15 mm. 
Fluorescence image obtained from the Ab (150 kDa) solute using confocal microscopy 
(right). Red box (~1000 μm wide, 500 μm tall) indicates the region of interest that was 
examined for this study. 
 
Fluorescent labeling of antibodies 
Each antibody or fragment was labeled using the Alexa Fluor-633 protein labeling kit 
(Thermo Fisher, A20170) using the protocol supplied by the manufacturer. Briefly, the 
pH of the protein solution was adjusted by adding 1/10 volume of 1M sodium 
bicarbonate (pH 8.5). Amine reactive dye (Thermo Fisher, Cat: A20170) was dissolved 
in dimethyl sulfoxide (DMSO) to a concentration of 50 mM immediately before 
conjugation. The dye and pH-adjusted protein were mixed at a 9:1 molar ratio and 
incubated at room temperature for 2h under constant rotation. Separation of free dye 
from protein was carried out using PD-10 desalting columns (GE Healthcare Cat: 17-
0851-01). Labeled protein was analyzed by analytical size-exclusion chromatography 
(SEC) and sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) to 
ensure minimal change in aggregation during conjugation. Protein concentration and 
degree of label was determined via absorbance readings at 280 nm and 632 nm. 
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Disassociation of the label from the antibodies was not deemed significant, as confirmed 
by independent experiments comparing diffusion from free label and the conjugated 
antibodies 24. 
 
Mechanical Compression 
Each group was placed into a 37°C incubator where the loaded group underwent 
unconfined cyclic compression with a custom-built, displacement-controlled bioreactor 
that maintained sterile conditions, as described previously 24,26. Superimposed on the 
15% static strain offset, singular sinusoidal strain amplitudes (0.25%, 1.25%, 2.5%, or 
5.0%) were applied to the loaded samples at a singular frequency of 1 Hz for 3 hours. 
The time-frame of this experiment was verified to be long enough to negate any 
potential artifacts due to lag between end of loading and imaging in a previous paper 24. 
The passive group served as a control, with only a 15% offset strain.  
 
Transport Analysis 
After loading, all slices were bisected along the long axis from the articular surface to 
deep zone, resulting in two slices of 2x2x1.15 mm. This new cut surface was assessed 
on an inverted confocal microscope stage (LSM 510, Zeiss, Oberkochen, Germany) to 
characterize the antibody penetration perpendicular to the articular surface (Figure 1). 
Laser power (λ: 635 nm, ~15 mW) was set so that the total fluorescence (with an 
emission λ of approximately 640 nm) intensity of the 8-bit image was roughly Gaussian 
and so that no pixels were saturated (pixel dwell time: ~0.5 ms). The pinhole was set to 
obtain a representative 30 μm optical section for each sample with a spatial resolution 
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of 1.35 μm/pixel. A 10x objective with a numerical aperture of 0.3 (Zeiss, Oberkochen, 
Germany) and a working distance of about 3 mm was used for all samples. A total of 6 
tiles were taken to fully capture the sample under these imaging conditions. 
 
This experiment was modeled as 1D diffusion, and steps were taken to negate any edge 
artifacts and any other unwanted effects in the image analysis. Background fluorescence 
was calculated from a 1000 μm2 square area sufficiently far away from the sample and 
subtracted from the sample fluorescence. Although minimal (< 1% of overall signal 
intensity) at this wavelength and laser power, autofluorescence of each sample was 
calculated from a 1000 μm2 area in the middle of the sample (where no solute was found 
on the time scale of the experiment) and subtracted from the total sample fluorescence. 
For all samples, column-wise pixel averages of the sample image data were obtained 
from the articular surface to 1000 μm deep into the tissue. This depth was chosen for 
image analysis because it captured the full penetration of all solutes, and limited 
potential artifacts arising from vasculature that may have been present deeper in this 
immature tissue. These averages were constrained to the middle 50% of the sample to 
avoid edge effects from the bottom and top of the sample. Limiting to the middle of the 
sample also helped avoid any transport artifacts if the loading platen did not maintain 
contact with the sample throughout the loading cycle. Although there is diffusional 
anisotropy evident in cartilage 27, the dimensions of the sample and application of the 
platen prohibited the effects of unwanted diffusion from biasing the results. 
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The solute fluorescence/concentration relationship was found by taking different 
dilutions of the solute and observing them under a confocal microscope (LSM 510, 
Zeiss, Oberkochen, Germany). The fluorescence of the antibody was found to be 
linearly correlated (R2 > 0.95) to solute concentration in the range of dilute 
concentrations (1-5 μM) used for these experiments (data not shown), and thus 
fluorescence values and concentration values could be interchanged to determine how 
the diffusivity of the solute changes with depth from the articular surface. After 
normalizing the fluorescence curves to the maximum value, fluorescence profile data 
were broken down into discrete “layers,” spaced 50 μm apart, for a total of 16 layers per 
sample.  
 
Using a RMS error minimization procedure for each layer, fluorescence data within that 
particular layer was analyzed with a transient 1D multi-layer diffusion model from Carr 
et al 28, enabling the calculation of local diffusivities within a sample as a function of 
depth. This model used a semi-analytical method based on the Laplace transform and 
an orthogonal eigenfunction expansion to solve the transient slab diffusion equation in 
1D for many layers 28. Fluorescence data were gathered up to 1000 μm from the surface 
and fluorescence values were normalized to the value at the articular surface. The model 
was fit to the average depth-wise fluorescence values obtained from the image analysis. 
A concentration value of one was input at x=0 (the articular surface). Since fluorescence 
in the center of all samples was negligible, the concentration of the sample was assumed 
zero at x=1000 μm. Concentration continuity was assumed between the 16 layers, so 
concentrations from one edge of a layer to the edge of the subsequent layer were 
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assumed the same. Each layer was assumed homogeneous. All samples were analyzed 
assuming a solute exposure time of three hours. Both loaded and passive samples had 
the same initial and boundary conditions. 
 
The model, which only describes transport, was used to investigate how solute 
diffusivity is affected locally within the heterogeneous cartilage matrix. For cyclically 
loaded samples, this model yields an “effective diffusivity” 24,29, which includes 
contributions from both convection and passive diffusion. In passive samples, our local 
diffusivity measurement only includes diffusion, which we call passive diffusivity. A 
measure of transport enhancement can be calculated by taking the ratio of these two 
metrics, which has been highly correlated to local peak fluid flow in a previous study 
24. Because of this relationship with fluid flow, comparing effective diffusivities to 
passive diffusivities is a good local assessment of how convection affects solute 
transport. While there are several metrics of quantifying convective contributions of 
transport 30,31, this method enables easy and accurate comparisons between samples 
across a range of loading conditions. Decoupling the convective and diffusive 
contributions was not viable with this model and experimental design. These local 
diffusivity functions were then compared to obtain information about how loading 
affected transport of the solute throughout the tissue depth. This model enabled accurate 
calculation of passive local diffusivity in static samples and an effective local diffusivity 
in loaded samples. 
 
Statistical Analysis 
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A repeated-measures three-way ANOVA was performed to determine the effect of 
solute size, loading amplitude, and depth (the repeated-measure) from the articular 
surface on local diffusivities, with subsequent Tukey post-hoc tests for pairwise 
comparisons. All statistics were carried out in Minitab 17 Statistical Software (State 
College, PA). 
 
Results 
Using the experimental setup described above, fluorescence images were obtained and 
analyzed using custom Matlab software to obtain fluorescence as a function of depth 
within the region of interest (Figure 1). For all solutes tested, the shape of the 
fluorescence curves suggest that diffusive behavior is heterogeneous through the depth 
of the tissue. Indeed, fitting these fluorescence profiles to a 1D diffusion curve with only 
one overall diffusion coefficient produced a poor fit (R2 < 0.5, data not shown). As such, 
we used a recently developed slab diffusion model for many layers in series to assess 
the suitability for this system and to identify distinct diffusive regions within the 
cartilage depth 28. Overall, having the multi-layer model contain 16 layers gave the best 
blend of low error and computation time. Larger layers resulted in unacceptable 
amounts of error between the model and data; whereas, smaller layers did not resolve 
any further distinguishing diffusive characteristics. Thus, this experimental setup 
captures all the most important diffusive effects that are evident as a function of tissue 
depth for these solutes. The one dimensional multi-layer diffusion model fit well to 
loaded and passive fluorescence curves of all solutes (coefficient of variances < 12.5%) 
(Figure 9).  
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Figure 9: Representative normalized fluorescence curve for the Ab (150 kDa) solute 
under passive conditions (blue) compared against the 16-layer diffusion model (solid 
black) (left). For this sample, average coefficient of variance was 6.4%. All solutes had 
average coefficient of variances less than 12.5%. Loaded and passive samples had 
equally good fits overall for all solutes. Average normalized fluorescence curve for Ab 
(150 kDa) through the articular surface shown (right). Standard deviations are 
represented by the shaded region for n = 8. For this solute, distinct changes in concavity 
were observed and therefore profiles could be roughly broken into three distinct regions. 
The articular surface region is characterized by a sharp decrease in fluorescence for the 
first 100 μm or so, followed by the plateau region where the fluorescence is relatively 
constant, followed by the deep region where there is a more rapid drop off of 
fluorescence. 
 
Qualitative analysis of solute fluorescence curves 
For all solutes tested, fluorescence curves were obtained from the articular surface to a 
depth of 1000 μm (Figure 9 and Figure 10). All solutes exhibited diffusive behavior that 
appeared to vary in three distinct regions: herein defined as the “surface region,” 
“plateau region,” and the “deep region” (Figure 9 and Figure 10). For all solutes, the 
surface region exhibited a sharp decrease in fluorescence for the first 100 μm into the 
tissue, followed by the plateau region where the fluorescence decreased more slowly 
from approximately 100 – 350 μm, followed by the deep region where there was a more 
rapid drop off of fluorescence. All solutes did not penetrate more than 1000 μm in the 
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3-hour diffusion experiments. Larger molecules, such as the DVD and Ab, seemed to 
have more abrupt transitions between these three regions than the smaller solutes in this 
study (Figure 10). To better understand and quantify these regions, local diffusivities 
were obtained by examining the fluorescence curves for each solute.  
 
Figure 10: Passive fluorescence profile comparison of the four differently sized solutes 
used. Error bars (standard deviation for n = 6-8) for all solutes are shown in shades 
surrounding average profiles. 
 
Effect of size and tissue depth on local passive diffusivities 
Overall, fluorescence profiles for solutes were similar up until approximately 350 μm 
deep (up until the “deep region”), where the solutes diverge according to their size (i.e. 
smaller ones penetrate further in the tissue) (Figure 11). Fluorescence curves were 
broken up into 16 layers and a multi-layer 1D diffusion model was used to determine 
 1 
2 
n = 7 n = 8 
n = 7 n = 6 
200 kDa 150 kDa 
50 kDa 25 kDa 
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local diffusivities as a function of depth for the passive solute condition (Figure 11). 
Overall, local diffusivities were heterogeneous throughout the depth of the tissue, and 
there were three distinct sections of these curves for each solute. On average, 
diffusivities for the DVD (200 kDa), Ab (150 kDa), Fab (50 kDa), and scFv (25 kDa), 
were 3.3, 3.4, 5.1, and 6.0 μm2/s from 0-100 μm (surface region). However, the size of 
the solute did not affect diffusivity significantly within this region (p > 0.05). 
Diffusivities increased to a maximum of 16.5, 18.5, 20.5, and 23.4 μm2/s for the DVD, 
Ab, Fab, and scFv, respectively, between 225-325 μm. These data are consistent with 
previous reports that diffusivity is inversely proportional to molecular weight, even for 
very large solutes 16. Calculated diffusivities at 225 μm, 275 μm, and 325 μm were 
higher than all other diffusivities in the tissue, for all solutes (p < 0.05). At 275 μm, the 
25 kDa and 50 kDa solute had higher diffusivities than the 150 kDa and 200 kDa 
antibodies (p < 0.05).  For all solutes, diffusivities then decreased to statistically similar 
values found within the surface region in the 400-800 μm range (deep region), and had 
no significant dependence on size (p > 0.05). However, smaller molecules, such as the 
Fab and scFv, had deeper overall fluorescence penetration into the tissue, because of 
higher trending diffusivities compared to the larger solutes within this “deep region” 
(Figure 11). For example, at 575 μm, scFv fluorescence intensity and average local 
diffusivity were about 2 times that of the DVD solute.  
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Figure 11: Passive fluorescence profile comparison of the four differently sized solutes 
used (left) along with the multi-layer diffusivities (right). Error bars denote standard 
deviations for all solutes (n = 7, 8, 7, 6 for DVD, Ab, Fab, scFv, respectively). 
Fluorescence curves for these solutes were visually similar up until 400 μm, where 
solute fluorescence diverged according to size. Overall, local diffusivities were 
heterogeneous throughout the depth of the tissue, and there were three distinct sections 
of these curves for each solute. On average, diffusivities for the DVD, Ab, Fab, and 
scFv, were 3.3, 3.4, 5.1, and 6.0 μm2/s from 0-100 μm, but size did not affect diffusivity 
significantly within this region (p > 0.05). Diffusivities increased to a maximum of 16.5, 
18.5, 20.5, and 23.4 μm2/s for the DVD, Ab, Fab, and scFv, respectively, between 225-
325 μm. Calculated diffusivities at 225 μm, 275 μm, and 325 μm were higher than all 
other diffusivities in the tissue, for all solutes (p < 0.05). Diffusivities then decreased to 
similar values found within the surface region in the 400-800 μm range (deep region), 
and had no significant dependence on size (p > 0.05). Values obtained from the 0-125 
μm range and 400-800 μm range were not different from each other, for any solute (p > 
0.05). 
 
Effect of loading on solute transport 
To examine how these solutes were affected by loading conditions for three hours at 1 
Hz, fluorescence profiles were obtained at 1.25%, 2.5%, and 5% cyclic strain (Figure 
12 and Figure S4-3). This loading approximates the strains and amplitudes experienced 
in articular cartilage in humans from walking (1 Hz, 1.25%) to vigorous exercising (5%) 
 1 
 2 
n  =  6 - 8  
n = 6-8 
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32. Local effective diffusivities were determined for the loaded conditions (Figure 13). 
Overall, most enhancement of the fluorescence profiles for all solutes was seen from 0 
– 400 μm from the articular surface, with highest transport enhancement (compared to 
respective passive diffusivities) occurring between 175-325 μm (p < 0.05). For most 
solutes, no significant transport enhancement was experienced in the first 125 μm of the 
tissue, at any loading condition (p > 0.05). As expected, solutes undergoing higher 
cyclic amplitudes (i.e. 5%) received more transport enhancement than ones undergoing 
less loading, from 175 μm to 325 μm (p < 0.05). Compared to passive controls, any 
loading condition applied maximally enhanced diffusivities from 1.5 to 3.4-fold near 
275 μm, but ultimately, local enhancement depended greatly on location within the 
tissue, solute size, and loading amplitude (Figure 13). For example, the DVD solute 
experienced a 3.4-fold maximal enhancement at 275 μm compared to passive controls 
at 5% amplitude, but only experienced a 1.4-fold enhancement at 75 μm. However, the 
scFv solute experienced a 2.2-fold maximal enhancement (also at 275 μm) at 5% 
amplitude, with a 1.3-fold enhancement at 75 μm. In general, larger solutes benefited 
from loading more than smaller ones, especially within the range 225-325 μm (p < 0.05). 
Overall, no loading-based enhancement can be observed deeper than 425 μm into the 
tissue for any solute (p > 0.05).  
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Figure 12: All four solutes’ fluorescence profiles for passive and loaded conditions. 
Lighter shades of color indicate greater loading amplitude. All cyclic loading was 
conducted at 1 Hz for 3 hours. Most enhancement of the fluorescence profiles for all 
solutes can be found from 0 – 400 μm from the articular surface. Sample sizes: N = 7, 
8, 4, 6 for passive, 1.25%, 2.5%, and 5% for DVD solute, respectively. Sample sizes: N 
= 8, 7, 6, 5 for passive, 1.25%, 2.5%, and 5% for Ab solute, respectively. Sample sizes: 
N = 7, 6, 7, 7 for passive, 1.25%, 2.5%, and 5% for Fab solute, respectively. Sample 
sizes: N = 6, 8, 7, 8 for passive, 1.25%, 2.5%, and 5% for scFv solute, respectively. 
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Figure 13: All four solutes’ depth-wise diffusivities for passive and loaded conditions. 
Lighter shades of color indicate greater loading amplitude. Error bars denote standard 
deviations with n = 4-8 for all solutes (see Figure 5 for specific sample size information). 
Loading increased diffusivities most from 0 – 400 μm from the articular surface, with 
highest diffusivity enhancement occurring between 225-325 μm (p < 0.05). For most 
solutes, no significant transport enhancement was experienced in the first 125 μm of the 
tissue, at any loading condition (p > 0.05). As expected, solutes undergoing higher 
cyclic amplitudes (i.e. 5%) received more transport enhancement than solutes 
undergoing less loading, from 125 μm to 325 μm (p < 0.05). In general, larger solutes 
benefited from loading more than smaller solutes, especially within the range 225-325 
μm (p < 0.05). Almost no loading based enhancement can be observed deeper than 425 
μm into the tissue. 
Discussion 
The objectives of this study were two-fold: to determine how the depth-dependent 
cartilage structure affects antibody penetration through the articular surface; and to 
1 
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DVD Ab 
Fab scFv 
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investigate how mechanical loading affects transport through the surface. This study 
showed that diffusion of 25 – 200 kDa antibody variants was greatly affected by the 
depth dependent structure of cartilage. For each solute, similar diffusivities were 
observed near the surface (0-100 μm) and in the deeper zones (> 400 μm), but all 
exhibited highest diffusivities within the region 150 – 350 μm from the surface. On 
average, diffusivities within this region were about 300-400% more than diffusivities 
found elsewhere. Additionally, cyclic mechanical loading enhanced transport of 
antibody variants 1.5 to 3.4-fold within the region 150-350 μm from the articular 
surface. Overall, loading had some positive effect on transport up to 375 μm, but did 
not affect transport past that depth. Previous work has established that enhancement of 
full-length antibodies through cartilage is approximately 2-3 fold 24, which is consistent 
with the level of enhancement noted herein and elsewhere 20. Additionally, diffusivities 
obtained from the articular surface and deeper regions are consistent with literature 
values for similarly-sized solutes 16,19,33. 
 
This novel technique enables the determination of local diffusivities for any 
fluorescently labeled solute in porous media. The cartilage samples were cut in a way 
that preserved the depth dependent nature of the cartilage. As in vivo, solutes in this 
study diffuse perpendicularly through the articular surface, which is crucial to 
understand the local diffusive mechanics that would be present within the joint tissue. 
The multi-layer model enabled quantification of local diffusivities and effective 
diffusivities for experiments involving passive diffusion and convective transport, 
respectively. The determination of local diffusivities with a relatively small (~ 50 μm) 
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resolution remains largely unstudied for different types of cartilage and may prove 
useful for other applications, such as tendon or ligament research. Although the model 
used describes transport only, including multi-phasic mixture theories would enable the 
prediction of local deformations and flows and be useful for future studies that 
incorporate more complex loading conditions. 
 
Neonatal bovine cartilage was chosen for this study for multiple reasons. This tissue is 
easy to obtain and to manipulate, and is overall very consistent in terms of physical 
properties 34. Additionally, mature equine cartilage (which has comparable permeability 
to mature human tissue 35,36) has similar levels of enhancement due to mechanical 
loading when compared to neonatal bovine tissue 24. Because mature and neonatal 
cartilages have similar compositional trends as a function of depth 35,37, implications of 
this study likely can be applied to healthy human tissue. 
 
While it is well known that cartilage can be discretized into three zones (superficial, 
middle, and deep) based on cell density, collagen content and organization, and 
aggrecan content 11,38,39, the effect of such variations on local macromolecular transport 
is not well understood. Ultimately, it is hypothesized that varying pore size due to both 
collagen content/organization and aggrecan content affects local diffusivities of solutes 
of this size 19,27. Overall, our data support the idea that there are distinct diffusive regions 
within cartilage for large (25 – 200 kDa) solutes and that local composition has a strong 
influence on local diffusive behavior. Specifically, we noted that diffusivity is highest 
approximately 275 μm below the surface (“plateau region”), where collagen and 
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proteoglycan concentrations are low, and collagen organization is low 37,39. Diffusivity 
is lowest and steady deeper in the tissue (“deep region”) where such concentrations are 
highest and steady 37. However, one would also expect the highest diffusivities to occur 
near the articular surface (“surface region”) because permeability, a strong correlate to 
diffusivity of a solute 37,40, is highest there. However, diffusivities were low (comparable 
to the deep region) at the surface, where proteoglycan and collagen concentrations are 
relatively low 37. Together, this supports that these sized molecules have a hard time 
diffusing through the highly organized collagen at the articular surface zone of the 
cartilage as well as the denser deep zone. Some studies have shown that diffusivities 
perpendicular to the collagen orientation (which would be the case for diffusion through 
the articular surface) may be hindered for larger solutes 27. Most similar to this study, it 
has been shown that large dextrans (40 kDa and 70 kDa) had lowest diffusivities in the 
superficial zone compared to deeper in the tissue, while small (3 kDa) and very large 
(500 kDa) had highest respective diffusivities within this region 19. Along with results 
contained herein, this supports that there are size-based thresholds that dramatically 
influence diffusion behavior as a function of depth in cartilage tissue. Collectively, data 
from our studies and others suggest that both matrix composition and organization are 
important determinants of local diffusivity. 
 
Another interesting result comes from the comparing passive diffusion curves between 
solutes (Figure 11). For example, one would expect a 25 kDa solute to penetrate and 
diffuse much better than a larger 200 kDa solute, especially in dense tissue. Although 
this is ultimately true, it is surprising that the 25 kDa solute only had about a 50% greater 
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diffusivity up until 375 μm, but then had a 100% greater diffusivity deeper than 375 μm. 
Near the articular surface, with large enough pore sizes, all solutes within 25 kDa – 200 
kDa can occupy the same space and diffuse approximately at the same rate. However, 
as pore size decreases from increasing matrix density, larger solutes seem to be hindered 
more significantly compared to smaller ones, resulting in a more drastic decrease in 
diffusivity as depth increases. Together, these data suggest that larger solutes are more 
readily affected by changes in matrix density in cartilage 41. 
 
In terms of loading-based enhancement, all solutes experienced some level of increased 
transport from the loading conditions tested. Higher amplitude loading led to higher 
effective diffusivities within the first 375 μm, with most enhancement (2.2 to 3.4-fold, 
depending on the solute) occurring near 275 μm (Figure 13). Bigger solutes benefited 
from loading more than smaller ones up to 375 μm, which supports the idea that bigger 
solutes experience a larger effect from mechanical stimulation 20,30. Additionally, 
previous work indicated that local transport was highly correlated with fluid flow 24. 
Interestingly, all four solutes undergoing 5% cyclic strain had approximately a 
maximum 50 μm2/s local effective diffusivity, independent of size. This provides further 
evidence that at high amplitudes, convection dominates transport of solutes within this 
size range, which is supported by a previous study 24. 
 
Fluid flow is an integral part of why large solutes are able to be convected into dense 
porous tissues such as cartilage 42–44. Frictional interactions between the solute of 
interest and tissue matrix has been shown to be very important in the modeling of these 
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processes 42,45. Consistent with another study 24, there was no transport enhancement 
deeper than 425 μm from the articular surface, which implies that there was no fluid 
flow further into the tissue. Besides fluid flow, other researchers have proposed that 
large solutes can become temporarily entrapped within smaller pores as the pores are 
compressed on the downstroke of mechanical loading, and then convected deeper into 
the matrix with future loading cycles 46. Higher loading amplitudes could increase the 
compression of these pores, and help higher loading magnitudes retain and convect 
solutes more than lower loading regimes 46. This phenomenon could also explain why 
mechanical loading enhances transport of larger molecules more so than smaller ones 
20,30. In our study, peak effective diffusivities under loading were quite similar (48-55 
μm2/s), suggesting that drag coefficients are similar across this wide range of antibody 
sizes. 
 
There are some limitations to this study. The applied mechanical loading to samples is 
not in a direction consistent with loading conditions found in vivo 47. Loading samples 
in the way described in the methods was designed to produce 1D flows perpendicular 
to the articular surface. As such, both diffusion and convection occurred in 1D 
perpendicular to the surface. This 1D approach elucidates contributions of flow that are 
important to transport through the articular surface. More complicated models of flow 
can be coupled with this data to further understand these important phenomena. 
Nevertheless, it is likely that fluid flow, which has been shown as a significant correlate 
to solute transport enhancement in cartilage 24,30,31, would have similar impacts in vivo. 
Because cartilage is poroelastic, there was likely significant platen separation during the 
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upstroke of the loading cycle at the amplitudes and frequency tested. Tests conducted 
on a loading frame with a load cell confirmed that total harmonic distortion of 10-35% 
were present. However, image analysis was performed in the middle 50% of the sample 
to avoid any edge artifacts near the surface that was in contact with the loading platen. 
Additionally, loading and passive samples underwent 15% pre-strain, which could 
cause decreased diffusivities of the solute of interest 48,49. Upon further investigation, 
diffusivities of samples undergoing this pre-strain did experience lower local 
diffusivities throughout the tissue compared to non-strained samples, but these 
differences were not significant. Most importantly, there were no differences in trends 
in local diffusivity between samples that experienced pre-strain and those that did not. 
This study does not look at how these solutes behave under equilibrium conditions, 
which could have elucidated how the solutes are partitioned locally within the tissue 
after long-term exposure. There is reason to believe that partitioning effects for these 
molecules are significant and represent yet another important factor that could influence 
therapeutic development in the future 50. Although we have not explicitly measured 
antibody binding, fluorescence profiles for all solutes in this paper were similar to a 
non-reactive antibody in a previous paper 24, as well as other large solutes in cartilage 
50. Finally, this study did not form an explicit relationship between tissue composition 
and structure and correlate them to local diffusivity measurements. Using spectroscopic 
techniques, such as Fourier transform infrared (FTIR) spectroscopy, can help confirm 
that the local tissue composition is indeed playing a role in the diffusive characteristics 
of these solutes. 
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Ultimately, two main points can be gathered from this study. Firstly, the effect of 
loading on large solutes through the articular surface is very significant, and this 
potentially holds great clinical significance for the development of exercise regimens in 
conjunction with antibody therapy 25. Because diseased OA cartilage has a lower 
proteoglycan content and is more permeable than healthy tissue 51, it is possible that 
antibody therapy could be even more effective than predicted when coupled with 
sufficient mechanical loading 51. Since the surface and middle zones of osteoarthritic 
cartilage produce many degradative cytokines 7, targeting these zones with therapeutics 
could prove to be most beneficial. Fortunately, our study supports that even the largest 
of antibodies are able to penetrate up to 400 μm fairly easily over 3 hours, which is on 
the order of in vivo synovial clearance times of solutes of this size 9. Additionally, 
loading at 1 Hz, which corresponds to the frequency of the walking gait cycle, seems to 
be optimal for loading based enhancement of antibodies 24. Another important point of 
this study was that the depth-dependent structure of cartilage greatly affects the 
diffusion of antibodies. For all solutes 25-200 kDa in size, local diffusivities were 
highest around 275 μm from the articular surface, while 300-400% lower near the 
articular surface and in the deeper zones. Additionally, smaller solutes were able to 
penetrate deeper into the tissue than bigger ones. Research into how other factors, such 
as solute charge, could unveil ways to further optimize transport into cartilage and lead 
to effective antibody-based treatments for OA. 
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Supplementary Material: 
 
Figure S4: All four solutes’ fluorescence profiles for passive and loaded conditions. 
Cyclic loading was conducted for 3 hours at 1 Hz and 1.25% cyclic loading amplitude. 
Mean values are shown for each solute, with shaded regions denoting standard 
deviations. 
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Figure S5: All four solutes’ fluorescence profiles for passive and loaded conditions. 
Cyclic loading was conducted for 3 hours at 1 Hz and 2.5% cyclic loading amplitude. 
Mean values are shown for each solute, with shaded regions denoting standard 
deviations. 
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n = 7 n = 8 
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Figure S6: All four solutes’ fluorescence profiles for passive and loaded conditions. 
Cyclic loading was conducted for 3 hours at 1 Hz and 5% cyclic loading amplitude. 
Mean values are shown for each solute, with shaded regions denoting standard 
deviations. 
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CHAPTER 4 
The Effect of Charge and Mechanical Loading on Antibody Diffusion through the 
Articular Surface of Cartilage4 
Abstract 
 Molecular transport of osteoarthritis (OA) therapeutics within articular cartilage is influenced 
by many factors, such as solute charge, that have yet to be fully understood. This study 
characterizes how solute charge influences local diffusion and convective transport of 
antibodies within the heterogeneous cartilage matrix. Three fluorescently-tagged solutes of 
varying pI (4.7-5.9) were tested in either cyclic or passive cartilage loading conditions. In each 
case, local diffusivities were calculated based on local fluorescence in the cartilage sample, as 
observed by confocal microscopy. In agreement with past research, local solute diffusivities 
within the heterogeneous cartilage matrix were highest around 200-275 μm from the articular 
surface, but 3-4 times lower at the articular surface and in the deeper zones of the tissue. 
Transport of all 150 kDa solutes was significantly increased by the application of mechanical 
loading at 1 Hz, but local transport enhancement was not significantly affected by changes in 
solute isoelectric point. More positively charged solutes (higher pI) had significantly higher 
local diffusivities 200-275 μm from the tissue surface, but no other differences were observed. 
This implies that there are certain regions of cartilage that are more sensitive to changes in solute 
charge than others, which could be useful for future development of OA therapeutics.  
 
 
4This work has been submitted for publication: C. DiDomenico and L. J. Bonassar, “The 
Effect of Charge and Mechanical Loading on Antibody Diffusion Through the Articular 
Surface of Cartilage.”  
Submitted to the Journal of Biomechanical Engineering. 
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Introduction 
To date, there is no clear, effective treatment of osteoarthritis (OA). This wide-spread, 
debilitating disease is known to be influenced by inflammatory cytokines excreted by 
native chondrocytes within articular cartilage 1–3. As such, it is hypothesized that 
therapeutic agents, such as antibodies, can be used to inhibit these inflammatory 
processes, provided they can diffuse sufficiently through the dense, avascular cartilage 
matrix and reach the source cells. Use of antibody therapy has been very successful in 
other diseases 4,5 and these drugs have many tunable properties, such as charge and 
molecular weight modification 6. However, the ability of these large molecules to target 
these chondrocytes is difficult, especially since synovial clearance times for drugs are 
on the order of hours 1,3,4,7–10. Additionally, because of the heterogeneous structure and 
composition of cartilage, there are many factors that could affect transport of these large 
molecules. 
 
The composition and structure of cartilage has implications for molecular transport. By 
dry weight, articular cartilage consists mainly of glycosaminoglycans (40%), and 
collagen type-II (60%) 11,12. As a result of the glycosaminoglycans (GAGs), cartilage 
has a very small pore size (~10 nm) 13 and a very high negative charge density 11,12. 
Increasing concentrations of collagen II and GAGs lead to decreasing pore size and 
increasing negative charge density deeper in the tissue 11,12,14. Additionally, orientation 
of collagen fibers changes from the surface to the deeper zone, starting as parallel to the 
surface and becoming perpendicular near the underlying bone 15. Recent work indicates 
that these structural and compositional changes cause large molecules to exhibit 
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spatially-dependent diffusive characteristics in cartilage that change with molecular 
weight (25-200 kDa) 16. There is evidence that more positively charged solutes diffuse 
more easily into articular cartilage because of attractive electrostatic interactions with 
the negatively charged matrix 17. Because therapeutic antibodies can easily be tuned to 
have different isoelectric points without loss of effective binding to their target in vivo 
6, this could be an effective way to obtain faster diffusion kinetics into cartilage. 
However, little is known about how these attractive forces affect larger solutes (> 100 
kDa), such as antibodies, and how solute charge affects local diffusion through cartilage. 
 
Because of the poroelastic nature of cartilage, mechanical stimulation of the tissue leads 
to convective movement that could increase transport of these large therapeutic 
molecules over passive diffusion alone. As such, mechanical loading has enhanced 
molecular transport for molecules such as insulin-like growth factor I (IGF-I) (MW: 7.6 
kDa), tissue inhibitor of metalloproteinase 1 (TIMP-1) (MW: 23 kDa), transforming 
growth factor-β (TGF-β) (MW: 25 kDa), and albumin (MW: 66 kDa) 18–21. 
Understanding this loading enhancement for large, charged molecules could lead to 
specialized physical therapy regimens that are tailored to the characteristics of the solute 
(MW, charge, etc.) administered 22. 
 
Therefore, the goals of this study are to: 1) investigate how charged antibodies of 
differing isoelectric points (pI) penetrate cartilage through the articular surface and 2) 
determine the effect of cyclic loading on the transport of charged antibodies through 
cartilage. 
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Methods 
Cartilage Harvest and Preparation 
As described previously 16,23, fresh, 2 mm thick cartilage (with articular surface, middle, 
and deeper tissue intact) was harvested from the patellofemoral groove of 1-3 day old 
bovids (8 experiments from ~12 different animals) (Gold Medal Packing, Rome, NY). 
From this tissue, 12-20 2x4x1.15 mm slices of tissue were obtained (Figure 1). These 
slices were randomly assigned to two different loading groups (cyclic and passive). 
Samples were placed in wells in 24-well plates so that the articular surface and deep 
zones were exposed to media on the lateral faces (Figure 1). An impermeable platen 
array was placed on top of each 24-well plate, compressing all sample thicknesses 
approximately 15%, from 1.15 mm to 1.0 mm. This arrangement reduced the effects of 
tissue swelling and limited diffusion perpendicular to the cut surfaces of the sample, 
while allowing the solute to freely diffuse perpendicular to the articular surface. Then, 
350 μl of one of 3 fluorescently labeled (Alexa Fluor 633) antibody variants (AbbVie 
Inc, Worcester, MA) were added to each well at a concentration of ~2.5 μM in phosphate 
buffered saline (PBS) (Corning, NY). These antibodies varied in isoelectric point (pI 
4.7, 5.2, 5.9), and were derived from the same 150 kDa antibody 16. Isoelectric point 
was determined from capillary electrophoresis, where the location of the maximum 
chemiluminescence was reported to be the pI of the molecule (Supplemental Figure S5). 
Fluorescent labeling and quality control tests were performed, as previously reported 16. 
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Figure 14: Cartilage cylinders were bisected and then sliced to obtain a final sample 
dimension of 4x2x1.15 mm (A). Samples were loaded in a way that caused fluid flow 
to be perpendicular to the articular surface (AS) and deep zone (DZ) (B). Representative 
image from confocal microscopy showing the fluorescence gradient perpendicular to 
the AS (C). The red box (~1000 μm wide, 500 μm tall) indicates the region of interest 
that was examined for this study. 
 
Cyclic Mechanical Compression 
Each loading group was placed into a 37°C incubator where the cyclic loading group 
underwent unconfined cyclic compression with a custom-built, displacement-controlled 
bioreactor that maintained sterile conditions, as described previously 23,24. 
Superimposed on the 15% static strain offset, singular sinusoidal strain amplitudes 
(1.25%, 2.5%, or 5.0%) were applied to the cyclic loading samples at a frequency of 1 
Hz for 3 hours. The time-frame (i.e. 3 hours) of this experiment was verified to be long 
enough to negate any potential artifacts due to lag between end of loading and imaging 
16,23. The passive group served as a control, with only a 15% offset strain. 
 
Transport Analysis 
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As previously described 16,23, after loading, all slices were bisected along the short axis 
from the articular surface to deep zone, resulting in two slices of 2x2x1.15 mm. This 
new cut surface was assessed on an inverted confocal microscope stage (LSM 710, 
Zeiss, Germany) to characterize the antibody penetration perpendicular to the articular 
surface (Figure 1). Then, 30 μm-thick optical sections for each sample were obtained, 
as previously described 16,23. 
 
This experiment was modeled as a 1-dimensional diffusion problem, as previously 
described 16,23. Background fluorescence and autofluorescence were mitigated using 
previously described method 16,23. Using custom Matlab code, column-wise pixel 
averages of sample image data were obtained from the articular surface to 1000 μm deep 
into the tissue. These averages were constrained to the middle 50% of the sample (see 
Figure 1) to avoid edge effects and any loading artifacts due to platen/sample separation 
during the loading cycle. Sample geometry and application of the platen also mitigated 
the effects of diffusion that was not perpendicular to the articular surface 16,23. 
 
Because of the linear relationship between fluorescence and concentration 23, local 
fluorescence values can be used to determine how the diffusivity of the solute changed 
with depth. After normalizing the fluorescence curves to the maximum value, local 
fluorescence data were broken down into discrete “layers,” spaced 75 μm apart, for a 
total of 13 layers per sample. This layer resolution captured all major features from the 
fluorescence curves while maintaining a low coefficient of variance (< 15%). Using a 
RMS error minimization procedure for each layer, fluorescence data within that 
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particular layer was analyzed with a transient 1D multi-layer diffusion model from Carr 
et al 25, as described previously 16,23. Collectively, these calculations enabled the 
determination for local diffusivities of both cyclic loading and passive samples for all 
experimental conditions.  
 
Statistical Analysis 
A repeated-measures, three-way ANOVA was performed to determine the effect of 
solute charge, loading amplitude, and depth (the repeated-measure) from the articular 
surface on local diffusivities, with subsequent Tukey post-hoc tests for pairwise 
comparisons. All statistics were carried out in Minitab 17 Statistical Software (State 
College, PA). 
 
Results 
Qualitative analysis of solute fluorescence curves 
Fluorescent intensity curves as a function of depth were calculated from sample images, 
for each experimental condition (cyclic and passive). The shape of all fluorescence 
curves suggest that diffusive behavior is heterogeneous through the depth of the tissue 
and appeared to vary in three distinct regions, as previously described (Figure 2) 16. Near 
the surface (0-100 μm), there was a rapid decrease in fluorescence, followed by a region 
(100 – 400 μm) of fluorescence that decreased more slowly, followed by another section 
(> 400 μm) with a more rapid fluorescence decrease. Fluorescence values trended higher 
(10-15%) for higher pI within the range 200-350 μm from the surface. 
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Figure 15: Average normalized fluorescence curve for all solutes (pI 4.7, 5.4, 5.9) 
through the articular surface. Standard deviations are represented by the shaded region 
for n = 5-7. Fluorescence values trended higher as pI increased within the region 100-
300 μm from the articular surface. 
 
Effect of charge and tissue depth on local passive diffusivities 
The aforementioned transport model calculated passive local diffusivities in static 
samples and effective local diffusivities (combining diffusive and convective 
phenomena) 23,26 in cyclic loading samples, with a low coefficient of variance (< 15%). 
Diffusivity calculated at 50 μm from the articular surface was about 4 μm2/s and did not 
vary with isoelectric point (p > 0.05). Between 200-300 μm deep, diffusivities increased 
to a maximum of 19.0, 16.8, and 15.0, μm2/s for solutes with an isoelectric point of 4.7, 
5.4, and 5.9, respectively (p < 0.05) (Figure 3). In this region, negative charge inhibited 
antibody diffusion, with the pI 4.7 antibody having a diffusivity 20-30% lower than that 
of the pI 5.9 antibody at 200, 275, and 350 μm (p < 0.05). Deeper in the tissue (500-
1000 μm), diffusivities were similar to those found at 50 μm and had no dependence on 
isoelectric point (p > 0.05). Fluorescence of all solutes did not penetrate further than 
800 μm into the tissue within the timeframe of the experiment.  
 1 
Depth from articular surface (μm) 
n = 6 n = 5 n = 7 
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Figure 16: Fluorescence curves for all solutes (passive condition) tested (left) and local 
diffusivities (right). Error bars denote standard deviations with n = 5-7 for all solutes. 
Overall, local diffusivities were heterogeneous throughout the depth of the tissue. On 
average, diffusivities for the pI 4.7, pI 5.4, and pI 5.9, were 3.8, 4.5, 4.6 μm2/s at 50 μm, 
but pI did not affect diffusivity significantly within this region (p > 0.05). Diffusivities 
increased to a maximum of 15.0, 16.9, and 19.0 μm2/s for the pI 4.7, pI 5.4, and pI 5.9 
solutes respectively, between 200-275 μm. Calculated diffusivities at 125 μm, 200 μm, 
and 275 μm were higher than all other diffusivities in the tissue, for all solutes (*: p < 
0.05). Diffusivities for pI 5.9 were higher than that of pI 4.7, between 200-375 μm (p < 
0.05). Diffusivities then decreased to similar values found within the surface region in 
the 400-800 μm range, and had no significant dependence on pI (p > 0.05). Values 
obtained from 50 μm and 425-800 μm range were not different from each other, for any 
solute (p > 0.05). 
 
Effect of loading on solute transport 
To examine how these solutes were affected by cyclic loading, effective local 
diffusivities were obtained after samples underwent 1.25%, 2.5%, and 5% cyclic strain 
at 1 Hz (Figure 4 and Figure S1). These loading conditions were chosen to estimate the 
possible in vivo strains in human knee cartilage 27. Overall, highest diffusivity 
enhancement was 2 to 3-fold compared to passive diffusivities, occurring between 225-
350 μm (p < 0.05). Comparing effective diffusivities to passive diffusivities has been 
1 
n = 5-7 
* 
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shown to be a good assessment of convective contributions in cyclically loaded samples 
16,23. At all cyclic loading conditions, no significant transport enhancement (ratio of 
effective diffusivities to passive diffusivities) was evident until 125 μm (p > 0.05) 
(Figure 4). As expected, solutes undergoing higher cyclic amplitudes (i.e. 5%) 
demonstrated higher transport enhancement than ones undergoing less loading, from 
125 μm to 325 μm (p < 0.05) (Figure S1). For all solutes, maximal loading enhancement 
(at 5% cyclic strain) was 2.5 to 3.1-fold at 200 μm. Loading had no effect on diffusivity 
deeper than 425 μm into the tissue (p > 0.05). Fluorescence curves for all loading 
conditions were not visibly different compared to their respective solute passive curves 
after 500 μm (Figures S2-S4). 
 
 
Figure 17: Fluorescence curves for pI 5.9 and 5% cyclic loading (left) and local 
diffusivities for all solutes at 5% cyclic loading (right). Error bars denote standard 
deviations with n = 5-7 for all solutes. Orange solid line denotes average passive 
diffusivity levels in the passive condition for all solutes. Cyclic loading at 5% cyclic 
strain and at 1 Hz increased fluorescence values between 150 and 400 μm. Solutes did 
not experience any significant differences in diffusivity values or trends at this loading 
amplitude (p > 0.05). Additionally, there were no differences between solute 
1 
5 %  c y c l i c  l o a d e d    
Passive 
n = 5-7 
n = 5-7 
5% loaded   
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diffusivities at 1.25% or 2.5% (shown in supplement). However, maximal transport 
enhancement increased for all solutes with increasing loading amplitude, as expected.  
 
Discussion 
This study examined how antibody charge affects diffusion through the articular surface 
of cartilage and investigated how transport of these charged molecules is affected by 
mechanical loading of the tissue. Using a previously-validated technique and methods 
16,23, this study showed that diffusion of pI 4.7-5.9 antibody variants was heterogeneous 
through the depth of cartilage. For each solute, local diffusivities were 250% higher 
200-300 μm from the articular surface, as compared to any other depth. Elsewhere in 
the tissue, diffusivities were at lower, similar values. Additionally, cyclic loading 
enhanced diffusivities 1.5 to 3-fold within this same region, but did not significantly 
enhance transport elsewhere. These depth-dependent diffusivities and loading-based 
enhancement trends are consistent with other studies looking at variously-sized solutes 
16,18,23,28–30. 
 
Because articular cartilage is heterogeneous 11,31,32, it is hypothesized that varying pore 
size due to both collagen content/organization and aggrecan content affects the diffusion 
characteristics of solutes, especially larger ones 29,33. Overall, our data are consistent 
with the idea that local variations in composition are reflected in variations in local 
diffusion of these large (150 kDa), charged solutes. Local solute diffusivities were 
lowest where collagen and aggrecan concentrations are highest (> 400 μm deep) 34. 
Additionally, diffusivities were highest around 200 μm, where constituent 
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concentrations and collagen organization are relatively low 34, which is consistent with 
work published on solutes with a range of molecular weights (25-200 kDa) 16. 
 
High matrix permeability near the articular surface 34,35 implies that solutes should 
diffuse fastest in this region. As noted elsewhere 16, local diffusivities were low at the 
surface (i.e. at 50 μm), even though collagen and aggrecan concentrations are relatively 
low 34. However, this instead suggests that the densely packed, highly aligned collagen 
within the surface region affects diffusion of these large, charged solutes 33. Another 
study showed that diffusion of large 40 and 70 kDa dextran molecules, but not small 3 
kDa dextran, were hindered significantly in the surface region but not in the middle 
region of articular cartilage 29. Thus, composition and collagen organization are likely 
important determinants of local diffusivity, especially for larger, charged solutes. 
 
The antibody with a pI of 5.9 had the highest local diffusivities. Since the cartilage 
matrix is highly negatively charged 11, this is consistent with attractive electrostatic 
interactions between the solute and matrix. However, these increased diffusivities were 
only found from 200-350 μm from the articular surface for the pI 5.9 solute. These data 
show that local diffusion and solute charge interactions are strongest in areas of the 
cartilage that are low in matrix content and collagen organization, just past the articular 
surface region (near 200 μm). Although not seen within the pI range tested in this study, 
it is possible that diffusion of more positively charged molecules would be elevated in 
the more negatively charged regions of the cartilage deeper in the tissue (> 500 μm) 11. 
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Overall, these data support the notion that large, more positively-charged molecules are 
more mobile in cartilage tissue 17,36, particularly in the sub-surface region. 
 
Ultimately, local transport enhancement due to mechanical loading was consistent with 
studies that used similar loading conditions 16,23. For all solutes, loading-based 
enhancement occurred within 400 μm and was highest around 200 μm (1.5 to 3.1-fold, 
depending on solute and loading condition). Previously, fluid flow has been highly 
correlated to solute transport enhancement 23. As such, all solutes had approximately 
the same maximum effective diffusivity (at around 200 μm) for every loading condition 
tested. Thus, at these loading conditions, it is unlikely that small changes (i.e. pI range 
of 1.2) in solute charge have any effect on transport enhancement in vivo.  
  
There are some limitations to this study. The loading direction used was chosen because 
of its production of generally predictable fluid flow patterns into the articular surface. 
Although the loading is not in a direction consistent with that in vivo 37, this method 
produced fluid flow perpendicular to the tissue surface, as predicted by models of joint 
loading 38,39. It is possible that a larger range of pI or longer experiments are needed to 
capture other differences that would appear between solutes. Because of the varying 
fixed charged density of the tissue, partition coefficients likely change as a function of 
depth in the tissue and could be another important molecular transport factor 36. 
Examination of how partition coefficient changes as a function of depth could be 
especially important for more highly-charged solutes. Finally, determination of explicit 
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correlations between local composition and/or collagen content/organization and local 
diffusivity would have been helpful, but was outside the scope of this study.  
 
Ultimately, negatively-charged antibodies penetrated ~800 μm into healthy cartilage in 
three hours, which is on the scale of the residence time of similarly-sized molecules 
within the joint in vivo 10. Transport of all 150 kDa solutes (pI 4.7-5.9) were significantly 
increased by the application of 1 Hz mechanical loading, but local transport 
enhancement was not significantly affected by changes in solute isoelectric point. In 
agreement with past research, local solute diffusivities within the heterogeneous 
cartilage matrix were highest around 200-275 μm from the articular surface, but 300-
400% lower at the articular surface and in the deeper zones 16. Significantly, more 
positively charged solutes (higher pI) had significantly higher local diffusivities within 
the range 200-275 μm, but no other differences were observed. This implies that there 
are certain regions of cartilage that are more sensitive to changes in solute charge than 
others. These data support that solute charge is yet another important factor that should 
be considered in the future development of arthritis therapeutics. 
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Supplementary Material 
 
Figure S7: All three solutes’ depth-wise diffusivities for 1.25% (left) and 2.5% (right) 
cyclic loading. Orange solid line denotes average passive diffusivity levels in the 
passive condition for all solutes. Error bars denote standard deviations with n = 5-7 for 
all solutes. Higher loading amplitude lead to higher effective diffusivities, as expected. 
However, there were no differences in diffusivity between solutes at any loading 
amplitude. 
 1 
n = 5-7 n = 5-7 
1.25% loading 2.5% loading 
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Figure S8: Fluorescence profiles for pI 4.7 solute in passive and cyclic loading 
conditions. Loading was conducted for 3 hours at 1 Hz and at 1.25%, 2.5%, and 5% 
cyclic loading amplitudes. Mean values are shown for each solute, with shaded regions 
denoting standard deviations for n = 4-8. 
  
 1 
n = 4-8 
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Figure S9: Fluorescence profiles for pI 5.4 solute in passive and cyclic loading 
conditions. Loading was conducted for 3 hours at 1 Hz and at 1.25%, 2.5%, and 5% 
cyclic loading amplitudes. Mean values are shown for each solute, with shaded regions 
denoting standard deviations for n = 4-8. 
 
Figure S10: Fluorescence profiles for pI 5.9 solute in passive and cyclic loading 
conditions. Loading was conducted for 3 hours at 1 Hz and at 1.25%, 2.5%, and 5% 
cyclic loading amplitudes. Mean values are shown for each solute, with shaded regions 
denoting standard deviations for n = 4-8. 
 1 
n = 4-8 
 1 
n = 4-8 
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Figure S11: Chemiluminescence vs. pI for the three solutes used in this study. 
Isoelectric point was determined by the maximum chemiluminescence value obtained 
from electrophoresis. 
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CHAPTER 5 
Measurement of Local Diffusion and Composition in Degraded Articular Cartilage 
Reveals the Unique Role of Surface Structure in Controlling Macromolecular 
Transport5 
Abstract 
Developing effective therapeutics for osteoarthritis (OA) necessitates that such molecules 
can reach and target chondrocytes within articular cartilage. However, predicting how well 
very large therapeutic molecules diffuse through cartilage is often difficult, and the 
relationship between local transport mechanics for these molecules and tissue 
heterogeneities in the tissue is still unclear. In this study, a 150 kDa antibody diffused 
through the articular surface of healthy and enzymatically degraded cartilage, which 
enabled the calculation of local diffusion mechanics in tissue with large compositional 
variations. Local cartilage composition and structure was quantified with Fourier transform 
infrared (FTIR) spectroscopy and second harmonic generation (SHG) imaging techniques. 
Overall, both local concentrations of aggrecan and collagen were correlated to local 
diffusivities for both healthy and surface-degraded samples (0.3 > R2 < 0.9). However, 
samples that underwent surface degradation by collagenase exhibited stronger correlations 
(R2 > 0.75) compared to healthy samples (R2 < 0.46), suggesting that the highly aligned 
collagen at the surface of cartilage acts as a barrier to macromolecular transport. 
 
5This work is to be submitted for publication: C. DiDomenico, A. Kaghazchi, and L. J. Bonassar, 
“Measurement of local diffusion and composition in degraded articular cartilage reveals the unique 
role of surface structure in controlling macromolecular transport.”  
To be submitted to the Journal of Biomechanics. 
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Introduction 
One of the most prominent types of joint disease is osteoarthritis (OA), for which a 
clear, effective treatment remains elusive. Recent research supports that chondrocytes 
within articular cartilage play a large role in joint disease initiation and progression by 
producing inflammatory cytokines such as such as interleukin-1 (IL-1) and tumor 
necrosis factor-alpha (TNF-α) 1–5. The use of antibodies (150 kDa) to bind to and inhibit 
these factors has been very successful in other diseases, such as rheumatoid arthritis 
(RA) 6,7. However, there is concern that these drugs will have trouble diffusing through 
the avascular articular cartilage to target source cells in vivo, especially since synovial 
fluid clearance times are on the order of hours 1,3,5,8,9. As such, macromolecular transport 
into the inherently complex cartilage tissue is an active area of investigation.  
 
There are well-known depth-dependent variations in composition and structure within 
articular cartilage, which is comprised of mainly of type-II collagen and aggrecan 10,11. 
Aggrecan, a large negatively charged proteoglycan, is responsible for a very small 
matrix pore size 12 and an increasing matrix density deeper in the tissue 10,11,13. Near the 
surface, collagen fibers are dense and highly aligned, but fiber organization changes 
throughout the depth of the tissue 14. The highly heterogeneous nature of this tissue has 
many implications for molecular diffusion. Several studies have shown that there are 
depth-dependent diffusive mechanics for a wide range of large solutes 15–17. However, 
these studies lack explicit correlations between local matrix composition and local 
diffusivity. Developing such relationships for larger therapeutics would be helpful in 
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healthy tissue, but it is also important to consider how disease or degradation of cartilage 
affects these relationships. 
 
This clinical progression of many types of arthritis manifests itself by a loss in aggrecan 
and collagen density 14,18–23, which have important implications for bulk drug transport 
24–26. To mimic in vivo degradation, matrix metalloproteinase-1 (MMP-1) 27–29 and other 
inflammatory cytokines, such as IL-1 29,30 and TNF-α 30,31, have been used to investigate 
the effects of degradation on cartilage structure and solute diffusion mechanics. These 
studies have demonstrated decreases in bulk and local mechanical properties 32–37 and 
increases to solute diffusion 24,25. Specifically, Torzilli reported an inverse dependence 
of solute diffusivity on local aggrecan content for inulin and 70 kDa dextran molecules 
24. Interestingly, diffusion of even larger molecules (e.g. antibodies, 150 kDa) exhibit 
unexpectedly slow diffusion through the superficial region 17, which is relatively low in 
aggrecan content 38. As such, it is hypothesized that these molecules are heavily affected 
by collagen structure, but this relationship has not been fully elucidated. 
 
Therefore, the overarching goal of this study is to investigate the relationship between 
local cartilage structure and composition and its effect on local antibody diffusion 
mechanics. Specifically, this study aims to elucidate the role of the surface layer of 
cartilage with regards to its effect on macromolecular diffusion through the articular 
surface.  
Methods 
Cartilage Harvest, Preparation, and Cartilage Surface Degradation 
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As described previously 17, fresh, sterile, 2 mm full-thickness cartilage was harvested 
from the patellofemoral groove of 1-3 day old bovine calves (~10 experiments/animals) 
(Gold Medal Packing, Rome, NY). These plugs (~16 per experiment) were rinsed in 
sterile phosphate buffered saline (PBS) (Corning, NY) and randomly assigned to two 
groups: undegraded (healthy) and surface-degraded (n = 8 per group). Surface-degraded 
samples had a drop (~10 μl) of either two different enzymes applied to the articular 
surface for 30 minutes at 37°C (Figure 18): 2 mg/mL of bacterial collagenase 
(Worthington, type II collagenase, Lakewood, NJ), to degrade both proteoglycans and 
collagen 37,39, or 200 μg/mL of trypsin (Cellgro, 0.25% trypsin EDTA, Manassas, VA), 
to degrade only proteoglycans 28,37. Sufficient surface tension of the drop prevented 
accidental degradation of the sides of the cartilage plugs. After degradation, samples 
were serially rinsed with protease inhibitors in 1x PBS for 10 minutes.  
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Figure 18: During sample preparation (A), cartilage explants were randomly assigned 
to three groups: 2 mg/ml collagenase, 200 μg/ml trypsin, or healthy controls. With the 
bottom third of all samples submerged in PBS, drops (~10 μl) of collagenase or trypsin 
were added to the articular surface of samples. After rinsing with protease inhibitors, 
samples were cut to obtain slices measuring 4x2x1.15 mm. Degraded and healthy slices 
were then exposed to a fluorescent antibody solution (B) so that diffusion would occur 
perpendicularly to the articular surface. After 3 hours of exposure, samples diffusion 
was examined with confocal microscopy. Compositional analysis was also performed 
with Fourier transform infrared spectroscopy (FTIR), second harmonic generation 
(SHG) imaging, biochemistry, and histology. Bulk aggrecan and collagen content were 
calculated with biochemistry techniques, and was normalized to dry weight for each 
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group (?̅?) (mg/mg). Using the average relative composition from FTIR and SHG (?̅?), 
relative concentrations were scaled point by point by the ratio of ?̅? and ?̅?. 
 
Solute Transport Setup 
For all samples, 2x4x1.15 mm slices of tissue were obtained 17 and placed in two 24-
well plates (one for healthy and one for degraded) such that the articular surface and 
deep zones were exposed to media on lateral faces (Figure 18). To limit unwanted 
diffusion and tissue swelling 17,40, an impermeable platen array was placed on top of 
each 24-well plate, compressing all samples ~ 15%. As in another study 17, 350 μl of a 
chemically-stable 17,40, fluorescently-labeled (Alexa Fluor 633) antibody (150 kDa) 
solution (AbbVie Inc, Worcester, MA) was added to each well at a concentration of ~ 
2.5 μM in PBS. Samples were exposed to this solution for 3 hours 17,40. 
 
Solute Transport Analysis (1-D Spatial Diffusion Model) 
After solute exposure, all slices were bisected perpendicular to the articular surface 17. 
This cut surface of one of these slices (2x2x1.15 mm) was assessed on a confocal 
microscope stage (LSM 710, Zeiss, Germany) to characterize antibody penetration 
perpendicular to the articular surface (Figure 18). Confocal microscope and laser 
settings were similar to those described previously 17,40. Column-wise pixel averages of 
sample image data (hereby defined as fluorescence profiles) were obtained from the 
articular surface to 1000 μm deep into the tissue. The sample geometry, averaging 
technique, and cutting procedure in these experiments mitigated the effects of diffusion 
in directions that were not perpendicular to the articular surface and other imaging 
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artifacts 17,40. These fluorescence profiles can be used in place of concentration profiles 
to inform local solute diffusion mechanics 17,40.  
 
Fluorescence profiles (normalized to the fluorescence value at x = 0 μm) were broken 
down into discrete “layers,” spaced 35 μm apart, for a total of 28 layers per sample 
(from 0 – 1000 μm). Using a root mean square (RMS) error minimization procedure for 
each layer, fluorescence data within that particular layer was fit to the appropriate local 
solution of a multi-layer, transient slab diffusion equation in 1D 41, as utilized in 
previous studies 17,40. The transport model was used to calculate how solute diffusivity 
is affected locally throughout the depth in both healthy and degraded samples (Figure 
19). Model assumptions and boundary conditions were the same as previously described 
17,40.  
 
Analysis of Gross Sample Composition (Biochemistry) 
Using the same bisected half of cartilage used for confocal imaging, biochemical 
analyses were performed, as previously described 42. These samples were weighed, 
refrozen, lyophilized, and weighed again. Samples were then digested with 1.25 mg/mL 
papain solution (Sigma-Aldrich, St. Louis, MO) overnight at 60°C and analyzed for 
sulfated glycosaminoglycan (GAG) content through a 1,9-dimethylmethylene blue 
assay 43 and for collagen through a hydroxyproline assay 44. Biochemical properties 
were normalized to the dry weight of the samples and averaged within healthy and 
degraded groups.  
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Analysis of Spatial Aggrecan Sample Composition (Histology) 
The other 2x2x1.15 mm section of cartilage was then fixed in formalin, embedded in 
paraffin, and sectioned into 4-μm thick sections on glass slides. Samples were dewaxed 
in serial xylene baths and rehydrated in serial washes of ethyl alcohol 38. These samples 
were then stained with Safranin-O for 11 minutes and dehydrated to visualize aggrecan 
within the tissue (Figure 20). 
 
Analysis of Spatial Aggrecan Content (Fourier Transform Infrared Spectroscopy) 
As reported previously 38, 4-um thick sections of all samples were also placed on 2-mm-
thick, 25 mm diameter infrared transparent BaF2 disks (Spectral Systems, Hopewell 
Junction, NY). Sections were dewaxed and rehydrated as described above. In 
transmission mode, a Hyperion 2000 Fourier transform infrared imaging (FTIR) 
microscope (Bruker, Billerica, MA) obtained sample absorbance spectra (average of 32 
background-corrected scans between 600 and 4000 cm-1) with a resolution of 4 cm-1 
using a 15x objective 38. These absorbance spectra were collected at equally spaced 
intervals (35 μm) over a rectangular region of 25 x 120 mm2, from the articular surface 
to the deep zone. Using a previously validated method 38, spectra were fit to a linear 
combination of a pure type II collagen spectrum 45, a pure aggrecan spectrum 45, and a 
linear baseline over a spectral window from 900 to 1725 cm-1 38. The resulting depth-
wise, pure-compound aggrecan coefficient, which is proportional to molecular 
concentration 38, was scaled to the results of the biochemical analysis by a single 
multiplicative factor. This factor was equal to the average group-specific aggrecan 
content from biochemistry (~ 22% of the dry weight) divided by the average pure-
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compound aggrecan coefficient for each sample. Using this factor enabled the 
calculation of absolute, group-specific, depth-wise concentrations of aggrecan (Figure 
20).  
 
Analysis of Spatial Collagen Content (Second Harmonic Generation Imaging) 
Although the FTIR method enabled calculation of the spatial collagen content, this 
method could not quantify disruption of the organization of the collagen matrix in 
degraded samples. As such, second harmonic generation (SHG) imaging was used to 
obtain a better overall picture of how this degradation protocol affected the 
concentration of organized collagen through the depth of the tissue 46. Using the bisected 
sample halves used for histology, an upright confocal microscope capable of SHG 
imaging (LSM 880, Zeiss, Germany) was used to image 13-μm thick, deparaffinized 
sections of all samples. A 20x water-immersion objective with a numerical aperture of 
0.17 captured a ~1.5 μm optical slice of each sample with a resolution of 0.35 μm/pixel. 
A circular polarizer was used to prevent changes in collagen orientation from affecting 
SHG intensity. With a laser excitation wavelength of 880 nm, a non-descanned detector 
(NDD) was used to capture SHG intensity profiles from the articular surface to the deep 
zone of the tissue (0-1000 um) with a 430 – 455 nm wavelength filter in place to mitigate 
autofluorescence of the collagen and other matrix constituents. Column-wise pixel 
averages of SHG image data were then obtained and converted to organized collagen 
concentration by taking the square root of each averaged pixel value 46. This depth-wise 
collagen concentration map for each sample was normalized to group-specific gross 
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collagen content (~ 52% of the dry weight) obtained from biochemistry, which resulted 
in absolute, organized collagen concentrations for all samples (Figure 21). 
 
Statistical Analysis 
Repeated-measures two-way analysis of variance (ANOVA) was performed to 
determine the effect of degradation and depth (the repeated-measure) from the articular 
surface on local diffusivities and local composition, with subsequent Tukey post-hoc 
tests for pairwise comparisons. Linear regression was performed to assess the 
relationship between local diffusivities and composition. Analysis of covariance 
(ANCOVA) was used to compare relationships between diffusivity and composition. 
All statistics were carried out in Minitab 17 Statistical Software (State College, PA). 
 
Results 
Transport Analysis 
For healthy and degraded samples, the shape of the fluorescence profiles obtained from 
confocal images suggest that diffusion behavior is highly heterogeneous throughout the 
depth of the tissue, consistent with previous studies 16,17,40. Degrading with collagenase 
or trypsin increased local fluorescence values up to 50% higher than healthy controls 
within 0 – 400 μm and changed the shape of the fluorescence profiles in this region, but 
no differences between groups were found past that depth. Increases in local 
fluorescence were observed in areas of lower aggrecan in all samples (Figure 19), 
supporting that aggrecan content and local transport mechanics are highly related. 
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Figure 19: Fluorescence images allow calculation of fluorescence profiles for all three 
groups and determination of how degradation affects local solute diffusivities (left). 
Transport analyses showing the fluorescence curves of all experimental conditions 
(middle) and their respective local diffusivities throughout the depth of the cartilage 
(right). Samples with the surfaces degraded by either enzyme (collagenase or trypsin) 
exhibited higher fluorescence compared to the healthy controls within the first 400 μm 
from the articular surface. Degradation with either trypsin or collagenase led to higher 
diffusivities compared to healthy within the first 350 μm (*: p < 0.05, repeated-measures 
two-way ANOVA), and all groups were statistically similar at depths more than 400 μm 
(with an average of 4 μm 2/s). Collagenase-treated samples exhibited the highest local 
diffusivities (70 μm2/s at 250 μm), compared to the trypsin-treated (40 μm2/s at 250 μm) 
or healthy samples (20 μm2/s at 250 μm), and highest diffusivities at the surface (0 μm) 
of the tissue (45 μm2/s), compared to the trypsin (10 μm2/s) or healthy (4 μm2/s) groups 
(p < 0.05). Error bars (both shaded and standard) denote standard deviations with n = 4 
- 8.  
 
Using a validated multi-layer diffusion model with 28 layers 17, all samples exhibited 
heterogeneous diffusivities through the depth of the tissue (Figure 19). Healthy samples 
exhibited a maximum local diffusivity of 20 μm2/s at 250 μm from surface (p < 0.05, 
repeated-measures two-way ANOVA), whereas values near the articular surface (0-100 
μm) and deeper zones (> 400 μm) were about 4 μm2/s (Figure 19). Degradation with 
either trypsin or collagenase led to higher diffusivities within the first 350 μm (p < 0.05), 
and all groups were statistically similar at depths more than 400 μm. Collagenase-
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treated samples exhibited the highest local diffusivities (70 μm2/s at 250 μm), compared 
to the trypsin-treated (40 μm2/s at 250 μm) or healthy samples, and highest diffusivities 
at the surface (0 μm) of the tissue (45 μm2/s), compared to the trypsin (10 μm2/s) or 
healthy (4 μm2/s) groups (p < 0.05). 
 
FTIR Analysis (Local Aggrecan Composition) 
A previously established 38, linear decomposition analysis was conducted to analyze 
how aggrecan content varied as function of depth in cartilage. Linearly decomposed 
spectra closely fit the actual FTIR absorbance spectra at all tissue depths, with average 
errors between 10-15%. Overall, the biochemistry-scaled aggrecan composition of both 
healthy and degraded samples varies as a function of depth (Figure 20), as previously 
reported 38. Degradation with collagenase or trypsin led to significant decreases (up to 
40%) in aggrecan content, within the first 210 and 420 μm, respectively (p < 0.05) 
(Figure 20). Consistently, there were visible decreases in Safranin-O histological 
staining intensity in the first 0 – 250 μm from the articular surface in samples that were 
treated with trypsin and collagenase. At 100 μm, the FTIR absorbance spectra for 
degraded samples exhibited lower absorbance values near wavenumbers (~1140 – 985 
cm-1) associated with carbohydrate content 45,47,48, consistent with these samples 
containing lower amounts of proteoglycan (aggrecan) near the surface. Absorbances 
near the amide I (1720 – 1590 cm-1) and amide III (1590 – 1492 cm-1) regions 48 were 
similar for all groups and depths, suggesting that that the gross amount of collagen 
content was unchanged across all sample groups. 
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Figure 20: Safranin-O histology images (left) demonstrate how trypsin and collagenase 
degrade the proteoglycans near the surface zone of the cartilage. Absorbance spectra 
from FTIR analysis for the degraded samples compared to normal healthy controls 
(middle) at a depth of 100 μm. Collagenase and trypsin both drastically changed the 
absorbance spectra by altering the carbohydrate peak height near (1140 – 985 cm-1), 
suggesting collagenase caused greater loss of proteoglycans (including aggrecan) 
compared to trypsin. Local aggrecan composition (right) was obtained by calculating 
the depth-dependent aggrecan fitting coefficient by decomposing FTIR absorbance data 
38. This coefficient was scaled to the average dry-weight aggrecan concentration 
obtained from biochemical analysis for each group (21 – 23%) (see Supplementary 
Figure 1). Degradation with collagenase or trypsin led to significant decreases (up to 
40%) in aggrecan content, within the first 210 and 420 μm, respectively (p < 0.05). 
Aggrecan content was statistically similar past 420 μm. 
 
SHG Analysis (Local Collagen Composition) 
Since FTIR could not identify the effects of collagenase on collagen organization, SHG 
imaging was used to assess local composition of organized collagen, scaled to 
biochemistry data 46. Overall, organized collagen concentration for the healthy group 
mirrored compositional trends in collagen reported elsewhere 38,48. As anticipated, 
organized collagen concentrations in trypsin-treated samples did not differ significantly 
from healthy controls, but collagenase-treated samples exhibited significantly lower 
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organized collagen concentrations within the first 50 μm from the articular surface (p < 
0.05) (Figure 21). 
  
Figure 21: SHG images demonstrate how these enzymes affect the distribution of 
organized collagen in the tissue (left) and normalized SHG intensity profiles (middle). 
As anticipated, organized collagen concentrations in trypsin-treated samples did not 
differ significantly from healthy controls (right), but collagenase-treated samples 
exhibited significantly lower organized collagen concentrations within the first 50 μm 
from the articular surface (p < 0.05).  
 
Correlation Analysis 
Local diffusivities were compared to local collagen content obtained from SHG and 
local aggrecan content obtained from FTIR analyses. Overall, concentrations of 
collagen and aggrecan were negatively correlated with local diffusivity in all groups 
(Figure 22). Aggrecan and collagen correlations for collagenase-treated samples 
differed from correlations from the healthy group (p < 0.05, ANCOVA). Additionally, 
aggrecan and collagen content were more strongly correlated with diffusivity in the 
degraded groups (trypsin: R2 = 0.45, 0.74; collagenase: R2 = 0.86, 0.75), compared to 
the healthy group (R2 = 0.31, 0.46). The relationship between local diffusivity and 
matrix density (addition of aggrecan and organized collagen content for each depth) was 
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different between all groups (p < 0.05, ANCOVA), with the collagenase-treated group 
exhibiting the steepest slope and strongest correlation (R2 = 0.84).  
 
 
 
Figure 22: Correlations comparing local diffusivities from the transport analysis to the 
local composition obtained from FTIR and SHG for healthy (A), trypsin-treated (B), 
and collagenase-treated (C) groups. Lighter shaded data designate points near the 
articular surface of samples (within 0 – 200 μm). Overall, concentrations of collagen 
and aggrecan were negatively correlated with local diffusivity in all groups. The slopes 
of the diffusivity/composition correlations for local aggrecan and collagen content are -
78 and -47 for healthy samples, -153 and -138 for trypsin-treated samples, and -293 and 
-285 for collagenase-treated samples, respectively. Aggrecan and collagen content were 
more strongly correlated with diffusivity in the degraded groups (trypsin: R2 = 0.45, 
0.74; collagenase: R2 = 0.86, 0.75), compared to the healthy group (R2 = 0.31, 0.46). 
Additionally, aggrecan and collagen correlations for collagenase-treated samples 
exhibited steeper diffusivity/concentration relationships compared to correlations from 
the healthy group (p < 0.05, ANCOVA). In contrast to both healthy and trypsin-treated 
samples, points near the articular surface of collagenase-treated samples fell closely to 
the overall regression lines, highlighting the prohibitive nature that collagen alignment 
has on macromolecular transport. 
Discussion 
The goal of this study was to investigate how the spatial diffusion mechanics of an 
antibody relate to local cartilage structure and composition in healthy and degraded 
samples. Consistent with previous research 17, diffusion kinetics of this antibody are 
highly heterogeneous. These spatially-dependent diffusivities were found to be related 
A B C
=
C 
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to local structure and composition (0.3 < R2 < 0.9). When the collagen structure near the 
articular surface of samples was disrupted with collagenase, correlations increased in 
strength (R2 > 0.75) and these samples exhibited much higher (up to an order of 
magnitude) local diffusivities at the surface. Ultimately, this study reveals that the 
aligned surface collagen of healthy cartilage dominates diffusive hindrance of large 
therapeutics. 
 
This study used two enzymes to target the two main constituents of articular cartilage: 
trypsin and collagenase. In cartilage, trypsin cleaves sulfated GAG chains from 
aggrecan (and other smaller proteoglycans) 24,49, thus allowing them to diffuse out of 
the tissue. In addition to removing proteoglycans 39,50, collagenase denatures the triple 
helix of collagen II, cleaving the collagen molecule into smaller fragments and 
degrading intermolecular crosslinks that enable formation of organized fibrils 39. Use of 
FTIR showed that collagenase and trypsin both decrease local concentrations of 
aggrecan (a proteoglycan). Unexpectedly, FTIR did not demonstrate differences for 
absolute collagen concentrations between healthy and collagenase-treated groups 
(Supplementary Figure 2). However, use of SHG images revealed lower amounts of 
organized collagen at the surface of collagenase-treated samples within the first 50 μm. 
Thus, collagenase did not have enough time to remove significant amounts of collagen 
protein from the matrix, but was able to disrupt collagen organization by fragmenting 
collagen fibrils 39. This study therefore elucidates the relationship the role of the 
collagen structure and aggrecan depletion on macromolecular transport.  
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Making local measurements revealed that enzymatic treatment had the most profound 
effect on the diffusivity of the surface region. Application of trypsin or collagenase 
resulted in higher local diffusivities (up to 10-fold compared to healthy) at depths up to 
400 μm from the tissue surface. Although both trypsin and collagenase treatments 
increased sample diffusivities, collagenase-treated samples exhibited significantly 
higher diffusivities than trypsin treated within 0 – 100 μm (Figure 2). Because both 
enzymes degraded aggrecan similarly in this region, the higher local diffusivities in 
collagenase-treated samples are likely due to disruption of the highly aligned collagen 
at the surface.  
 
Correlations between local composition and diffusivity also point to the importance of 
the surface layer on macromolecular transport. Across all depths, healthy samples had 
the weakest correlations between aggrecan content and local diffusivity (R2 < 0.46), 
whereas these correlations for collagenase-treated samples were stronger (R2 > 0.75). 
In general, correlations were weakened in healthy samples by regions in the top 200 μm 
(light points in Figure 5), which had much lower diffusivity than would be predicted by 
relationships formed from the middle and deep regions of samples (dark points in Figure 
5). Importantly, the surface and deeper zone points within collagenase-treated samples 
formed strong, uniform relationships between local diffusivity and composition (Figure 
5c). Furthermore, if the surface points (within 0 – 200 um) were removed from the 
aggrecan correlation for the trypsin-treated group, the resulting abbreviated regression 
exhibits similar slope (m = -356) to that of the collagenase-degraded group (m = -293). 
Because the only major change between these two groups are differences in collagen 
 145 
 
structure within this region (see Figure 3 and Figure 4), this further supports the 
conclusions that an intact collagenous surface zone acts as a selective barrier to large 
solutes and that aggrecan content is a strong predictor of diffusivity in degraded 
cartilage and in the deeper zones of healthy cartilage.  
 
Although the highly aligned collagen layer at the surface has major implications for 
macromolecular transport, there is strong evidence that aggrecan concentration is more 
important for transport deeper in the tissue, where collagen content was similar for all 
groups. Compared to healthy samples at 150 μm, aggrecan content was ~ 43% lower for 
collagenase-treated samples and 25% lower for trypsin-treated samples, whereas 
diffusivities were ~ 4 and 3 times higher in this region, respectively. Thus, even a small 
decrease in aggrecan content can lead to a significant increase in local diffusivity for 
large solutes. These data are consistent with data from smaller molecules (inulin and 70 
kDa dextran) 24. Ultimately, both the surface layer and aggrecan content are critical 
factors in determining macromolecular transport throughout the depth of cartilage. 
 
While this study uses a well-established and validated experimental procedure for 
antibody diffusion 17,40, using these degradative enzymes raise some unanswered 
questions. Although desired, it is currently unknown how to degrade only the collagen 
matrix without affecting aggrecan in cartilage [?]. As such, the correlations obtained for 
collagenase-treated samples intrinsically include effects from degrading both 
constituents of cartilage. However, we argue that this type of degradation is more 
clinically relevant, since natural degradation in vivo would be similar to collagenase 
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degradation 39. There is also reason to believe that the local partition coefficient is being 
significantly affected by degradation of the aggrecan in the tissue. Fluorescence images 
show large bands of increased fluorescence that match up well with areas of lower 
aggrecan content from histology (Figure 2). Thus, it is likely that these areas are 
experiencing higher local partition coefficients, but these were not calculated in this 
study. These experiments were not conducted on mature cartilage tissue. However, 
because the structure and heterogeneities of articular cartilage are similar across species 
and age 11,51 [?], the composition and diffusivity relationships are likely transferrable to 
other types of cartilage, including adult human tissue. 
 
With the application of FTIR and SHG techniques on well-established diffusion 
protocols 17,40, this is the first study to directly examine the relationship between local 
structure/composition and local diffusion mechanics of a large therapeutic antibody 
(150 kDa) in cartilage. Overall, both local concentrations of aggrecan and collagen were 
highly correlated to local diffusivities and the highly aligned collagen at the articular 
surface was found to hinder transport of antibodies into the tissue. These relationships 
are relevant to both healthy and diseased human cartilage. With the application of in 
vivo techniques to determine local cartilage composition, such as magnetic resonance 
imaging (MRI), these data can be used to help inform and develop targeted therapies 
that are based on patient-specific cartilage composition.   
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Supplementary Material: 
   
Figure S12: Graphical depiction of the linear decomposition method to obtain local 
cartilage composition for a healthy sample at 100 μm from the articular surface. 
Measured articular cartilage spectra from FTIR were best fit to the addition of a collagen 
spectra, an aggrecan spectra, and a baseline that accounts for instrument-specific 
deviations and drift that can occur with different environmental conditions 52. This linear 
decomposition method was used to determine local aggrecan content of all samples by 
scaling the coefficient, c2, to the average dry weight aggrecan content obtained from 
biochemical analysis for each group (~ 21 – 23%). Error between measured spectra and 
best fit spectra were consistently less than 15%, for all samples and depths.  
  
AC spectra
=  𝑐1 × (Pure collagen II spectra) +   
𝒄𝟐 × (Pure aggrecan spectra) + 
[𝑐3 × (wavenumber) + 𝑐4] 
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Figure S13: Comparison of local collagen content calculated from FTIR (left) and SHG 
(right). Both methods give similar trends in collagen content as a function of depth. 
However, data calculated from FTIR decomposition did not exhibit significant 
differences between groups at any depth. Meanwhile, collagenase-treated data from 
SHG exhibited significantly lower organized collagen concentrations within the first 50 
μm from the articular surface (p < 0.05). Thus, SHG is more sensitive to the changes 
that collagenase imposes on the matrix for this degradation protocol. Likely, longer 
exposure times to collagenase would have resulted in differences between groups for 
the FTIR analysis as well.  
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CHAPTER 6 
Assessing Transport of Therapeutics in Articular Cartilage: A Review of Experimental 
Data from the Last Half Century6 
Abstract 
Objective: For the last half century, transport of nutrients and therapeutics in articular cartilage 
has been studied with various in vitro systems that attempt to model in vivo conditions. 
However, experimental technique, tissue species, and tissue storage condition (fresh/frozen) 
vary widely and there is debate on the most appropriate model system. Additionally, there is 
still no clear overarching framework with which to predict solute transport properties based on 
molecular characteristics. This review aims to develop such a framework, and to assess whether 
experimental procedure affects trends in transport data. 
 
Methods: Solute data from 31 published papers that investigated transport in healthy articular 
cartilage were obtained and analyzed for trends. 
 
Results: Here, we show that diffusivity of spherical and globular solutes in cartilage can be 
predicted by molecular weight and hydrodynamic radius via a power-law relationship. This 
relationship is robust for many solutes, spanning 5 orders of magnitude in molecular weight and 
was not affected by variations in cartilage species, age, condition (fresh/frozen), and 
experimental technique. Traditional models of transport in porous media exhibited mixed 
effectiveness at predicting diffusivity in cartilage, but were good in predicting solute partition 
coefficient.  
 
Conclusion: Ultimately, these robust relationships can be used to accurately predict and improve 
transport of solutes in adult human cartilage and enable the development of better optimized 
arthritis therapeutics.  
 
6This work has been submitted for publication: C. DiDomenico and L. J. Bonassar, 
“Assessing Transport of Therapeutics in Articular Cartilage: A Review of Experimental Data 
from the Last Half Century.”  
Submitted to the Osteoarthritis and Cartilage. 
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Introduction 
During arthritis, cartilage homeostasis is disrupted from various inflammatory factors 
that are produced from joint tissues1–5. For instance, there is evidence that diseased 
chondrocytes within cartilage produce inflammatory cytokines and play a significant 
role in osteoarthritis (OA) progression1,6–8. Thus, effective treatment of OA necessitates 
penetration of therapeutic molecules into cartilage to reach target chondrocytes9–11. 
Small non-steroidal anti-inflammatory drugs (NSAIDs) and steroids (~ 0.5 nm in size) 
are currently used to treat OA9,12–14, but there is interest in developing larger therapeutics 
(up to 6 nm in size)15. Use of large therapeutic antibodies have been effective in other 
arthritic diseases, including rheumatoid arthritis (RA)4, but remains understudied for 
treatment of OA. Because of the wide variation in size of potential therapeutics (0.5 – 6 
nm in hydrodynamic radii), understanding how molecular transport occurs within highly 
heterogeneous cartilage is important to the design of future therapies. 
 
Articular cartilage is a highly dense, avascular tissue that relies on diffusion of nutrients 
and growth factors to maintain equilibrium with the surrounding synovial fluid in the 
joint space. It is comprised of two main solid components, type-II collagen (18%) and 
aggrecan (8%)16,17. In this tissue, large collagen fibrils (~ 50 nm in diameter)18 are highly 
aligned along the surface and transition to a more perpendicular alignment to the 
subchondral bone in the deep region19. Because of the negatively-charged 
glycosaminoglycans (GAGs) attached to aggrecan, articular cartilage is highly charged 
and has a very small effective pore size16–18,20. Additionally, the concentrations of these 
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components vary spatially within the tissue and lead to many different heterogeneities 
that affect solute transport.  
 
The first body of work that investigated molecular transport in cartilage dates to over 
50 years ago 20,21. Studies conducted by Maroudas et al20–23 primarily investigated 
diffusion kinetics of smaller ions and sugars, which are important to the homeostasis of 
cartilage in vivo16. As our understanding of smaller solutes grew, others investigated 
kinetics of small proteins and growth factors24–26, which are also found naturally in the 
joint space. Near the turn of the 21st century, the focus of the field turned to dextrans, 
linear polysaccharides that have been used as surrogates for larger molecules because 
of their customizability27. Consequently, dextrans were used to investigate how 
transport was affected by large changes in hydrodynamic size or molecular weight (3 
kDa – 500 kDa)28–30. Despite their therapeutic potential, transport of large antibodies 
(25 – 200 kDa) has only recently been comprehensively examined15,31,32. Ultimately, 
the diversity of molecules studied for transport in cartilage is remarkable, and there are 
dozens of studies that have contributed to the knowledge in this field. However, despite 
this work, there is no clear framework from which to predict transport of these 
molecules, which range widely in size and shape. Developing such a framework can be 
very useful in deciding which molecules are most appropriate for use as arthritis 
therapies. 
 
In this review, we first describe techniques used to measure transport in porous media 
such as cartilage. We then consolidate transport data from 31 individual studies on 47 
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unique solutes spanning 7 Da – 500 kDa and 0.1 – 16 nm (summarized in Supplementary 
Table S1). Analysis of such data demonstrate that diffusivity of spherical solutes is 
strongly predicted (R2 = 0.81) by molecular weight and hydrodynamic radius with a 
power-law relationship. This relationship is insensitive to the specific experimental 
procedure used and tissue age or species. Further, we review the extent to which such 
trends in data can be explained by steric hindrance or frictional drag of molecules 
moving through the cartilage matrix. We end on a discussion of future work that should 
be done to further strengthen the findings from this review and how such findings can 
inform design of therapeutics. 
Experimental techniques used to measure transport 
For the last half-century, transport fundamentals have been studied with in vitro systems 
that attempt to maintain a high degree of physiologic relevance to in vivo conditions. 
Even though these systems measure transport in different ways, all result in 
quantification of diffusivities and/or partition coefficients (Table 2). All such methods 
require measuring solute concentration in cartilage, either in bulk tissue or locally. For 
example, computed tomography (CT)33–37 uses radio-opaque tracers to measure and 
spatially map solutes. Nuclear magnetic resonance (NMR) spectroscopy26,38,39 relies on 
molecular vibrations and relaxations to measure and track local solutes. Other methods, 
such as solute desorption techniques18,21,23,24,30,40–43 or diffusion cells20,22,23,25,43–46, rely 
on quantifying a volume of solute that diffuses through a sample over a given time, often 
using fluorescent or radioactive labels. Additionally, there are methods that track local 
fluorescence of a labeled solute within cartilage, such as fluorescence recovery after 
photobleaching (FRAP)32,47, and fluorescence gradient techniques28,29,32,46–48. 
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Table 2: Summary of how experimental techniques have been used to quantify transport. 
All of these methods rely on visualizing a solute in cartilage, either by using contrast 
agents, NMR-active solutes, or attaching fluorophores or radiolabels to the solute of 
interest. In general, most of these techniques have been used to measure average, bulk 
transport properties, except for FRAP. To date, local transport properties have not been 
extensively studied, but can be measured using most techniques (denoted with at *). 
Experimental 
Technique 
Method of 
Visualizing 
Solute 
Have been used to 
measure bulk transport? 
Have been used to 
measure local transport? 
Diffusivity 
Partition 
Coefficient 
Diffusivity 
Partition 
Coefficient 
Computed 
Tomography 
Radioactive 
contrast 
agent 
Yes Yes Yes Yes 
Nuclear 
Magnetic 
Resonance 
NMR-active 
solute 
Yes − * − 
Diffusion Cell 
Radiolabel 
or 
fluorophore 
Yes − * − 
Solute 
Absorption and 
Desorption 
Radiolabel 
or 
fluorophore 
Yes Yes * * 
Fluorescence 
Recovery after 
Photobleaching 
Fluorophore − − Yes − 
Fluorescence 
Gradient 
Fluorophore Yes Yes Yes * 
 
Before the turn of the 21st century, widespread use of diffusion cells and solute 
absorption/desorption protocols have enabled a much better understanding of transport 
on a large (bulk) scale. Even today, they remain popular and are very robust in their 
ability to study transport. Recently, other techniques, such as FRAP and fluorescence 
gradient protocols, were developed that enabled the study of transport on a more local 
scale (< 100 μm) (Table 2). These techniques rely on high-resolution microscopic 
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techniques to visualize fluorescently-tagged molecules in cartilage. Other more 
clinically-motivated techniques, such as CT, have also been used to study local 
transport. Because of its very high resolution, the continued use of CT for solute 
transport is very promising. 
Characterizing transport mechanics 
Extracting trends from 50 years of work in this field requires an understanding of how 
molecular transport is analyzed in porous tissues, such as cartilage. Molecular transport 
is a complex phenomenon that is governed by three main contributions: stagnant liquid 
film generation at the cartilage-fluid interface; the solute partition coefficient; and the 
mobility of the solute inside cartilage23. For the techniques described above, 
contributions of transport due to stagnant film generation can be neglected due to 
stirring of the solute bath or by using thick tissue samples23. Additionally, because of 
joint movement and tissue thickness (~ 1 mm), stagnant film generation is likely 
negligible in vivo. As such, this review will only focus on analysis of solute mobility 
and partition coefficient.  
 
Solute mobility 
Three main phenomena dominate solute mobility: diffusion, how fast a molecule will 
move along a concentration gradient; convection, the movement of solutes induced by 
interstitial fluid flow; and electrochemical migration49–53, movement induced by charge-
based interactions between the solute and matrix. Mobility (i.e. transport) of solutes can 
therefore be accurately described by the addition of diffusive, convective, and 
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electrochemical flux49,54,55. Assuming Fickian diffusion and incompressible fluid flow, 
the total solute flux into cartilage can be defined as54,55: 
?⃗? = 𝒋𝒅𝒊𝒇𝒇𝒖𝒔𝒊𝒐𝒏 + 𝒋𝒄𝒐𝒏𝒗𝒆𝒄𝒕𝒊𝒐𝒏 + 𝒋𝒆𝒍𝒆𝒄𝒕𝒓𝒐𝒄𝒉𝒆𝒎𝒊𝒄𝒂𝒍 = −𝑫𝜵𝑪 + 𝝎?⃗⃗?𝑪 −
𝑫𝑪𝒛𝑭
𝑹𝑻
𝜵𝝍 (𝑬𝒒. 𝟏) 
where J is the solute flux, D is the solute diffusivity, C is the concentration of the solute, 
ω is the solute convection coefficient (also known as the retardation coefficient), v is 
the interstitial fluid velocity relative to the solid matrix, z is the net charge of the 
molecule, F is Faraday’s constant, R is the universal gas constant, T is the absolute 
temperature of the solution, and ψ is the electrical potential. The diffusivity and 
convection coefficient quantify the diffusive speed of the molecule and the ratio of 
solute convective velocity to interstitial fluid velocity, respectively. These metrics can 
be measured as an average for the entire tissue, or measured locally32. If electrochemical 
gradients are not considered, both the convection and diffusion coefficient can 
intrinsically include steric, hydrodynamic, and physiochemical effects of the solute in 
cartilage49. Overall, there are many potential solutions to Eq. 1, with and without 
convection and electrochemical gradients considered56,57. Because the vast majority of 
research has focused on quantifying solute diffusion, this review will focus on 
synthesizing diffusion data in the absence of significant contributions from convection 
or electrochemical gradients. 
 
Partition coefficient 
Partition coefficient, which is the equilibrium concentration of the solute in the cartilage 
compared to the concentration of the solute in the surrounding bath, usually varies 
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between 0 and 1, but it can be higher than unity in some cases22,45,46. The partition 
coefficient of a solute depends on the volume accessible to the solute in the tissue 
matrix, and the affinity of the matrix for the solute22. Because of the small pore network 
of cartilage, some solutes are can only occupy a portion of the total available pores, 
which causes the partition coefficient to be less than unity. Electrostatic forces between 
charged solutes and the negatively charged matrix also can drastically affect 
partitioning. The partition coefficient can be measured for the whole tissue or it can be 
measured locally within the cartilage22,43,58.  
Assessing frameworks for solute transport in cartilage 
Even though there has been no explicit framework developed for cartilage, several 
empirical relations have been proposed to describe how diffusivity changes with 
molecular weight or solute size in other porous media. Diffusivity has been described 
with the relation55,59,60: 
𝑫 = 𝑨𝟏(𝑴𝑾)
−𝒂𝟐  (𝑬𝒒. 𝟐) 
where A1 is an empirical constant, MW is the molecular weight of the solute, and a2 is 
an empirical constant. These constants depend on many tissue and solute factors55. 
Additionally, diffusivities have been shown to follow a similar relationship with 
hydrodynamic radius61. To date, these relationships were developed from observing 
solutes of varying size/MW diffuse through membrane filters60,61 and various 
tissues59,62, but these relations have not been extensively tested for solutes in cartilage. 
Thus, we will examine solute diffusivity and partition coefficient with respect to the 
relationship in Eq. 2. 
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Solute diffusivity depends on molecular weight and hydrodynamic radius 
The combined effort of this field over 50 years has generated a significant cohort of data 
that can be used to assess the relationship between molecular size and solute transport 
in cartilage. Diffusivity data collected from the literature (from 31 studies and 47 unique 
solutes) were examined across a range of molecular weights and hydrodynamic radii 
(Figure 23). Data was also divided up into two solute groups: “linear” and “spherical.” 
Dextran and chondroitin sulfate have demonstrated the ability to change from a random 
coil conformation to a more chain-like (linear) conformation in solution63, and were 
classified as linear. All other solutes were classified as spherical, with chemical 
compositions that dictate a more rigid structure in solution. Ultimately, across spherical 
solute data, the relationship between solute diffusivity and molecular weight (7 Da – 
200 kDa) or hydrodynamic radius (0.1 to 7 nm) was well described (R2 = 0.81) by a 
power-law relationship stated in Eq. 2. Diffusivities of linear solutes, such as dextran, 
were not well described (R2 = 0.07 – 0.25) by a power-law and deviated significantly 
from spherical solutes (ANCOVA, p < 0.05). The disparity between spherical and linear 
solute data suggests that linear solutes exhibit fundamentally different transport 
mechanics in cartilage64. As such, all future data analyses will investigate linear and 
spherical solutes separately. 
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Figure 23: Variability in diffusivity is largely predicted by solute molecular weight or 
hydrodynamic radius. Pooled solute diffusivity data from 31 individual papers, plotted 
as a function of solute molecular weight (MW) (left) and hydrodynamic radius (right). 
Data includes spherical (filled points) and “linear” (open points) solutes. All “linear” 
solute data points were obtained from diffusion studies using variously sized dextran or 
chondroitin sulfate molecules. All other solutes were classified as spherical. Values for 
hydrodynamic radii were obtained directly from the cited literature; if this was not cited, 
an empirical relationship (𝒓𝒔 = 𝟎. 𝟎𝟑𝟑𝟐𝑴𝑾
𝟎.𝟒𝟔𝟑)65, was used to estimate 
hydrodynamic radius. Spherical solute diffusivity in cartilage was found to be very 
strongly correlated (black) to both molecular weight and hydrodynamic radius, 
obtaining an R2 = 0.81 for both solute metrics. Best fits for linear solutes (gray) were 
weak (R2 < 0.3), and deviated from spherical solutes, indicating that linear solutes 
diffuse differently in cartilage tissue. On average, linear solutes had higher diffusivities 
than spherical solutes of similar size, which may be due to the ability of linear solutes 
to change conformation as they move through the matrix. 
 
There has been a wide variety of techniques and tissues sources used to study solute 
transport in cartilage. As such, there is considerable debate about the appropriateness of 
these tissue sources and techniques. To assess whether these techniques and tissue 
sources function similarly, we evaluated the relationship between diffusivity and 
 166 
molecular weight or size with respect to experimental technique. Spherical solute data 
was grouped into experimental techniques: computed tomography/nuclear magnetic 
resonance spectroscopy (CT/NMR), diffusion cell, solute desorption, and fluorescence 
gradient (Figure 24A). Tissue was also separated into tissue types: adult human, mature 
bovine and equine, and immature bovine cartilage (Figure 24B). Finally, data was also 
separated based on tissue storage condition before experimentation: fresh or frozen 
(Figure 24C). Ultimately, there were no differences in relationship between spherical 
solute size and diffusivity across all data groupings (ANCOVA, using log-transformed 
data, p > 0.05). These trends strongly support that diffusivity for spherical solutes can 
be accurately predicted in cartilage regardless of tissue age and species or experimental 
technique. These data were also compared to several mechanistic transport models, 
presented below. 
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Figure 24: The relationship between solute diffusivity and size does not depend on 
measurement technique, tissue species, tissue age, or tissue storage method. Pooled 
solute diffusivity data compared against different experimental techniques (left), tissue 
species/age (middle), and tissue storage condition (right). Data was grouped into 5 
different experimental techniques: computed tomography/nuclear magnetic resonance 
spectroscopy (CT/NMR), diffusion cell, solute desorption, fluorescence recovery after 
photobleaching (FRAP), and fluorescence gradient (left). Linear solutes (open points) 
were also included for completeness in graph A, but only spherical solutes were 
included in the best-fit curves (black). Tissue was also separated into tissue types: adult 
human, mature bovine and equine, and immature bovine cartilage (middle). Finally, data 
was also separated based on tissue storage condition before experimentation: either 
fresh or frozen (right). Across all data groupings for spherical solutes, the relationship 
between diffusivity and size did not differ between groups or from the relationship 
formed from the pooled data (ANCOVA, using log-transformed data, p > 0.05). This 
strongly supports that diffusivity can be accurately predicted in cartilage regardless of 
the parameters used in individual experiments. 
 
Models exhibit mixed effectiveness in predicting solute transport 
Mechanistic models have been used to predict transport of solutes in various porous 
media, such as soil and hydrogels. However, there is limited assessment of these models 
for their ability to describe transport in cartilage, and this assessment has been limited 
to narrow ranges of solute size43. Additionally, the appropriateness of such models to 
predict transport for larger therapeutics, such as antibodies or growth factors, is unclear. 
We examined three prominent transport models with varying assumptions. Due to the 
formulation of these models, they are only appropriate for spherical molecules, and not 
linear solutes. These models assume that diffusivity of spherical solutes in cartilage can 
be approximated by multiplying the solute diffusivity in water by frictional 
(hydrodynamic) or steric hindrance factors55. Additionally, they rely on the assumption 
that solute diffusivity decreases as the size of the diffusing solute approaches the size of 
the pores in the matrix. One prominent relation, was developed by Renkin et al66: 
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𝐷 = (1 −  𝜆)2 ∙  (1 − 2.1𝜆 + 2.1𝜆3 − 0.95𝜆5) ∗ 𝐷0 ≈ (1 − 
𝑟𝑠
𝑟𝑝
)
4
∗ 𝐷0 (𝐸𝑞. 3) 
 
where λ is defined as rs/rp, rs is the hydrodynamic radius of the solute, rp is the effective 
pore size of the matrix, D is the diffusivity of the solute in cartilage and D0 is the solute 
diffusivity in free solution. Typical effective pore radii for this tissue range from 4-10 
nm, with highest values near the articular surface16,21. The solute diffusivity in free 
solution of a dilute, spherical (and most linear67,68) solute in solution can be calculated 
using the Stokes-Einstein equation69,70: 
 
𝐷0 = 
𝑘𝐵𝑇
6𝜋𝜂𝑟𝑠
 (𝐸𝑞. 4) 
 
where kB is Boltzmann’s constant, T is the absolute temperature of the solution, and η is 
the solvent viscosity. In Eq. 3, the first term represents exclusion of solute from the 
membrane pores based on geometrical considerations and the second term represents 
hydrodynamic drag on the solute molecules due to the pores71.  
 
The Brinkman model, based on hydrodynamic theory72, relates solute diffusivity to 
solute hydrodynamic radius and the Darcy permeability of the cartilage tissue 73:  
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𝐷 =  
1
1 +
𝑟𝑠
√𝜅
+
𝑟𝑠2
3𝜅
∗ 𝐷0 (𝐸𝑞. 5) 
        
where κ is the Darcy permeability of cartilage (~ 1 nm2 74,75), an intrinsic property of 
the tissue that quantifies how easily interstitial fluid flow can occur. The Darcy 
permeability can also be thought of as a surrogate for pore size in the matrix, with 
smaller values representing a smaller pore size. 
 
For spherical solutes across a broad range (0.1 – 7.6 nm) of hydrodynamic sizes, both 
the Brinkman and Renkin models fit pooled data poorly, assuming an effective pore 
radius of 7 nm and a Darcy permeability of 1.0 nm2 (Figure 25), which were chosen to 
represent averages reported in the literature. For the Renkin model, the root-mean-
squared error (RMSE) including all data points was 328 μm2/s, and the coefficient of 
variance (COV) was 116%. For the Brinkman model, RMSE was 287 μm2/s, and the 
COV was 101%. If model parameters were optimized to minimize error across all 
collected data, values for the effective pore radius was 3.6 nm and Darcy permeability 
was 0.4 nm2. Using these optimized parameters did not reduce RMSE significantly (< 
20%), and so the use of average literature values was deemed appropriate. With these 
literature-based parameters, models generally overestimated D for smaller solutes (rs < 
0.5 nm) and underestimated D for larger (rs > 5 nm) solutes. These two popular models 
are thus not ideal for predicting solute diffusivity in cartilage. 
 170 
 
 
Figure 25: Mechanistic transport models are inconsistent in predicting solute diffusivity 
in cartilage. Transport models for solute diffusivity (left) and partition coefficient (right) 
were compared to aggregate literature data. Diffusivities for all spherical solutes were 
compared to three prominent models (left): Renkin, Brinkman, and Clague and 
Phillips66,73,76. Across this spherical solute data, root mean square (RMS) error [μm2/s], 
coefficient of variance (COV), and R2 are presented (based on untransformed data). 
Both the Brinkman and Renkin models did not fit pooled data adequately, assuming an 
effective pore radius of 7 nm and a Darcy permeability of 1.0 nm2. The pooled data was 
well-fit to the Clague and Phillips relation assuming a total volume fraction of 0.25 and 
an effective fiber radius of 4 nm. However, a simple power-law relationship was found 
to best-fit the data. Right: The Ogston model was used to predict partition coefficients 
of spherical solutes assuming a volume fraction and effective fiber radius of aggrecan 
to be 0.08 and 0.475 nm, respectively. Overall, for neutrally-charged, spherical solutes, 
the Ogston model was predictive of solute partition coefficient. Partition coefficients 
for linear solutes (open points), such as dextran, deviated significantly from spherical 
solutes. 
 
Ultimately, one of the only known transport relations that was accurate over the entire 
range of pooled spherical solute data was a model developed for stiff hydrogels by 
Clague and Phillips 76. The first term of this relation accounts for the steric exclusion of 
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the solute from the cartilage matrix, while the second term accounts for hydrodynamic 
drag imparted on the solute76: 
 
𝑫 = (𝟏 +
𝟐
𝟑
𝜶)
−𝟏
∗ 𝒆𝒙𝒑(−𝝅𝜽𝒕
𝟎.𝟏𝟕𝟒 𝒍𝒏(𝟓𝟗.𝟔
𝒓𝒇,𝒕
𝒓𝒔
)
) ∗ 𝑫𝟎 ;  𝜶 =  𝜽 ∗ (
𝒓𝒔 + 𝒓𝒇,𝒕
𝒓𝒇,𝒕
)
𝟐
(𝑬𝒒. 𝟔) 
where θt is total matrix fiber fraction (typically ranging from 0.20-0.35 in healthy 
articular cartilage77,78), and rf,t is the effective fiber radius for all matrix constituents. 
The individual effective fiber radii of the GAGs, aggrecan core protein, and collagen in 
cartilage have been reported to be 0.55 nm, 0.4 nm, and 11-50 nm, respectively77,79,80. 
Thus, the effective fiber radius of all combined constituents in cartilage has been 
estimated to be between 2-6 nm77. The pooled data from the literature was moderately 
well-fit to this relation assuming a total volume fraction of 0.25 and an effective fiber 
radius of 4 nm (Figure 25). For this model, the RMSE was 194 μm2/s, COV was 69%, 
and R2 was 0.71. If model parameters were optimized to minimize error, values for the 
effective fiber radius was 3.68 nm and fiber volume fraction of cartilage was 0.20, which 
is consistent with assumed literature values. Due to the complexity of molecular 
transport, many more transport models exist63,72, but they were not found to better 
predict the pooled data. 
 
The fact that a simple, empirical power-law relationship better predicted solute 
diffusivity compared to mechanistic transport models is notable. Additionally, these 
mechanistic models were inconsistent in predicting diffusivity. The Clague and Phillips 
model includes both steric and hydrodynamic solute/matrix interactions, which is likely 
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why this model outperformed the Brinkman (hydrodynamic) and Renkin (steric) 
models. However, all current transport models were developed specifically for 
hydrogels with only one fiber species, which may not be appropriate for cartilage. These 
models also do not attempt to account for charge or osmotic interactions between the 
solute and matrix. With the exception of the Clague and Phillips model, we urge caution 
in using these models to estimate diffusivity of most solutes in cartilage, and argue that 
cartilage-specific models that include both steric and hydrodynamic solute/matrix 
effects be developed in the future. 
 
Partitioning depends on solute size 
As with diffusivity, molecular size would be expected to influence partitioning of solute 
in cartilage. To assess such effects, solute partition coefficients were collected from a 
host of studies across a range of solute sizes (Figure 25). Because we only wanted to 
analyze data as a function of solute size, data for charged ions (such as Na+) and other 
significantly charged (5 > isoelectric point, pI > 8) solutes were not included in this 
analysis (Figure 25). Overall, partition coefficients for both spherical and linear solutes 
decreased exponentially with solute hydrodynamic radius (Figure 25). However, linear 
solutes consistently had higher partition coefficients than similarly-sized spherical 
solutes. With respect to partition coefficients and diffusivities, it is apparent that linear 
solutes and spherical solutes exhibit vastly different transport mechanics in cartilage 
tissue. This literature data was also compared to a mechanistic model, presented below. 
 
Ogston partitioning model is accurate 
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One popular relation, based on steric exclusion theory81, was derived by Ogston80,82 to 
describe partitioning of spherical solutes in cartilage by linear rod-like macromolecules 
(most commonly assumed to be sulfated GAGs or the entire aggrecan molecule)43,55. 
Literature data was compared to the Ogston model43 that considers partitioning of 
solutes from the entire aggrecan molecule:  
𝐾 =
exp(−𝜃𝑎𝑔𝑔 (1 +
𝑟𝑠
𝑟𝑓,𝑎𝑔𝑔
)
2
)
1 − 𝜃𝑎𝑔𝑔
 (𝐸𝑞.  7)
 
 
where θagg is the volume fraction of aggrecan, rf,agg is the average effective fiber radius 
of aggrecan in cartilage, and K is the partition coefficient of the solute. The solid volume 
fraction and effective fiber radius of aggrecan in healthy articular cartilage is about 0.08, 
and 0.475 nm, respectively43,77,78,80. Based on this Ogston model, solute partition 
coefficients are very sensitive to the size of the solute and aggrecan density22.  
 
Overall, for neutrally-charged, spherical solutes, the Ogston model (Eq. 7) was 
predictive of solute partition coefficient values previously reported (Figure 25). Across 
data for spherical solutes, the Ogston model exhibited a RMSE of 0.21, COV of 40%, 
and a R2 of 0.63, assuming a solid volume fraction and effective fiber radius of aggrecan 
to be 0.08, and 0.475 nm, respectively. These literature-based parameters were within 
10% of model parameters that were optimized for error minimization. As anticipated, 
partition coefficients of linear solutes were not well predicted by the Ogston model 
(Figure 25).  
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Discussion 
This review consolidates over 50 years of cartilage transport data that has been collected 
using a wide variety of solutes, experimental techniques, and tissue types. The synthesis 
of this very large cohort of data enables us to make several important conclusions. First, 
linear molecules, such as dextrans, exhibited significantly higher diffusivities and 
partition coefficients compared to spherical solutes. Even though the study of linear 
solutes in cartilage is useful, they are clearly not good predictors of transport for 
similarly-sized proteins. Second, a simple power-law relationship fit all spherical solute 
data very well (R2 = 0.81), spanning several orders of magnitude in molecular weight 
(7 Da – 200 kDa). Additionally, the relationship between solute diffusivity and solute 
size did not change with different experimental techniques, tissue species used, or tissue 
condition prior to use (fresh/frozen). This robust relationship, valid across several orders 
of magnitude in solute size, allows researchers to accurately predict solute transport in 
cartilage and design arthritis therapies that have optimized transport kinetics. 
Surprisingly, this power-law relationship holds beyond the average pore size of cartilage 
(~ 6 nm), which suggests that the tissue consists of a wider distribution of pore sizes 
than previously thought. This also opens the possibility that even larger (> 7.5 nm) 
molecules can penetrate cartilage. As such, nanoparticles, which can be functionalized 
with various therapeutics83, could be a promising avenue for future arthritis therapies.  
 
Despite many significant findings with the analysis of this large data set, several 
prominent knowledge gaps remain. With the discovery of a strong, simple empirical 
relationship between solute diffusivity and solute size, one would expect that 
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mechanistic transport models would also be predictive of solute diffusivities. 
Unfortunately, reported transport models were not consistent in their ability to predict 
solute diffusivities over a broad range of solute sizes. This is likely because all such 
models have been designed specifically for hydrogels with one fiber type, and may be 
too simple to describe cartilage. Additionally, these models clearly assume a very 
narrow distribution of pore sizes, and cannot account for the hierarchical pore structure 
that is evident in articular cartilage. While the best hydrogel-based transport model 
(Clague and Phillips76) was accurate (COV: 69%, R2: 0.71) over the entire data range, 
development of a new transport model designed specifically for cartilage would be 
useful and could help predict transport locally within the tissue. The success of the 
Clague and Phillips model also indicates the importance of including both steric 
hindrance and frictional effects in future cartilage-based models.  
 
The relationships in this review were assessed with transport data from healthy articular 
cartilage. However, clinical treatment of OA is usually administered after tissue damage 
has occurred. This tissue damage likely increases the ability of solutes to penetrate 
cartilage30,84, but few studies have investigated this phenomenon30,85–87. As such, 
developing new relationships or mechanistic models that consider the local composition 
of the cartilage would be very helpful to develop new strategies for arthritis treatments 
with patients with late-stage OA. 
 
Ultimately, we discovered a very strong empirical relationship between bulk diffusivity 
and solute size across a large range of solute radii (0.1 – 7.6 nm) and molecular weights 
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(10 Da – 200 kDa). This empirical relationship was more predictive of solute diffusivity 
than any published mechanistic model and was insensitive to the experimental method 
and tissue species used. Additionally, partitioning of solutes over this range was well 
predicted by an existing mechanistic model. This predictive power of these relationships 
is very useful for the design and customization of arthritis therapeutics with the most 
desirable transport kinetics into articular cartilage. 
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Supplementary Material: 
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Solute Shapea 
MW 
(Da) 
Hydrodynamic 
Radius (nm)b 
Diffusivity 
(μm2/s)c 
D0 
(μm2/s)d 
D/D0 
Partition 
Coefficient 
(K)e 
Tissue 
Usedf 
Method to 
Obtain 
Diffusivity 
Tissue 
Conditiong 
Reference Notes 
Li+ Spherical 7 0.08 1423 2847 0.50 - 
Immature 
bovine 
Nuclear 
magnetic 
resonance 
(NMR) 
Fresh 
39 Burstein 
1993 
1 
Water Spherical 18 0.10 1200 2327 0.52 1.00 
Adult 
human 
Diffusion cell 
(Radiolabel) 
Frozen 
21 Maroudas 
1968 
 
Water Spherical 18 0.10 1396 2327 0.60 - 
Immature 
bovine 
Nuclear 
magnetic 
resonance 
(NMR) 
Fresh 
39 Burstein 
1993 
 
Na+ Spherical 23 0.10 500 2327 0.21 1.50 
Adult 
human 
Diffusion cell 
(Radiolabel) 
Frozen 
21 Maroudas 
1968 
12 
Na+ Spherical 23 0.10 1466 2327 0.63 - 
Immature 
bovine 
Nuclear 
magnetic 
resonance 
(NMR) 
Fresh 
39 Burstein 
1993 
 
Cl- Spherical 35 0.18 750 1293 0.58 0.75 
Adult 
human 
Diffusion cell 
(Radiolabel) 
Frozen 
21 Maroudas 
1968 
11 
K+ Spherical 39 0.14 740 1724 0.43 - 
Adult 
human 
Diffusion cell 
(Radiolabel) 
Frozen 
21 Maroudas 
1968 
12 
Ca+ Spherical 40 0.18 150 1270 0.10 3.00 
Adult 
human 
Diffusion cell 
(Radiolabel) 
Frozen 
21 Maroudas 
1976 
12 
Urea Spherical 60 0.18 600 1293 0.46 1.00 
Adult 
human 
Diffusion cell 
(Radiolabel) 
Frozen 
23 Maroudas 
1970 
 
Sulfate Spherical 96 0.24 300 962 0.31 0.60 
Adult 
human 
Diffusion cell 
(Radiolabel) 
Frozen 
22 Maroudas 
1976  
11 
Sulfate Spherical 96 0.35 240 665 0.36 0.68 
Mature 
bovine 
Diffusion cell 
(Radiolabel) 
Frozen 25 Garcia 1996  11 
Leucine Spherical 139 0.33 169 (4°C) 
372 
(4°C) 
0.45 - 
Adult 
human 
(hip) 
Diffusion cell 
(Radiolabel) 
Frozen 43 Nimer 2003 1 
Sodium Iodide Spherical 150 0.34 475 744 0.64 - 
Mature 
bovine 
Computed 
tomography 
(CT) 
Fresh 
33 Kulmala 
2010  
1 
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Solute Shapea 
MW 
(Da) 
Hydrodynamic 
Radius (nm)b 
Diffusivity 
(μm2/s)c 
D0 
(μm2/s)d 
D/D0 
Partition 
Coefficient 
(K)e 
Tissue 
Usedf 
Method to 
Obtain 
Diffusivity 
Tissue 
Conditiong 
Reference Notes 
Sodium Iodide Spherical 150 0.34 428 744 0.58 0.90 
Mature 
bovine 
Solute 
desorption 
(Fluorophore) 
Frozen 85 Chin 2013 1 
Sodium Iodide Spherical 150 0.34 475 744 0.64 0.70 
Mature 
bovine 
Computed 
tomography 
(CT) 
Fresh 35 Silvast 2013 
1, 9, 
12 
Sodium Iodide Spherical 150 0.34 474.7 1052 0.45 0.77 
Mature 
bovine 
Computed 
tomography 
(CT) 
Fresh 
37 Kokkonen 
2017 
1, 9 
Sodium Iodide Spherical 150 0.34 838 744 1.13 0.74 
Mature 
bovine 
Solute 
desorption 
(Other) 
Frozen 
88 Shafieyan 
2014 
1 
Glucose Spherical 180 0.37 608 894 0.68 0.72 
Immature 
bovine 
Solute 
desorption 
(Radiolabel) 
Frozen 89 Torzilli 1998   
Glucose Spherical 180 0.37 403 894 0.45 0.76 
Mature 
bovine 
Solute 
desorption 
(Radiolabel) 
Frozen 90 Torzilli 1987  1 
Glucose Spherical 180 0.37 403 894 0.45 0.76 
Mature 
bovine 
Solute 
desorption 
(Radiolabel) 
Frozen 30 Torzilli 1997   
Glucose Spherical 180 0.37 563 894 0.63 0.67 
Mature 
bovine 
Solute 
desorption 
(Radiolabel) 
Frozen 89 Torzilli 1998   
Glucose Spherical 180 0.37 483 (37°C) 
894 
(37°C) 
0.54 0.36 
Mature 
equine 
and 
bovine 
Solute 
desorption 
(Radiolabel) 
Frozen 
91 Allhands 
1984 
15 
Glucose Spherical 180 0.37 220 632 0.35 0.90 
Adult 
human 
Diffusion cell 
(Radiolabel) 
Frozen 
21 Maroudas 
1968 
 
Thymidine Spherical 242 0.46 320 506 0.63 0.78 
Mature 
bovine 
Diffusion cell 
(Radiolabel) 
Frozen 25 Garcia 1996  
Fluorescein Spherical 332 0.49 - 477 - 0.7 
Immature 
bovine 
Fluorescence 
gradient 
Frozen 92 Albro 2011 1, 4 
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Solute Shapea 
MW 
(Da) 
Hydrodynamic 
Radius (nm)b 
Diffusivity 
(μm2/s)c 
D0 
(μm2/s)d 
D/D0 
Partition 
Coefficient 
(K)e 
Tissue 
Usedf 
Method to 
Obtain 
Diffusivity 
Tissue 
Conditiong 
Reference Notes 
Sucrose Spherical 342.3 0.50 130 465 0.28 1.00 
Adult 
human 
Diffusion cell 
(Radiolabel) 
Frozen 
23 Maroudas 
1970 
 
Tetra-methyl-
rhodamine 
(TMR) 
Spherical 430 0.55 70 423 0.17 1.69 
Mature 
bovine 
Solute 
desorption 
(Fluorophore) 
Frozen 58 Quinn 2000 
2, 7, 
12 
Tetra-methyl-
rhodamine 
(TMR) 
Spherical 430 0.55 52 423 0.12 1.71 
Mature 
bovine 
Solute 
desorption 
(Fluorophore) 
Frozen 93 Quinn 2001 
3, 7, 
12 
Gadolinium-
diethylenetria
mine 
pentaacetic 
acid (DTPA) 
Spherical 530 0.61 140 540 0.26 0.62 
Mature 
bovine 
Computed 
tomography 
(CT) 
Fresh 
37 Kokkonen 
2017 
9, 11 
Gadolinium-
diethylenetria
mine 
pentaacetic 
acid (DTPA) 
Spherical 530 0.61 187 381 0.49 0.47 
Mature 
bovine 
Solute 
desorption 
(Other) 
Frozen 
88 Shafieyan 
2014 
11 
Gadolinium-
diethylenetri-
amine 
pentaacetic 
acid (DTPA) 
Spherical 530 0.61 140 381 0.37 - 
Immature 
bovine 
Nuclear 
magnetic 
resonance 
(NMR) 
Frozen 26 Foy 2001  
Gadopentetate 
Dimeglumine 
Spherical 548 0.62 254 378 0.67 - 
Mature 
bovine 
Computed 
tomography 
(CT) 
Fresh 
33 Kulmala 
2010 
1 
Gadodiamide Spherical 574 0.63 161 370 0.44 - 
Mature 
bovine 
Computed 
tomography 
(CT) 
Fresh 
33 Kulmala 
2010 
1 
Raffinose Spherical 594 0.56 290 416 0.70 0.48 
Mature 
bovine 
Diffusion cell 
(Radiolabel) 
Frozen 25 Garcia 1996  
Sodium 
Diatrizoate 
Hydrate 
Spherical 636 0.66 145 353 0.41 0.39 
Mature 
bovine 
Solute 
desorption 
(Other) 
Frozen 
88 Shafieyan 
2014 
1, 11 
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Solute Shapea 
MW 
(Da) 
Hydrodynamic 
Radius (nm)b 
Diffusivity 
(μm2/s)c 
D0 
(μm2/s)d 
D/D0 
Partition 
Coefficient 
(K)e 
Tissue 
Usedf 
Method to 
Obtain 
Diffusivity 
Tissue 
Conditiong 
Reference Notes 
Sodium 
Diatrizoate 
Hydrate 
Spherical 636 0.66 475 499 0.95 0.70 
Mature 
bovine 
Computed 
tomography 
(CT) 
Fresh 
37 Kokkonen 
2017 
1, 11 
Pf-Pep Spherical 760 0.62 100 375 0.27 3.00 
Mature 
bovine 
Diffusion cell 
(Radiolabel) 
Fresh 45 Byun 2010 12 
Ioxaglate Spherical 1269 0.91 143 256 0.56 - 
Mature 
bovine 
Computed 
tomography 
(CT) 
Fresh 
33 Kulmala 
2010 
1 
Ioxaglate Spherical 1269 0.91 90 256 0.35 0.65 
Mature 
bovine 
Computed 
tomography 
(CT) 
Fresh 35 Silvast 2013 
1, 9, 
11 
Iodixanol Spherical 1550 1.00 20 234 0.09 - 
Mature 
equine 
Computed 
tomography 
(CT) 
Frozen 36Arbabi 2015 1, 6 
Inulin Spherical 5000 1.52 97 (37°C) 
217 
(37°C) 
0.45 0.62 
Mature 
bovine 
Solute 
desorption 
(Radiolabel) 
Frozen 90 Torzilli 1987 13 
Inulin Spherical 5000 1.52 93 (37°C) 
217 
(37°C) 
0.43 0.62 
Mature 
bovine 
Solute 
desorption 
(Radiolabel) 
Frozen 30 Torzilli 1997  
Inulin Spherical 5000 1.52 25 153 0.16 0.09 
Adult 
human 
Diffusion cell 
(Radiolabel) 
Frozen 
23 Maroudas 
1970 
 
Inulin Spherical 5000 1.52 22 153 0.15 0.15 
Adult 
human 
Diffusion cell 
(Radiolabel) 
Fresh 
94 
Schneiderman 
1995 
 
Insulin-like 
growth factor-1 
(IGF-1) 
Spherical 7650 2.09 26 (12°C) 
81 
(12°C) 
0.32 1.39 
Mature 
bovine 
Diffusion cell 
(Radiolabel) 
Fresh 44 Garcia 2003 1, 12 
Gadolinium-
lysozyme 
Spherical 14300 2.80 25 83 0.30 - 
Immature 
bovine 
Nuclear 
magnetic 
resonance 
(NMR) 
Frozen 26 Foy 2001  
Gadolinium-
trypsinogen 
Spherical 24000 4.70 5.0 50 0.10 - 
Immature 
bovine 
NMR Frozen 26 Foy 2001  
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Solute Shapea 
MW 
(Da) 
Hydrodynamic 
Radius (nm)b 
Diffusivity 
(μm2/s)c 
D0 
(μm2/s)d 
D/D0 
Partition 
Coefficient 
(K)e 
Tissue 
Usedf 
Method to 
Obtain 
Diffusivity 
Tissue 
Conditiong 
Reference Notes 
Antibody 
Fragment 
(single chain 
fragment 
variable, scFv) 
Spherical 25000 2.65 10 (37°C) 
124 
(37°C) 
0.08 - 
Immature 
bovine 
Fluorescence 
gradient 
Fresh 
31 DiDomenico 
2017 
5, 6 
Tissue 
inhibitors of 
metalloprotein
ases (TIMP-1) 
Spherical 28000 3.80 16 61 0.26 0.20 
Mature 
bovine 
Diffusion cell 
(Radiolabel) 
Fresh 95 Garcia 1998 1 
Gadolinium-
ovalbumin 
Spherical 45000 3.50 4.0 66 0.06 - 
Immature 
bovine 
Nuclear 
magnetic 
resonance 
(NMR) 
Frozen 26 Foy 2001  
Antibody 
Fragment 
(antigen-
binding, Fab) 
Spherical 50000 3.03 9.3 (37°C) 
109 
(37°C) 
0.09 - 
Immature 
bovine 
Fluorescence 
gradient 
Fresh 
31 DiDomenico 
2017 
5, 6 
Hemoglobin Spherical 64500 3.18 13 73 0.17 0.04 
Adult 
human 
Diffusion cell 
(Radiolabel) 
Frozen 
23 Maroudas 
1970 
 
Serum 
Albumin 
Spherical 66000 3.48 20 67 0.30 0.01 
Adult 
human 
Diffusion cell 
(Radiolabel) 
Frozen 
22 Maroudas 
1976 
 
Avidin Spherical 66000 3.50 38 (37°C) 
94 
(37°C) 
0.40 6.00 
Immature 
bovine 
Diffusion cell 
(Fluorophore) 
Fresh 
46 Bajpayee 
2014 
8, 12 
NeutraAvidin Spherical 66000 3.50 38 (37°C) 
94 
(37°C) 
0.40 0.44 
Immature 
bovine 
Diffusion cell 
(Fluorophore) 
Fresh 
46 Bajpayee 
2014 
8 
Transferrin Spherical 80000 4.30 - 54 - 0.02 
Immature 
bovine 
Fluorescence 
gradient 
Frozen 92 Albro 2011 4 
Antibody (IgG) Spherical 150000 5.22 11 45 0.25 0.01 
Adult 
human 
Diffusion cell 
(Radiolabel) 
Frozen 
22 Maroudas 
1976 
 
Antibody (IgG) Spherical 150000 5.22 8.4 (37°C) 
63 
(37°C) 
0.13 - 
Immature 
bovine 
Fluorescence 
gradient 
Fresh 
31 DiDomenico 
2017 
5, 6 
Antibody (IgG) Spherical 150000 5.22 4.2 (37°C) 
63 
(37°C) 
0.07 - 
Immature 
bovine 
Fluorescence 
gradient 
Frozen 
32 DiDomenico 
2016 
5, 7 
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Solute Shapea 
MW 
(Da) 
Hydrodynamic 
Radius (nm)b 
Diffusivity 
(μm2/s)c 
D0 
(μm2/s)d 
D/D0 
Partition 
Coefficient 
(K)e 
Tissue 
Usedf 
Method to 
Obtain 
Diffusivity 
Tissue 
Conditiong 
Reference Notes 
Antibody (IgG) Spherical 150000 5.22 2.0 (37°C) 
63 
(37°C) 
0.03 - 
Mature 
equine 
Fluorescence 
gradient 
Frozen 
32 DiDomenico 
2016 
5, 7 
Antibody (IgG) Spherical 150000 5.22 4.5 (37°C) 
63 
(37°C) 
0.07 - 
Immature 
bovine 
Fluorescence 
gradient 
Fresh 
96 DiDomenico 
2016 
5, 7 
Antibody (IgG, 
pI 5.9) 
Spherical 150000 5.51 8.2 (37°C) 
60 
(37°C) 
0.14 - 
Immature 
bovine 
Fluorescence 
gradient 
Fresh 
97 DiDomenico 
2017  
5,6 
Antibody (IgG, 
pI 5.4) 
Spherical 150000 6.03 7.8 (37°C) 
55 
(37°C) 
0.14 - 
Immature 
bovine 
Fluorescence 
gradient 
Fresh 
97 DiDomenico 
2017 
5,6 
Antibody (IgG, 
pI 4.7) 
Spherical 150000 6.12 7.2 (37°C) 
54 
(37°C) 
0.13 - 
Immature 
bovine 
Fluorescence 
gradient 
Fresh 
97 DiDomenico 
2017 
5,6 
Modified 
Antibody (dual 
variable 
domain, DVD) 
Spherical 198000 7.59 7.8 (37°C) 
43 
(37°C) 
0.18 - 
Immature 
bovine 
Fluorescence 
gradient 
Fresh 
31 DiDomenico 
2017 
5,6 
             
Solute Shapea 
MW 
(Da) 
Hydrodynamic 
Radius (nm)b 
Diffusivity 
(μm2/s)c 
D0 
(μm2/s)d 
D/D0 
Partition 
Coefficient 
(K)e 
Tissue 
Usedf 
Method to 
Obtain 
Diffusivity 
Tissue 
Conditiong 
Reference Notes 
Dextran 3K Linear 3000 1.75 65 133 0.49 0.87 
Mature 
bovine 
Solute 
desorption 
(Fluorophore) 
Frozen 58 Quinn 2000 2, 7 
Dextran 3K Linear 3000 1.75 30 133 0.23 1.15 
Mature 
bovine 
Solute 
desorption 
(Fluorophore) 
Frozen 93 Quinn 2001 3, 7 
Dextran 3K Linear 3000 1.75 76 133 0.57 - 
Mature 
porcine 
Fluorescence 
recovery after 
photobleaching 
(FRAP) 
Fresh 28 Leddy 2003 6 
Dextran 3K Linear 3000 1.75 - 133 - 0.13 
Immature 
bovine 
Fluorescence 
gradient 
Frozen 92 Albro 2011 4 
Dextran 4K Linear 4000 1.54 31 151 0.21 0.30 
Mature 
bovine 
Solute 
desorption 
(Fluorophore) 
Frozen 85 Chin 2013  
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Solute Shapea 
MW 
(Da) 
Hydrodynamic 
Radius (nm)b 
Diffusivity 
(μm2/s)c 
D0 
(μm2/s)d 
D/D0 
Partition 
Coefficient 
(K)e 
Tissue 
Usedf 
Method to 
Obtain 
Diffusivity 
Tissue 
Conditiong 
Reference Notes 
Dextran 10K Linear 10000 2.36 267 (37°C) 
139 
(37°C) 
1.92 0.65 
Mature 
bovine 
Solute 
desorption 
(Radiolabel) 
Frozen 90 Torzilli 1987 13 
Dextran 10K Linear 10000 2.36 374 (37°C) 
139 
(37°C) 
2.68 0.57 
Mature 
bovine 
Solute 
desorption 
(Radiolabel) 
Frozen 89 Torzilli 1998  
Dextran 10K Linear 10000 2.70 - 86 - 0.03 
Immature 
bovine 
Fluorescence 
gradient 
Frozen 92 Albro 2011 4 
Chondroitin 
Sulfate 
Linear 20000 3.25 89 71 1.24 0.23 
Mature 
bovine 
Solute 
desorption 
(Fluorophore) 
Frozen 85 Chin 2013 1 
Dextran 20K Linear 20000 3.26 158 (37°C) 
101 
(37°C) 
1.56 0.26 
Mature 
equine 
and 
bovine 
Solute 
desorption 
(Radiolabel) 
Frozen 
91 Allhands 
1984 
 
Dextran 20K Linear 20000 3.26 103 (37°C) 
101 
(37°C) 
1.02 0.54 
Mature 
bovine 
Solute 
desorption 
(Radiolabel) 
Frozen 90 Torzilli 1987 13 
Dextran 40K Linear 40000 4.78 28 49 0.58 0.10 
Mature 
bovine 
Solute 
desorption 
(Fluorophore) 
Frozen 85 Chin 2013  
Dextran 40K Linear 40000 4.78 40 49 0.82 0.36 
Mature 
bovine 
Solute 
desorption 
(Fluorophore) 
Frozen 58 Quinn 2000 2, 7 
Dextran 40K Linear 40000 4.78 19 49 0.39 0.16 
Mature 
bovine 
Solute 
desorption 
(Fluorophore) 
Frozen 93 Quinn 2001 3, 7 
Dextran 40K Linear 40000 4.78 58 49 1.19 - 
Mature 
porcine 
Fluorescence 
recovery after 
photobleaching 
(FRAP) 
Fresh 28 Leddy 2003 6 
Dextran 70K Linear 70000 5.80 37 40 0.92 - 
Mature 
porcine 
Fluorescence 
recovery after 
photobleaching 
(FRAP) 
Fresh 28 Leddy 2003 6 
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Solute Shapea 
MW 
(Da) 
Hydrodynamic 
Radius (nm)b 
Diffusivity 
(μm2/s)c 
D0 
(μm2/s)d 
D/D0 
Partition 
Coefficient 
(K)e 
Tissue 
Usedf 
Method to 
Obtain 
Diffusivity 
Tissue 
Conditiong 
Reference Notes 
Dextran 70K Linear 70000 5.80 35 40 0.86 0.01 
Adult 
human 
(ankle) 
Fluorescence 
recovery after 
photobleaching 
(FRAP) 
Frozen 27 Fetter 2006 6 
Dextran 70K Linear 70000 5.80 35 40 0.88 0.02 
Adult 
human 
Fluorescence 
recovery after 
photobleaching 
(FRAP) 
Frozen 27 Fetter 2006 6 
Dextran 70K Linear 70000 5.80 40 (37°C) 
57 
(37°C) 
0.70 0.38 
Mature 
bovine 
Solute 
desorption 
(Radiolabel) 
Frozen 30 Torzilli 1997  
Dextran 70K Linear 70000 7.40 - 31 - 0.02 
Immature 
bovine 
Fluorescence 
gradient 
Frozen 92 Albro 2011 4 
Dextran 500K Linear 500000 15.90 9.0 15 0.61 - 
Mature 
porcine 
Fluorescence 
recovery after 
photobleaching 
(FRAP) 
Fresh 28 Leddy 2003 6 
 
Superscripts: 
a 
Chondroitin sulfate or dextran molecules were considered linear molecules; all others were considered 
spherical 
b 
All radii were taken from primary or secondary sources in the literature. If no size information was found 
on a solute, the empirical relation (𝑟𝑠 = 0.0332𝑀𝑊
0.463, 65), was used where noted 
c 
All diffusivities are averages that were taken in a direction perpendicular to the articular surface and at 
zero tissue strain, unless otherwise noted 
d 
The Stoke’s Einstein equation (Eq. 4) was used to calculate free diffusivity at 23°C, unless otherwise 
noted 
e Solute absorption/desorption technique used to calculate partition coefficient, unless otherwise noted 
f All tissue sources were from stifle or knee joints, unless otherwise noted 
g Denotes how the tissue was stored before experimentation took place 
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Notes: 
1 
Empirical relationship (𝑟𝑠 = 0.0332𝑀𝑊
0.463, 65) used to calculate 
hydrodynamic radius 10 Fluorescence gradient technique used to determine partition coefficient 
2 Diffusivity taken at 0.05 strain 11 Negatively charged, excluded from partition coefficient analysis 
3 Diffusivity taken at 0.08 strain 12 Positively charged, excluded from partition coefficient analysis 
4 Diffusivity taken at 0.10 strain 13 Partition coefficient and diffusivity taken at t = 1 hr. 
5 Diffusivity taken at 0.15 strain 14 Negatively charged, excluded from partition coefficient analysis 
6 Average diffusivity through the depth of tissue 15 Positively charged, excluded from partition coefficient analysis 
7 Diffusivity in direction parallel to articular surface 16 Partition coefficient and diffusivity taken at t = 1 hr. 
8 Effective diffusivity cited   
9 
Computed tomography (CT) technique used to determine partition 
coefficient   
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CHAPTER 7 
Conclusions and Future Directions 
The goal of this dissertation was to investigate how large molecules, such as antibodies 
and antibody fragments, are transported through cartilage tissue. Long-term, this 
knowledge is valuable to the development of therapies that rely on transport of these 
types of drugs into cartilage. Before the turn of the 21st century, researchers in this field 
had assumed that any molecule larger than albumin (~ 4 nm) could not sufficiently 
penetrate cartilage to be useful as a therapeutic agent1. Even today, some argue that 
antibodies (~ 5.5 nm) are too large to enter cartilage, which is simply not true based on 
various evidence in this dissertation. One probable reason for this misconception is due 
to the small average pore size of cartilage (~ 5 nm). As such, there has been a focus on 
development of smaller drugs so that they could sufficiently penetrate the tissue. That 
sentiment is slowly changing. There are now several animal studies and clinical trials 
with much larger drugs, including antibodies and growth factors, which have been 
shown to sufficiently penetrate cartilage2–4. Even though these studies support that these 
large drugs can penetrate cartilage, very few studies have looked at local diffusion 
mechanics of these large proteins, critical components to fully understanding and 
developing new large arthritis therapeutics. As a result, current drug determinations are 
not based on a firm understanding on the transport kinetics of the molecule of interest. 
This is especially true because of the inherent heterogeneities of cartilage. These data in 
this dissertation therefore bridges this information gap and opens up new possibilities 
for arthritis treatments. 
 
 199 
There are many arthritic diseases that interrupt the homeostasis of the joint space and 
cause a large societal and economic burden5. Many of these diseases precipitate the 
release of inflammatory factors that cause widespread joint degeneration, instability, 
and pain6–8. There are several main types of arthritis where drug penetration into 
articular cartilage can be beneficial to disease treatment. The two most common types 
of arthritis are rheumatoid arthritis (RA) and osteoarthritis (OA). In RA, systemic 
inflammation and increased levels of inflammatory cytokines leads to widespread joint 
destruction if left untreated. Because of the systemic nature of this disease, anti-
inflammatory drugs, such as antibodies that are administered intra-muscularly, can 
dramatically reduce or halt disease progression and subsequent joint degeneration. 
Because of the systemic nature of administration, a small fraction of antibodies 
inevitably ends up in the joint synovial fluid, which results in the articular cartilage 
coming into direct contact with the drugs. Interestingly, there is relatively little 
information about how these drugs interact with the cartilage tissue during RA. Based 
on data solely from this dissertation, there is strong evidence that these drugs are able 
to diffuse through the cartilage matrix, and it is likely that they would exhibit some sort 
of anti-inflammatory effect on the chondrocytes in this disease. Because use of these 
anti-inflammatory drugs is so effective at halting RA progression, it seems like this 
effect would be relatively small compared to more systemic targets, such as the 
synovium. However, one cannot deny that this effect would be beneficial to the cartilage 
in the long-run as well. 
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Treating OA is another story. Because disease initiation is thought to originate in 
cartilage, administering drugs in a way that is efficacious is extremely difficult. 
Currently, intra-articular injections are the only way to administer efficacious number 
of drugs to the cartilage tissue. However, because of the high turnover rate of synovial 
fluid, most of the currently used smaller drugs, such as steroids, do not last in the joint 
space for more than 1 day, and their effects do not extend past several weeks after 
administration. Additionally, there is mixed evidence that intra-articular injections of 
either steroids or other small anti-inflammatory molecules are effective3,4. This has 
pushed the field toward use of larger molecules to try to increase drug half-lives in the 
joint. 
 
Another treatment for early-stage OA is injection of high molecular weight hyaluronic 
acid into the joint. This highly viscous substance is able to reduce friction in the joint 
space by altering synovial fluid viscosity, which in turn will lower shear strains imparted 
on the chondrocytes in the cartilage and slow subsequent cartilage wear4. These 
injections have also been shown to last in the joint for many hours (days), which 
increases its therapeutic potential compared to shorter-lived therapeutic strategies. 
Unfortunately, these types treatment strategies have also been limited in effectiveness. 
As a result, the current focus of the field has now turned to relatively large therapeutics, 
such as growth factors and antibodies, which are large enough to have long half-lives, 
but not so large that they cannot fit into the pores of the cartilage matrix. As this 
dissertation shows, this brings a new host of challenges that need to be addressed. 
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Learning from decades of previous research, any new strategies to treat OA most likely 
need to have the following: (1) an extremely long joint half-life; (2) ability to get into 
the cartilage; (3) and ability to be retained within the cartilage matrix for a long time. 
The data from this dissertation allows researchers to be informed about how well 
antibodies and similarly-sized proteins move through the dense articular cartilage, a 
critical component in developing new therapeutics. Ultimately, there are several main 
findings to this dissertation. 
 
Diffusion of antibodies is heterogeneous through the depth of cartilage due to 
changes in local cartilage composition (Chapter 3 and 5) 
In these chapters, local molecular diffusion of a full-sized antibody molecule (150 kDa) 
was highly influenced by local matrix density in healthy and degraded articular 
cartilage. Overall, the diffusion kinetics of whole and fragmented antibodies were 
highly heterogeneous, with maximal diffusivities for both healthy and degraded samples 
occurring near 250 μm away from the articular surface of cartilage. This heterogeneous 
diffusion behavior are consistent with zonal diffusivities found from using 40 kDa and 
70 kDa dextrans9. Thus, both linear (dextran) and spherical solutes (antibodies) within 
this size range (40 – 200 kDa), diffuse best between the highly organized, collagenous 
surface zone and the dense deeper zones. 
 
These diffusion heterogeneities were found to be related to local composition (0.3 < R2 
< 0.9). Such correlations were strongest (R2 > 0.8) for samples that underwent collagen 
damage, and these samples exhibited higher local diffusivities at the surface, compared 
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to trypsin-degraded or healthy samples. Therefore, our data supports that the highly 
organized collagenous surface zone acts as a selective barrier to large solutes, which 
agrees with research looking at diffusional anisotropy through the surface zone of 
cartilage tissue for linear dextran molecules10. In OA, this organized surface layer is 
often disrupted11, and therefore diseased cartilage would not hinder large solutes as 
much as healthy tissue. Ultimately, our studies confirm a strong link between local 
diffusion kinetics and local composition, and that the highly organized surface collagen 
significantly slows diffusion of large solutes, such as antibodies. 
 
The fact that large molecules are substantially affected by both cartilage structure and 
composition is not entirely surprising. Because of the small effective pore size of 
cartilage (~5 nm), molecules close to this pore size will likely be very sensitive to 
changes in collagen structure and/or composition. Additionally, the effective pore size 
of cartilage is thought to decrease significantly through the depth of cartilage, which 
will in turn affect diffusion of molecules approaching the local pore size.  
 
Future directions 
Even though these data were produced using degraded cartilage, which is sought to 
mimic compositional and structural changes that would be evident from disease in vivo, 
it would be beneficial to complete these types of experiments again with osteoarthritic 
tissue. With diseased human tissue, one can relate diffusion to stages of OA, which 
would hold great clinical significance. 
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Based on the steep slopes on our diffusivity/aggrecan correlations, diffusion is 
extremely sensitive to aggrecan changes. Because of this, it is hypothesized that there 
are percolation thresholds (minimum concentration values) for aggrecan in relation to 
local diffusivity. The development of a percolation model (and/or other similar FE 
transport models) that would be able to explain changes in diffusive behavior as a 
function of composition, and perhaps solute size, would be helpful further to pinpoint 
changes in transport of various therapeutics. 
 
Convective transport during cyclic loading significantly increases overall 
transport (Chapter 2 and 3) 
Convective contributions from cyclic loading for a 150 kDa antibody were found to be 
maximal at 1 Hz and 5% cyclic strain, for a variety of cartilage tissue obtained from 
different animal species12. In these chapters, bulk solute transport in the radial direction 
in loaded samples was 2-3 times higher than transport in passive samples. Additionally, 
local transport of variously sized solutes (25-200 kDa) was enhanced (2-4 fold) up to 
400 μm from the articular surface. Areas of local transport enhancement were highest 
near the sample periphery (and near the articular surface13), where fluid velocity was 
highest. These data support the idea that obtaining the best combination of fluid velocity 
and fluid penetration depth is important to maximizing solute transport enhancement12. 
 
Ultimately, cyclic mechanical loading of cartilage leads to a significant enhancement 
(up to 3-fold) of solute transport at physiologic strain amplitudes (1 – 5%) and 
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frequencies (0.1 – 2 Hz). These data support that joint movement is very important for 
sufficient penetration of arthritis therapeutics in vivo.  
 
Future Directions 
These loading-based enhancements were found primarily using healthy articular 
cartilage. Because degradation of cartilage will lead to significant gains in diffusivities, 
it is unclear how much mechanical loading would help transport (both diffusivity and 
partition coefficient) in vivo. The complex loading conditions and geometries of 
cartilage in vivo make this a very difficult transport problem, but finite element models 
could prove useful in elucidating some of the finer details in relation to convective 
transport in cartilage. Additionally, it would be useful to perform similar experiments 
with degraded and/or diseased cartilage to see if changes in composition play a large 
role in convective transport. 
 
Solute charge aids local transport (Chapter 4) 
In Chapter 4, solute charge was shown to alter local diffusion mechanics for antibody 
molecules (150 kDa) within 125 – 300 μm from the articular surface of the cartilage14. 
In this region, a 5.9 pI antibody exhibited a 20% increase in diffusivity compared to that 
of a pI 4.7 molecule. Within this range of isoelectric points, its seems that charge 
interactions between matrix and solute were only significant at certain aggrecan 
concentrations that were present in this region.  
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Thus, increasing positive solute charge is associated with higher local diffusivities. 
Positively charged solutes also are retained in the cartilage tissue for longer periods of 
time2. Thus, relying on reversible binding of positively charged solutes can be used to 
increase effectiveness of future drug therapies. These effects are ultimately linked to 
strong electrostatic interactions between the solute and the negatively charged cartilage 
matrix. These data support that isoelectric point represents another tunable property that 
could be changed to optimize macromolecular transport within cartilage.  
 
Future directions 
Despite a local difference in diffusivity of these charged solutes, it would be very 
interesting to investigate how large changes of pI relates to local diffusivity and local 
partition coefficients. The field already is aware of the benefits to bulk partition 
coefficient by using positively charged molecules, but local changes are still not well-
understood. Elucidating these local changes can lead to advances in localized, targeted 
therapies that target specific regions of the cartilage.  
 
Solute transport in articular cartilage can be accurately predicted based on 
molecular size (Chapter 6) 
In Chapter 6, over a wide solute size range (0.1 – 7.6 nm), solute diffusivity in articular 
cartilage was accurately predicted with an empirical relationship that was not dependent 
on experimental procedure, tissue species, or tissue age. For spherical solutes, such as 
antibodies, the relationship between solute diffusivity and molecular weight or 
hydrodynamic radius was well-described by a power-law relationship (R2 = 0.81). 
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Diffusivities of linear solutes, such as dextran, were not well-described by a power-law 
(R2 = 0.25) and its diffusivity/size relationship deviated significantly from spherical 
solutes. It is ultimately unclear whether another metric other than hydrodynamic radius 
would be a better predictor of linear solute diffusion, such as persistence length of these 
molecules. 
 
The strong empirical relationship reported herein strongly supports that diffusivity for 
spherical solutes can be accurately predicted in cartilage regardless of the experimental 
parameters used in individual experiments. Additionally, the disparity between 
spherical and linear solute data supports that linear solutes exhibit fundamentally 
different transport mechanics in cartilage, possibly due to their ability to change 
conformation while in the cartilage matrix. While further understanding the diffusion 
mechanics of linear solutes in cartilage would be helpful, our data supports that they are 
overestimate transport kinetics for similarly-sized spherical solutes. On the other hand, 
potential therapeutic, spherical molecules, such as antibodies and large drug-carrying 
nanoparticles, hold more clinical importance and should be the focus of future study. 
 
Future Directions 
Based on literature data, even solutes larger than the effective pore size of cartilage can 
diffuse through the entire depth of the tissue. This raises some interesting opportunities 
for macromolecular therapeutic design. For instance, nanoparticles (rs ≥ 3 nm) have 
been used to deliver customizable effects to cancer cells15, but these particles have never 
been used to target cartilage chondrocytes directly. These molecules can easily be 
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customized to bind to collagen in the cartilage matrix and be functionalized with various 
therapeutics, likely giving these molecules extremely long joint half-lives and great 
therapeutic potential. Preliminary data shows that these nanoparticles diffuse as 
expected by their molecular size (see Appendix). A nanoparticle of radius 3.2 nm had a 
diffusivity through the articular surface of around 9 μm2/s, which is similar to that of a 
2.75 nm antibody fragment. Significantly changing the charge or binding characteristics 
would be the next steps for this project. 
 
Similarly, we have also investigated the diffusion properties of very large aggrecan 
mimetics, which aim to replenish areas of depleted native aggrecan in cartilage. 
Collaborators at Drexel University have shown the healing properties of these large 
molecules in a mouse model16. The healing potential of these molecules are thought to 
be from their ability to sufficiently diffuse (although slowly) and bind in the surface 
regions of the cartilage tissue, which our data supports (see Appendix). Because these 
aggrecan mimetics can be modified heavily in size and shape, further understanding 
how these changes affect the diffusive properties is clinically important.  
 
Likewise, delivery of antibodies using microspheres and delivery of large (rs ~ 25 nm) 
viral vectors to modify diseased chondrocytes remains unstudied for arthritis therapy4,17. 
Even though these macromolecules would diffuse slowly through cartilage, they could 
be modified with binding domains to maximize joint residence times, which could make 
their development more feasible. Furthermore, it would be interesting to determine an 
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upper threshold for molecular size for solutes that can penetrate both healthy and 
degraded cartilage. 
 
Additionally, Chapter 6 investigated current mechanistic transport models and noted 
that they were inconsistent in predicting solute diffusivity in cartilage. Mechanistic 
transport models can include two different types of solute interactions with the matrix: 
steric hindrance and hydrodynamic (frictional) effects. Both the Brinkman 
(hydrodynamic) and Renkin (steric) models only include one type of solute/matrix 
interaction. The Clague and Phillips model includes both steric and hydrodynamic 
solute interactions, and is likely why this model outperformed the others. However, all 
current transport models were developed specifically for hydrogels with only one fiber 
species, which may not be appropriate for cartilage. Thus, cartilage-specific models that 
include both steric and hydrodynamic solute/matrix effects should be developed in the 
future.  
 
Clinical Interpretations 
Because of the double network formed from aggrecan and collagen within cartilage, this 
network gives way to two sets of different pores through which solutes can diffuse. One 
set of pores, between GAG chains (~5 nm), give the tissue a small average pore size 
because of the high density of GAGs within the tissue. On the other hand, spaces in 
between collagen fibrils result in pores that are much larger (~50 nm). These larger 
pores are likely more important to diffusion in regions of relatively low GAG content, 
such as near the articular surface. These larger spaces inevitably help even 16 nm 
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molecules (500 kDa dextran) penetrate the full depth of the tissue, albeit slowly9,10. 
These facts open the field to new arthritis therapeutic strategies.  
 
Furthermore, arthritic cartilage will likely have significantly larger pores than healthy, 
which will cause larger amounts of macromolecular transport within the tissue in these 
cases. Thus, data from this dissertation likely underestimates macromolecular diffusion 
in degraded cartilage. Additionally, the data from Chapter 6 likely underestimates 
transport, because the vast majority of transport data collected from the literature has 
been from healthy articular cartilage. Indeed, this dissertation shows the effect of 
degradation on transport (Chapter 5), with an increase in diffusivity of large molecules 
up to an order of magnitude in highly degraded regions (e.g. surface). Surprisingly, these 
dramatic increases were only due to moderate degradation of the articular cartilage. 
Based on histological images of aggrecan (Safrinin-O), these degradation protocols 
present in Chapter 5 would only result as Grade 1 or 2 osteoarthritis on the OARSI scale 
in humans 18. 
 
These dramatic increases in cartilage transport based only early-moderate stages of OA 
have other implications. The strong power-law relationship found in Chapter 6 would 
likely shift upwards as cartilage degradation progresses to later stages of OA. Whether 
this would be a uniform shift at all sizes of molecules is less clear. There is evidence 
that degradation affects smaller molecules less so than larger ones19. Thus, it is possible 
that degradation of cartilage would lead to a flattening of the curve found in Chapter 6, 
with the most drastic increase in diffusivity for the largest molecules. This intrinsically 
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makes sense, since dramatically increasing the pore size of the tissue would likely have 
bigger effects on molecules that already “struggle” to fit into them.  
 
Despite this deep understanding of transport, this dissertation seemingly supports that 
these drugs would probably not make the best treatments, because of their slow diffusion 
rates in cartilage. Even though OA cartilage would likely increase the transport rate of 
these drugs, it is very likely that unmodified variations of these drugs would not persist 
in the joint space and/or cartilage for long enough to be effective at changing the 
behavior of the native or diseased chondrocytes in the long-term. We have not yet found 
a drug that can achieve this goal. However, because of the size of these drugs, these 
drugs are more able to be retained within the matrix, which is a crucial factor in drug 
efficacy. Additionally, because of their size and customizability, these macromolecules 
can be heavily modified to further resist leaving the tissue, such as increasing solute 
charge3,4. With transport information obtained from our experiments, the field should 
focus on modifying these large molecules so they can sufficiently bind to the cartilage 
matrix and obtain the longest possible intra-articular half-life. Encapsulation of these 
drugs in microspheres, attaching them to nanoparticles, and/or increasing their charge 
could lead us to a better solution to treat cartilage disease. Ultimately, these molecules 
are promising therapeutics as long as we can make sure that they reside in the joint and 
cartilage tissue for as long as possible. 
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Significance 
Because OA is so prevalent and often debilitating, understanding how to better treat and 
alleviate symptoms of OA would have far-reaching effects to many people. Since the 
introduction of antibody treatments for RA, such as AbbVie’s Humira®, have surfaced, 
hundreds of thousands of people have experienced significant prognosis improvement. 
If a similar treatment for OA was developed, it would likely have a similar impact. 
Treatments would help with mobility and quality of life of the patient, leading to 
increased productivity and decreased future medical costs. This dissertation and its 
findings are a step in the right direction to develop OA treatments that are firmly 
grounded in an understanding of macromolecular transport. 
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APPENDIX: 
Cyclic loading based enhancement based on molecular size (using historic data): 
 
Convective transport enhancement increases drastically with solute size. Previous 
studies on the effects of loading or fluid convection on overall solute transport were 
examined for trends (summarized below). Data from convection studies were grouped 
into three categories that quantified solute transport enhancement in distinct ways: total 
flux enhancement (from 3 studies), equilibrium concentration enhancement (from 2 
studies), and equilibration rate enhancement (from 5 studies). Total flux enhancement 
was defined as the ratio of total solute flux (convection and diffusion) to solute diffusive 
flux. Solute equilibrium concentration enhancement was defined as an equilibrium 
concentration ratio between samples undergoing mechanical loading and non-loaded 
samples. Studies that quantified solute diffusivities, solute equilibration times, or 
desorption rates between loaded and non-loaded samples were defined as the 
equilibration rate enhancement group. These specific data groupings included many 
different loading regimes that were used across the 10 total studies. Nevertheless, total 
flux, equilibrium concentration, and equilibration rate enhancements generally 
increased as the size of both linear (open points) and spherical (filled points) solutes 
increased (R2: 0.19 - 0.95, power-law fit to log-transformed data). 
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Summary of convective transport of solutes: 
 
*: empirical relationship (rs = 0.0332MW
0.463, 138), was used to estimate 
hydrodynamic radius. 
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Diffusion of variously-sized aggrecan mimetics (Drexel University Collaboration): 
  
Diffusion of nanoparticles (Material Science Collaboration): 
 
Multi-layer diffusion code for Matlab: 
function [ucorrected,sumsquarederror] = 
ModifiedMultDiff(m,kappa,l0,lm,l,u0,Lbnd,Rbnd,tspan,interface,varargi
n) 
% MULTDIFF Solves the one-dimensional multilayer diffusion problem 
using a 
%                 Semi-Analytic method. 
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% 
%   MULTDIFF solves the transient diffusion equation in a one-
dimensional  
%   composite slab of finite length consisting of multiple layers. 
The code 
%   is applicable to both perfect and imperfect contact at the 
interfaces  
%   between adjacent layers and either Dirichlet, Neumann or Robin 
boundary 
%   conditions at the ends of the slab. 
%   
%   MULTDIFF is an implementation of the semi-analytic method 
%   proposed by Carr and Turner based on the Laplace Transform and an  
%   orthogonal eigenfunction expansion. 
% 
%   Full details can be found in the paper:  
%   E. J. Carr and I. W. Turner. 
% 
%   Description: 
%   -----------------------------------------------------------------
------ 
%   MULTDIFF solves the standard diffusion equation in each layer  
%   (l(i-1) < x < l(i)): 
% 
%      du_(i)/dt = d/dx * (kappa(i) * du_(i)/dx),   i = 1,...,m, 
%    
%   subject to the following initial and external boundary 
conditions: 
%    
%      u_(i)(x,t) = u0(x)                           at t = 0 
%      aL * u_(1)(x,t) + bL * du_(1)/dx(x,t) = cL   at x = l0 
%      aR * u_(m)(x,t) + bR * du_(m)/dx(x,t) = cR   at x = lm 
% 
%   where u_(i) is the solution in layer i, kappa(i) is the 
diffusivity in  
%   layer i (constant) and aL, bL, cL, aR, bR and cR are constants. 
% 
%   Either perfect or imperfect contact is imposed at the interfaces  
%   between adajacent layers (at x = l(i), i = 1,...,m-1): 
% 
%    - Perfect contact  
%       u_(i)(x,t) = u_(i+1)(x,t)                            
%       kappa(i) * u_(i)(x,t) = kappa(i+1) * u_(i+1)(x,t) 
% 
%    - Imperfect contact 
%       kappa(i) * du_(i)/dx(x,t) = H(i) * (u_(i+1)(x,t) - 
u_(i)(x,t)) 
%       kappa(i+1) * du_(i+1)/dx(x,t) = H(i) * (u_(i+1)(x,t) - 
u_(i)(x,t))        
%    
%   Usage: 
%   -----------------------------------------------------------------
------ 
%   [U,X] = multdiff(m,kappa,l0,lM,l,u0,bcs,tspan,'Perfect') 
%   [U,X] = multdiff(m,kappa,l0,lM,l,u0,bcs,tspan,'Perfect',options) 
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%   [U,X] = multdiff(m,kappa,l0,lM,l,u0,bcs,tspan,'Imperfect',H) 
%   [U,X] = 
multdiff(m,kappa,l0,lM,l,u0,bcs,tspan,'Imperfect',H,options) 
% 
%   Input Arguments: 
%   -----------------------------------------------------------------
------ 
%   m           Number of layers. Must be an integer greater than or 
equal  
%               to 3.   
%   kappa       A vector of length M containing the diffusivity 
values  
%               in each layer such that the diffusivity in Layer i is 
given 
%               by kappa(i) (i = 1,...,m).   
%   l0          x coordinate of the left boundary of the slab 
%   lm          x coordinate of the right boundary of the slab 
%   l           A vector of length M-1 containing the locations of 
the 
%               interfaces between adjacent layers such that the 
interface  
%               between Layer i and Layer i+1 is located at L(i)  
%               (i = 1,...,m-1). 
%   u0          A function handle specifying the initial condition. 
The  
%               function uint = u0(X) should accept a vector argument 
x and  
%               return a vector result uint. Use array operators .*, 
./ and  
%               .^ in the definition of u0 so that it can be 
evaluated with 
%               a vector argument. 
%   Lbnd        A cell array specifying the boundary condition at the 
x=l0. 
%               Lbnd takes the form {type,aL,bL,cL}, where type is 
one of 
%                    'Dirichlet': aL ~= 0 and bL = 0 
%                    'Neumann':   aL = 0 and bL ~= 0 
%                    'Robin':     aL ~= 0 and bL ~= 0 
%   Rbnd        A cell array specifying the boundary condition at the 
x=lm. 
%               Rbnd takes the form {type,aR,bR,cR}, where type is 
one of 
%                    'Dirichlet': aR ~= 0 and bR = 0 
%                    'Neumann':   aR = 0 and bR ~= 0 
%                    'Robin':     aR ~= 0 and bR ~= 0 
%   tspan       A vector specifying the times at which a solution is  
%               requested. To obtain solutions at specific times  
%               t0,t1,...,tf, use TSPAN = [t0,t1,...,tf]. 
%   interface   Internal boundary conditions at interfaces between 
adjacent 
%               layers. inteface can be either 'Perfect' or 
'Imperfect'. 
%   H           A vector of length m-1 containing the contact  
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%               transfer coeffecients at the interfaces between 
adjacent  
%               layers such that the coefficient between layer i and  
%               layer i+1 is given by H(i) (i = 1,..,m-1).  
%               * Applicable to imperfect contant only. 
%   options     An (optional) set of solver options. Fields in the  
%               structure options are 
%                - N    number of eigenvalues to use in expansions 
%                       [N = 50 by default] 
%                - NX   number of divisions within each slab. U(:,j) 
gives 
%                       the solution at x = l(i-1):(l(i)-l(i-
1))/NX:l(i)  
%                       and t = tspan(j). 
%                       [NX = 50 by default] 
%                - NZ   number of poles in CF method (see cf.m)   
%                       [NZ = 14 by default] 
%                - Hp   value of contact transfer coefficient to  
%                       approximate perfect contact condition 
%                       [Hp = 1e6 by default]                       
% 
%   Output Arugments: 
%   -----------------------------------------------------------------
------ 
%   u   Matrix of solution values. u(:,j) gives the solution on the 
entire 
%       slab (l0 <= x <= lm) at time t = tspan(j) and at the grid 
points  
%       returned in the output vector x. 
%   x   Vector of grid points at which solution is given. x is a 
vector  
%       taking the form x = [x1,x2,...,xm]', where: 
%          x1 = l0:(l(1)-l0)/NX:l(1) 
%          xi = l(i-1):(l(i)-l(i-1))/NX:l(i), i = 2,..,m-1 
%          xm = l(m-1):(lm-l(m-1))/NX:lm 
% 
%   Example: 
%   -----------------------------------------------------------------
------ 
%   u0 = @(x) zeros(size(x)); 
%   [u,x] = multdiff(3,[1,0.1,1],0.0,1.0,[0.3,0.7],u0,... 
%          {'Dirichlet',1.0,0.0,1.0},{'Dirichlet',1.0,0.0,0.5},... 
%          [0.02,0.05,0.1,0.2,0.5,1.0],'Perfect'); 
% 
  
% Default values 
AbsTol = 1e-10; 
RelTol = 1e-6; 
  
% AbsTol = 1e-14; 
% RelTol = 1e-10; 
  
% -------------------------------------------------------------------
------ 
% Check inputs 
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% -------------------------------------------------------------------
------ 
if nargin < 10 
    error('Not enough input arguments.'); 
elseif nargin == 10 
    if strcmp(interface,'Imperfect') 
        error('H must be specified for imperfect contact at 
interfaces.'); 
    end 
    options = struct;     
elseif nargin == 11 
    if strcmp(interface,'Perfect') 
        options = varargin{1}; 
    elseif strcmp(interface,'Imperfect') 
        H = varargin{1}; 
        options = struct; 
    end 
elseif nargin == 12 
    if strcmp(interface,'Perfect') 
        error('Too many input arguments for interface = 
''Perfect''.'); 
    elseif strcmp(interface,'Imperfect') 
        H = varargin{1}; 
        options = varargin{2}; 
    end     
else 
    error('Too many input arguments.'); 
end 
  
% Number of layers 
if round(m) ~= m || m < 3 
    error('m must be an integer greater than or equal to 3.') 
end 
  
% Diffusivities 
if length(kappa) ~= m || sum(kappa > 0) ~= m 
    error('kappa must be a vector of length m with kappa(i)>0.') 
end 
  
% Slab left and right boundary 
if l0 > lm 
    error('l0 must be less than lm.') 
end 
  
% Interfaces 
if length(l) ~= m-1 || sum(diff(l)>0) ~= m-2 
    error('l must be a vector of length m-1 with with increasing 
values.') 
elseif l(1) <= l0 || l(m-1) >= lm 
    error('l(1) must be greater than l0 and l(m-1) must be less than 
lm.'); 
end 
  
% Initial condition 
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if ~isa(u0,'function_handle') || nargin(u0) ~= 1 
    error('u0 must be a function handle of the form uint = u0(x).'); 
end 
  
% Boundary conditions 
if ~isa(Lbnd,'cell') || length(Lbnd) ~= 4 
    error(['Lbnd must be a cell array of length 4.']); 
end 
if ~isa(Rbnd,'cell') || length(Rbnd) ~= 4 
    error(['Rbnd must be a cell array of length 4.']); 
end 
  
% Time vector 
tlength = length(tspan); 
if sum(tspan > 0) ~= tlength 
    error('tspan must have entries that are greater than or equal to 
0.') 
end 
  
% Internal boundary conditions at interfaces 
if strcmp(interface,'Perfect') || strcmp(interface,'Imperfect') 
else 
    error('interface must be either ''Perfect'' or ''Imperfect''.') 
end 
  
% Check options structure 
if ~isa(options,'struct') 
    error('options must be a structure.') 
end 
Names = {'N','NX','NZ','Hp'}; 
fn = fieldnames(options); 
for i = 1:length(fn) 
    j = strcmp(fn(i),Names); 
    if sum(j) == 0 
        error('Invalid option ''%s''.',fn{i}); 
    end 
end 
% Number of eigenvalues to use in expansions 
if isfield(options,'N') 
    N = options.N; 
    if round(N) ~= N && N < 1 
        error('options.N must be an integer greater than or equal to 
1.') 
    end 
else 
    N = 50; % Default 
end 
% Number of divisions within each slab 
if isfield(options,'NX') 
    NX = options.NX;  
    if round(NX) ~= NX && NX < 1 
        error('options.NX must be an integer greater than or equal to 
1.') 
    end 
else 
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    NX = 250; % Default 
end 
% Number of poles in CF method (see cf.m)   
if isfield(options,'NZ'),  
    NZ = options.NZ; 
    if round(NZ) ~= NZ && NX < 1 
        error('options.NZ must be an integer greater than or equal to 
1.') 
    end 
else 
    NZ = 14; % Default 
end 
% Value of contact transfer coefficient to approximate perfect 
contact  
% condition 
if isfield(options,'Hp') 
    if strcmp(interface,'Perfect') 
        Hp = options.Hp; 
        if Hp < 0 
            error('options.Hp must be greater than or equal to 0.') 
        end 
    else 
        warning('options.Hp is specified but not used.') 
    end 
else 
    Hp = 1.0e6; % Default 
end 
if strcmp(interface,'Perfect') 
    H = Hp*ones(m-1,m); 
end 
  
% Get boundary condition constants 
Ltype = Lbnd{1}; 
Rtype = Rbnd{1}; 
aL    = Lbnd{2}; 
bL    = Lbnd{3}; 
cL    = Lbnd{4}; 
aR    = Rbnd{2}; 
bR    = Rbnd{3}; 
cR    = Rbnd{4}; 
  
% Check boundary conditions are implemented correctly 
if sum(strcmp(Ltype,{'Dirichlet','Neumann','Robin'})) == 0 
    error(['Boundary condition at left boundary must be one of 
either',... 
        ' ''Dirichlet'', ''Neumann'' or ''Robin''.']); 
end 
if sum(strcmp(Rtype,{'Dirichlet','Neumann','Robin'})) == 0 
    error(['Boundary condition at right boundary must be one of 
either',... 
        ' ''Dirichlet'', ''Neumann'' or ''Robin''.']); 
end 
if aL == 0 && strcmp(Ltype,'Dirichlet') 
    error('Dirichlet condition at left boundary cannot have aL = 
0.'); 
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end 
if bL == 0 && strcmp(Ltype,'Neumann') 
    error('Neumann condition at left boundary cannot have bL = 0.'); 
end 
if aR == 0 && strcmp(Rtype,'Dirichlet') 
    error('Dirichlet condition at right boundary cannot have aR = 
0.'); 
end 
if bR == 0 && strcmp(Rtype,'Neumann') 
    error('Neumann condtion at right boundary cannot have bR = 0.'); 
end 
if strcmp(Ltype,'Dirichlet') && bL ~= 0 
    error('Dirichlet condition at left boundary cannot have bL = 
0.'); 
end 
if strcmp(Rtype,'Dirichlet') && bR ~= 0 
    error('Dirichlet condition at right boundary cannot have bR = 
0.'); 
end 
if strcmp(Ltype,'Neumann') && aL ~= 0 
    error('Neumann condition at left boundary cannot have aL = 0.'); 
end 
if strcmp(Rtype,'Neumann') && aR ~= 0 
    error('Neumann condition at right boundary cannot have aR = 0.'); 
end 
if (aL == 0 || bL == 0) && strcmp(Ltype,'Robin') 
    error('Robin condition at left boundary cannot have aL = 0 or bL 
= 0'); 
end 
if (aR == 0 || bR == 0) && strcmp(Rtype,'Robin') 
    error('Robin condition at left boundary cannot have aR = 0 or bR 
= 0'); 
end 
if strcmp(Ltype,'Robin') && aL/bL < 0 
    warning('Robin condition at left boundary must have aL/bL > 0.'); 
end 
if strcmp(Rtype,'Robin') && aR/bR < 0 
    warning('Robin condition at right boundary must have aR/bR > 
0.'); 
end 
if aL == 0 && bL == 0 
    error('Boundary condition is incorrect at left boundary (aL = bL 
= 0).') 
end 
if aR == 0 && bR == 0 
    error('Boundary condition is incorrect at left boundary (aR = bR 
= 0).') 
end 
  
if strcmp(Ltype,'Neumann') && strcmp(Rtype,'Neumann') && ... 
        (kappa(1)*bR*cL + kappa(m)*bL*cR) ~= 0 
    error(['If Neumann boundary conditions are applied at both ends 
then ', ... 
        'kappa(1)*bR*cL + kappa(m)*bL*cR must be equal to zero.']) 
end 
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% -------------------------------------------------------------------
------ 
% Compute function w(x) that satisfies non-homogeneous BCs 
% 
% Slab 1: 
% w1(x) = w(1) + w(2)*x            for Dirichlet, Robin 
% w1(x) = w(1)*x + w(2)*x^2        for Neumann 
% 
% Slab i = 2,..,m-1: 
% wi(x) = w(2*i-1) + w(2*i)*x      for Dirichlet, Robin, Neumann 
% 
% Slab m: 
% wm(x) = w(2*m-1) + w(2*m)*x      for Dirichlet, Robin 
% wm(x) = w(2*m-1)*x + w(2*m)*x^2  for Neumann 
% 
% So we want to solve the linear system of equations: 
% 
%  kappa(1)*w_(1)'(l(1)) = H(1)*(w_(2)(l(1)) - w_(1)(l(1)) 
%  kappa(1)*w_(1)'(l(1)) = kappa(2)w_(2)'(l(1)) 
%                     . 
%                     . 
%                     . 
%  kappa(m-1)*w_(m-1)'(l(m-1)) = H(m-1)*(w_(m)'(l(m-1))-w_(m-1)'(l(m-
1))) 
%  kappa(m-1)*w_(m-1)'(l(m-1)) = kappa(m) * w_(m)'(l(m-1)) 
%  aL * w_(1)(l0) + bL * w_(1)'(l0) = cL 
%  aR * w_(m)(lm) + bR * w_(m)'(lm) = cR 
% -------------------------------------------------------------------
------ 
  
A = zeros(2*m,2*m); 
b = zeros(2*m,1); 
  
% if strcmp(Ltype,'Neumann') && strcmp(Rtype,'Neumann') 
%      
%     % Interface conditions 
%     for i = 1:m-1 
%         A(2*i-1,2*i-1) = l(i)+1/H(i)*kappa(i); 
%         A(2*i-1,2*i)   = 2*kappa(i)*l(i)/H(i)+l(i)^2; 
%         A(2*i-1,2*i+1) = -l(i); 
%         A(2*i-1,2*i+2) = -l(i)^2; 
%         b(2*i-1) = 0; 
%          
%         A(2*i,2*i-1) = kappa(i); 
%         A(2*i,2*i) = 2*kappa(i)*l(i); 
%         A(2*i,2*i+1) = -kappa(i+1); 
%         A(2*i,2*i+2) = -2*kappa(i+1)*l(i); 
%         b(2*i) = 0; 
%     end 
%      
%     % Right boundary condition 
%     A(2*m-1,2*m)   = 2*bR*lm; 
%     A(2*m-1,2*m-1) = bR; 
 226 
%     b(2*m-1)       = cR; 
%      
%     % Left boundary condition 
%     A(2*m,1) = bL; 
%     b(2*m)   = cL; 
     
  
% else 
     
    % Interface conditions 
    for i = 1:m-1 
        A(2*i-1,2*i-1) = 1.0; 
        A(2*i-1,2*i)   = (kappa(i)/H(i)) + l(i); 
        A(2*i-1,2*i+1) = -1.0; 
        A(2*i-1,2*i+2) = -l(i); 
        b(2*i-1)       = 0.0; 
         
        A(2*i,2*i)   = kappa(i); 
        A(2*i,2*i+2) = -kappa(i+1); 
        b(2*i)       = 0.0; 
    end 
     
    % Right boundary condition 
    A(2*m-1,2*m)   = bR+aR*lm; 
    A(2*m-1,2*m-1) = aR; 
    b(2*m-1)       = cR; 
     
    % Left boundary condition 
    A(2*m,1) = aL; 
    A(2*m,2) = -bL+aL*l0; 
    b(2*m)   = cL; 
     
% end 
  
if strcmp(Ltype,'Neumann') && strcmp(Rtype,'Neumann') 
    i = 1; 
    A(2*m+1,2*i-1) = l(1) - l0; 
    A(2*m+1,2*i)   = (l(1)^2-l0^2)/2; 
    b(2*m+1)       = 
integral(u0,l0,l(1),'AbsTol',AbsTol,'RelTol',RelTol); 
    for i = 2:m-1 
        A(2*m+1,2*i-1) = l(i)-l(i-1); 
        A(2*m+1,2*i)   = (l(i)^2-l(i-1)^2)/2; 
        b(2*m+1)       = b(2*m+1) + integral(u0,l(i-
1),l(i),'AbsTol',AbsTol,'RelTol',RelTol); 
    end 
    i = m; 
    A(2*m+1,2*i-1) = lm-l(m-1); 
    A(2*m+1,2*i)   = (lm^2-l(m-1)^2)/2; 
    b(2*m+1)       = b(2*m+1) + integral(u0,l(m-
1),lm,'AbsTol',AbsTol,'RelTol',RelTol); 
end 
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w = A\b; 
% pause; 
% w = 0.5*ones(size(w)) 
% pause; 
  
% -------------------------------------------------------------------
------ 
% Eigenvalues 
% -------------------------------------------------------------------
------ 
eigs = zeros(N,m); 
  
% Slab 1 (First slab) 
switch Ltype 
    case 'Dirichlet' 
        eigs(:,1) = (2*[0:N-1]+1)'*pi/(2*(l(1)-l0)); 
    case 'Neumann' 
        eigs(:,1) = [0:N-1]'*pi/(l(1)-l0); 
    case 'Robin' 
        eigs(:,1) = eigvals(l(1),l0,aL/bL,N); 
end 
  
% Slab 2,..., m-1 (Middle slabs) 
for i = 2:m-1 
    eigs(:,i) = [0:N-1]'*pi/(l(i)-l(i-1)); 
end 
  
% Slab m (End slab) 
switch Rtype 
    case 'Dirichlet' 
        eigs(:,m) = (2*[0:N-1]+1)'*pi/(2*(lm-l(m-1))); 
    case 'Neumann' 
        eigs(:,m) = [0:N-1]'*pi/(lm-l(m-1)); 
    case 'Robin' 
        eigs(:,m) = eigvals(lm,l(m-1),aR/bR,N); 
end 
  
% -------------------------------------------------------------------
------ 
% Eigenfunction normalisation constants 
% -------------------------------------------------------------------
------ 
eigs_norm = zeros(N,m); 
  
% Slab 1 (First slab) 
for n = 1:N 
     
    if strcmp(Ltype,'Dirichlet') 
        eigs_norm(n,1) = sqrt(2/(l(1)-l0)); 
    elseif strcmp(Ltype,'Neumann') 
        if n == 1 
            eigs_norm(n,1) = sqrt(1/(l(1)-l0)); 
        else 
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            eigs_norm(n,1) = sqrt(2/(l(1)-l0)); 
        end 
    elseif strcmp(Ltype,'Robin') 
        lambda = eigs(n,1); 
        eigs_norm(n,1) = sqrt((2*(1+(bL^2/aL^2)*lambda^2))/... 
            ((bL/aL)+(l(1)-l0)*(1+(bL^2/aL^2)*lambda^2))); 
    end 
     
end 
  
% Slab 2,..., m-1 (Middle slabs) 
for i = 2:m-1 
    eigs_norm(1,i) = sqrt(1/(l(i)-l(i-1))); 
    for n = 2:N 
        eigs_norm(n,i) = sqrt(2/(l(i)-l(i-1))); 
    end 
end 
  
% Slab m (End slab) 
for n = 1:N 
     
    if strcmp(Rtype,'Dirichlet') 
        eigs_norm(n,m) = sqrt(2/(lm-l(m-1))); 
    elseif strcmp(Rtype,'Neumann') 
        if n == 1 
            eigs_norm(n,m) = sqrt(1/(lm-l(m-1))); 
        else 
            eigs_norm(n,m) = sqrt(2/(lm-l(m-1))); 
        end 
    elseif strcmp(Rtype,'Robin') 
        lambda = eigs(n,m); 
        eigs_norm(n,m) = sqrt((2*(1+(bR^2/aR^2)*lambda^2))/... 
            ((bR/aR)+(lm-l(m-1))*(1+(bR^2/aR^2)*lambda^2))); 
    end 
     
end 
  
% eigs_norm 
  
% -------------------------------------------------------------------
------ 
% Grid spacing within each slab 
% -------------------------------------------------------------------
------ 
xgrid = zeros(NX+1,m); 
  
% Slab 1 (First slab) 
xgrid(:,1) = l0:(l(1)-l0)/NX:l(1); 
  
% Slabs 2,...,m 
for i = 2:m-1 
    xgrid(:,i) = l(i-1):(l(i)-l(i-1))/NX:l(i); 
end 
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% Slab m (First slab) 
xgrid(:,m) = l(m-1):(lm-l(m-1))/NX:lm; 
  
% -------------------------------------------------------------------
------ 
% Initial conditions - expand in terms of eigenfunctions 
% -------------------------------------------------------------------
------ 
c = zeros(N,m); % Coefficients 
  
% Slab 1 (First slab) 
for n = 1:N 
    lambda = eigs(n,1); 
    prod = @(x) (u0(x)-wfunc(1,Ltype,Rtype,x,m,w)) .* ... 
        eigfunc(lambda,1,Ltype,Rtype,x,m,l0,lm,l); 
    c(n,1) = 
eigs_norm(n,1)*integral(prod,l0,l(1),'AbsTol',AbsTol,'RelTol',RelTol)
; 
end 
  
% Slabs 2,...,m 
for i = 2:m-1 
    for n = 1:N 
        lambda = eigs(n,i); 
        prod = @(x) (u0(x)-wfunc(i,Ltype,Rtype,x,m,w)) .* ... 
            eigfunc(lambda,i,Ltype,Rtype,x,m,l0,lm,l); 
        c(n,i) = eigs_norm(n,i)*integral(prod,l(i-
1),l(i),'AbsTol',AbsTol,'RelTol',RelTol); 
    end 
end 
  
% Slab m 
for n = 1:N 
    lambda = eigs(n,m); 
    prod = @(x) (u0(x)-wfunc(m,Ltype,Rtype,x,m,w)) .* ... 
        eigfunc(lambda,m,Ltype,Rtype,x,m,l0,lm,l); 
    c(n,m) = eigs_norm(n,m)*integral(prod,l(m-
1),lm,'AbsTol',AbsTol,'RelTol',RelTol); 
end 
% wfunc(1,Ltype,Rtype,x,m,w) 
% wfunc(m,Ltype,Rtype,x,m,w) 
% c 
  
% Plot initial condition 
u = zeros(NX+1,m); 
for n = 1:N 
    for i = 1:m 
        lambda = eigs(n,i); 
        u(:,i) = u(:,i)+c(n,i)*... 
            eigs_norm(n,i)*... 
            eigfunc(lambda,i,Ltype,Rtype,xgrid(:,i),m,l0,lm,l); 
    end 
end 
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usoln = reshape(u,(NX+1)*m,1); 
x = reshape(xgrid,(NX+1)*m,1); 
  
% % % figure; 
% % % % for i = 1:m 
% % % %     uint(:,i) = u0(xgrid(:,i))-
wfunc(i,Ltype,Rtype,xgrid(:,i),m,w); 
% % % % end 
% % % % for i = 1:m 
% % % %     u(:,i) = u(:,i) + wfunc(i,Ltype,Rtype,xgrid(:,i),m,w); 
% % % % end 
% % % usoln = reshape(u,(NX+1)*m,1); 
% % % plot(x,usoln,'r') 
% % % % hold on 
% % % %plot(x,reshape(uint,(NX+1)*m,1),'b') 
% % % drawnow 
% % % hold off 
% % % % pause; 
  
% eigs 
% pause; 
  
% norm(u(end,1)-u(1,2),inf) 
% pause; 
  
% Get weights and poles for use in inverse transform 
[zk,ck] = cf(NZ); 
  
usoln = zeros((NX+1)*m,tlength); 
  
% Time loop 
for j = 1:tlength 
     
    t = tspan(j); 
     
    % Solution (at given time) 
    u = zeros(NX+1,m); 
     
    for i = 1:m 
        u(:,i) = wfunc(i,Ltype,Rtype,xgrid(:,i),m,w); 
    end 
     
%     if strcmp(Ltype,'Neumann') && strcmp(Rtype,'Neumann') 
%         u(:,1) = u(:,1)+2*kappa(1)*w(2)*sqrt(l(1)-l0)*t; 
%         for i = 2:m-1 
%             u(:,i) = u(:,i)+2*kappa(i)*w(2*i)*sqrt(l(i)-l(i-1))*t; 
%         end 
%         u(:,m) = u(:,m)+2*kappa(m)*w(2*m)*sqrt(lm-l(m-1))*t; 
%     end 
     
    % Compute inverse Laplace transform of interface functions 
    vbar = zeros(m-1,NZ/2); 
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    for k = 1:NZ/2 
         
        A    = zeros(m-1,m-1); 
        vr   = zeros(m-1,1); 
        b    = zeros(m-1,1); 
         
        poles = 2*k-1; 
        s = zk(poles)/t; 
         
%         if strcmp(Ltype,'Neumann') && strcmp(Rtype,'Neumann') 
%             b(1) =  2*kappa(2)*w(4)*sqrt(l(2)-l(1))/s^2 ... 
%                 -2*kappa(1)*w(2)*sqrt(l(1)-l0)/s^2; 
%             for i = 2:m-2 
%                 b(i) = 2*kappa(i+1)*w(2*(i+1))*sqrt(l(i+1)-
l(i))/s^2 ... 
%                    -2*kappa(i)*w(2*i)*sqrt(l(i)-l(i-1))/s^2; 
%             end 
%             b(m-1) = 2*kappa(m)*w(2*m)*sqrt(lm-l(m-1))/s^2 ... 
%                -2*kappa(m-1)*w(2*(m-1))*sqrt(l(m-1)-l(m-2))/s^2; 
%         end 
         
        for n = 1:N 
             
            % Interface 1 (between layers 1 and 2) 
            lambda = eigs(n,1); 
            phin_r = eigfunc(lambda,1,Ltype,Rtype,l(1),m,l0,lm,l); 
            s1     = s+kappa(1)*lambda^2; 
            A(1,1) = A(1,1)+eigs_norm(n,1)^2*phin_r*phin_r/s1; 
            b(1)   = b(1)-c(n,1)*eigs_norm(n,1)*phin_r/s1; 
             
            lambda = eigs(n,2); 
            phin_l = eigfunc(lambda,2,Ltype,Rtype,l(1),m,l0,lm,l); 
            phin_r = eigfunc(lambda,2,Ltype,Rtype,l(2),m,l0,lm,l); 
            s2     = s+kappa(2)*lambda^2; 
            A(1,1) = A(1,1)+eigs_norm(n,2)^2*phin_l*phin_l/s2; 
            A(1,2) = A(1,2)-eigs_norm(n,2)^2*phin_l*phin_r/s2; 
            b(1)   = b(1)+c(n,2)*eigs_norm(n,2)*phin_l/s2; 
             
            % Middle interfaces 
            for i = 2:m-2 
                lambda   = eigs(n,i); 
                phin_l   = cos(lambda*(l(i)-l(i-1))); 
                phin_r   = 1.0; 
                s1       = s+kappa(i)*lambda^2; 
                A(i,i-1) = A(i,i-1)-
eigs_norm(n,i)^2*phin_l*phin_r/s1; 
                A(i,i)   = A(i,i)+eigs_norm(n,i)^2*phin_r*phin_r/s1; 
                b(i)     = b(i)-c(n,i)*eigs_norm(n,i)*phin_r/s1; 
                 
                lambda   = eigs(n,i+1); 
                phin_l   = cos(lambda*(l(i+1)-l(i))); 
                phin_r   = 1.0; 
                s2       = s+kappa(i+1)*lambda^2; 
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                A(i,i)   = 
A(i,i)+eigs_norm(n,i+1)^2*phin_l*phin_l/s2; 
                A(i,i+1) = A(i,i+1)-
eigs_norm(n,i+1)^2*phin_r*phin_l/s2; 
                b(i)     = b(i)+c(n,i+1)*eigs_norm(n,i+1)*phin_l/s2; 
            end 
             
            % Interface m (between layers m and m-1) 
            lambda     = eigs(n,m-1); 
            phin_l     = eigfunc(lambda,m-1,Ltype,Rtype,l(m-
2),m,l0,lm,l); 
            phin_r     = eigfunc(lambda,m-1,Ltype,Rtype,l(m-
1),m,l0,lm,l); 
            s2         = s+kappa(m-1)*lambda^2; 
            A(m-1,m-2) = A(m-1,m-2)-eigs_norm(n,m-
1)^2*phin_l*phin_r/s2; 
            A(m-1,m-1) = A(m-1,m-1)+eigs_norm(n,m-
1)^2*phin_r*phin_r/s2; 
            b(m-1)     = b(m-1)-c(n,m-1)*eigs_norm(n,m-1)*phin_r/s2; 
             
            lambda     = eigs(n,m); 
            phin_l     = eigfunc(lambda,m,Ltype,Rtype,l(m-
1),m,l0,lm,l); 
            s1         = s+kappa(m)*lambda^2; 
            A(m-1,m-1) = A(m-1,m-
1)+eigs_norm(n,m)^2*phin_l*phin_l/s1; 
            b(m-1)     = b(m-1)+c(n,m)*eigs_norm(n,m)*phin_l/s1; 
             
        end 
         
        for i = 1:m-1 
            A(i,i) = A(i,i)+(1.0/H(i)); 
        end 
         
        % Laplace transform of v evaluated at zk(poles)/t 
        vbar(:,k) = A\b; 
%         norm(b - A*vbar(:,k),'inf'); 
%         pause; 
        %vbar(:,k) = zeros(size(b)); 
         
    end 
     
    % Form the sums corresponding to interfaces 
    for n = 1:N 
         
        % Compute inverse Laplace transform of 
v(1)/(s+kappa*lambda^2) 
        lambda = eigs(n,1); 
        vr(1) = 0; 
        for k = 1:NZ/2 
            poles = 2*k-1; 
            s = zk(poles)/t; 
            vr(1) = vr(1)-... 
                ck(poles)*vbar(1,k)/(t*(s+kappa(1)*lambda^2)); 
 233 
        end 
        vr(1) = 2*real(vr(1)); 
        u(:,1)  = u(:,1)+eigs_norm(n,1)^2*vr(1)*... 
            eigfunc(lambda,1,Ltype,Rtype,l(1),m,l0,lm,l)*... 
            eigfunc(lambda,1,Ltype,Rtype,xgrid(:,1),m,l0,lm,l); 
%         n 
%         abs(eigs_norm(n,1)^2*vr(1)*... 
%             eigfunc(lambda,1,Ltype,Rtype,l(1),m,l0,lm,l)*... 
%             eigfunc(lambda,1,Ltype,Rtype,xgrid(:,1),m,l0,lm,l)) 
%         pause; 
         
        for i = 2:m-1 
            lambda = eigs(n,i); 
            vr(i-1) = 0; 
            for k = 1:NZ/2 
                poles = 2*k-1; 
                s = zk(poles)/t; 
                vr(i-1) = vr(i-1)-... 
                    ck(poles)*vbar(i-1,k)/(t*(s+kappa(i)*lambda^2)); 
            end 
            vr(i-1) = 2*real(vr(i-1)); 
            u(:,i) = u(:,i)-eigs_norm(n,i)^2*vr(i-1)*... 
                eigfunc(lambda,i,Ltype,Rtype,l(i-1),m,l0,lm,l)*... 
                eigfunc(lambda,i,Ltype,Rtype,xgrid(:,i),m,l0,lm,l); 
            vr(i) = 0; 
            for k = 1:NZ/2 
                poles = 2*k-1; 
                s = zk(poles)/t; 
                vr(i) = vr(i)-ck(poles)*... 
                    vbar(i,k)/(t*(s+kappa(i)*lambda^2)); 
            end 
            vr(i) = 2*real(vr(i)); 
            u(:,i) = u(:,i)+eigs_norm(n,i)^2*vr(i)*... 
                eigfunc(lambda,i,Ltype,Rtype,l(i),m,l0,lm,l)*... 
                eigfunc(lambda,i,Ltype,Rtype,xgrid(:,i),m,l0,lm,l); 
        end 
         
        % Compute inverse Laplace transform of v(m-
1)/(s+kappa*lambda^2) 
        lambda = eigs(n,m); 
        vr(m-1) = 0; 
        for k = 1:NZ/2 
            poles = 2*k-1; 
            s = zk(poles)/t; 
            vr(m-1) = vr(m-1)-ck(poles)*... 
                vbar(m-1,k)/(t*(s+kappa(m)*lambda^2)); 
        end 
        vr(m-1) = 2*real(vr(m-1)); 
        u(:,m) = u(:,m)-eigs_norm(n,m)^2*vr(m-1)*... 
            eigfunc(lambda,m,Ltype,Rtype,l(m-1),m,l0,lm,l)*... 
            eigfunc(lambda,m,Ltype,Rtype,xgrid(:,m),m,l0,lm,l);         
    end 
     
%     u = zeros(size(u)); 
    % Form the sums corresponding to initial condition 
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    for n = 1:N         
        % Slabs 1,..,m 
        for i = 1:m 
            lambda = eigs(n,i); 
            u(:,i) = u(:,i)+exp(-t*kappa(i)*lambda^2)*c(n,i)*... 
                eigs_norm(n,i)*... 
                eigfunc(lambda,i,Ltype,Rtype,xgrid(:,i),m,l0,lm,l); 
%             if i == 1 
%                 n 
%                 exp(-t*kappa(i)*lambda^2)*c(n,i)*... 
%                 eigs_norm(n,i)*... 
%                 eigfunc(lambda,i,Ltype,Rtype,xgrid(:,i),m,l0,lm,l) 
%                 pause; 
%             end 
        end         
    end 
  
    usoln(:,j) = reshape(u,(NX+1)*m,1); 
     
end 
global ASDIFFCORRECTED sumsquarederror ErrorBro ucorrected 
u = usoln; 
x = reshape(xgrid,(NX+1)*m,1); 
  
  
% n = numel(u); 
% ucorrected = interp1(1:n, u, linspace(1,n, 1000/numel(u)*n), 
'nearest'); 
%  
% hh = size(ucorrected); 
% for i=1:hh(2) 
%     ErrorBro(1,i) = (abs(ucorrected(i) - ASDIFFCORRECTED(i))).^2; 
% end 
% sumsquarederror = sum(ErrorBro); 
% plot(ucorrected) 
% hold on 
% plot(ASDIFFCORRECTED) 
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function [zk,ck] = cf(n) 
% Computes the poles zk and residues ck by the Caratheodory-Fejer 
method 
% for the type (n,n) best approximation to exp(z) on the negative 
real  
% line. 
% 
% For full details see: 
% J. A. C. Weideman L. N. Trefethen and T. Schmelzer (2006) Talbot 
% quadratures and rational approximations. BIT Numer. Math., 46:653-
670. 
% 
% The following code is given in Figure 4.1 of the above paper. 
  
K = 75;                     % no of Cheb coeffs 
nf = 1024;                  % no of pts for FFT 
w = exp(2i*pi*(0:nf-1)/nf); % roots of unity 
t = real(w);                % Cheb pts (twice over) 
scl = 9;                    % scale factor for stability 
F = exp(scl*(t-1)./(t+1+1e-16)); % exp(x) transpl. to [-1,1] 
c = real(fft(F))/nf;        % Cheb coeffs of F 
f = polyval(c(K+1:-1:1),w); % analytic part f of F 
[U,S,V] = svd(hankel(c(2:K+1))); % SVD of Hankel matrix 
s = S(n+1,n+1);             % singular value 
u = U(K:-1:1,n+1)'; v = V(:,n+1)'; % singular vector 
zz = zeros(1,nf-K);         % zeros for padding 
b = fft([u zz])./fft([v zz]); % finite Blaschke product 
rt = f-s*w.^K.*b;           % extended function r-tilde 
rtc = real(fft(rt))/nf;     % its Laurent coeffs 
zr = roots(v); qk = zr(abs(zr)>1); % poles 
qc = poly(qk);              % coeffs of denominator 
pt = rt.*polyval(qc,w);     % numerator 
ptc = real(fft(pt)/nf);     % coeffs of numerator 
ptc = ptc(n+1:-1:1); ck = 0*qk; 
  
for k = 1:n                 % calculate residues 
    q = qk(k); q2 = poly(qk(qk~=q)); 
    ck(k) = polyval(ptc,q)/polyval(q2,q); 
end 
  
zk = scl*(qk-1).^2./(qk+1).^2; % poles in z-plane 
ck = 4*ck.*zk./(qk.^2-1);   % residues in z-plane 
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function eig_func = eigfunc(lambda,i,Ltype,Rtype,x,m,l0,lm,l) 
% Defines the eigenfunctions for the different layers and boundary 
% conditions.  
  
if i == 1 
    switch Ltype 
        case 'Dirichlet' 
            eig_func = sin(lambda*(x-l0)); 
        case 'Neumann' 
            eig_func = cos(lambda*(x-l0)); 
        case 'Robin' 
            eig_func = cos(lambda*(l(1)-x)); 
    end 
elseif i == m 
    switch Rtype 
        case 'Dirichlet' 
            eig_func = sin(lambda*(lm - x)); 
        case 'Neumann' 
            eig_func = cos(lambda*(lm - x)); 
        case 'Robin' 
            eig_func = cos(lambda*(x-l(m-1))); 
    end 
else 
    eig_func = cos(lambda*(l(i)-x)); 
end 
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function eigs = eigvals(a,b,c,N) 
% Solves the nonlinear equation: 
% 
% f(lambda) = lambda * tan(lambda*(a-b)) = c 
% 
% numerically for the first N non-negative values of lambda, using a 
% combination of the bisection method and Newton's method. 
% 
% Solution to this equation is required to compute the eigenvalues 
when 
% Robin conditions are applied at either the left or right 
boundaries. 
  
f = @(lambda) lambda * sin(lambda*(a-b)) - c*cos(lambda*(a-b)); 
for i = 1:10 
    g = chebfun(f,[0,10^i]); 
    r = roots(g); 
    numroots = length(r); 
    if numroots >= N 
        r = r(1:N); 
        break; 
    end 
end 
eigs = r; 
  
% pause; 
%  
% MaxIters = 20; 
% tol      = 1e-8; 
% eigs     = zeros(N,1); 
%  
% if c > 0 
%     n = 0; 
%     converged = false; 
%      
%     lambda_left  = 0.0; 
%     lambda_right = (2*n+1) * pi / (2 * (a-b)); 
%      
%     % Initial guess (midpoint) 
%     lambda = (lambda_left+lambda_right)/2; 
%      
%     f = compute_func(lambda,a,b,c); 
%     absf0 = abs(f); 
%      
%     for k = 1:MaxIters 
%         fdash = compute_fdash(lambda,a,b,c); 
%         lambda = lambda - f / fdash; 
%         f = compute_func(lambda,a,b,c); 
%         if abs(f)/absf0 < tol 
%             converged = true; 
%             break; 
%         end 
%     end 
%      
%     if converged == true 
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%         eigs(1) = lambda; 
%     else 
%         warning('Failed to converge when finding eigenvalue 
(n=%i)\n',n+1); 
%     end 
%      
% end 
%  
% nu = 0; 
% n = 0; 
% while nu < N 
%      
%     n = n + 1; 
%      
%     converged = false; 
%      
%     if c < 0 
%         lambda_left  = max((2*n+1) * pi / (2 * (a-b)),0.0); 
%         lambda_right = (2*(n+1)+1) * pi / (2 * (a-b)); 
%     else 
%         lambda_left  = max((2*(n-1)+1) * pi / (2 * (a-b)),0.0); 
%         lambda_right = (2*n+1) * pi / (2 * (a-b)); 
%     end 
%      
%     % Initial guess (midpoint) 
%     lambda = (lambda_left + lambda_right)/2; 
%      
%     f = compute_func(lambda,a,b,c); 
%     for k = 1:MaxIters 
%         fdash = compute_fdash(lambda,a,b,c); 
%         lambda = lambda - f / fdash; 
%         f = compute_func(lambda,a,b,c); 
%         if abs(f) < tol 
%             converged = true; 
%             break; 
%         end 
%     end 
%      
%     if converged == true 
%         unique_eig = true; 
%         for i = 0:nu-1 
%             if abs(lambda - eigs(i+1)) < 1e-4*eigs(i+1) 
%                 unique_eig = false; 
%                 break; 
%             end 
%         end 
%         if unique_eig 
%             eigs(nu+1) = lambda; 
%             nu = nu + 1; % Unique eigenvalue counter 
%             if nu == N 
%                 break; 
%             end 
%         end 
%     else 
 239 
%         warning('Failed to converge when finding eigenvalue 
(n=%i)\n',n+1); 
%     end 
%      
% end 
%  
% eigs = sort(eigs); 
%  
% end 
%  
% % Sub-functions 
% % Compute function f(lambda) 
% function f = compute_func(lambda,a,b,c) 
% f = lambda * sin(lambda*(a-b)) - c*cos(lambda*(a-b)); 
% end 
% % Compute derivative f'(lambda) 
% function fdash = compute_fdash(lambda,a,b,c) 
% fdash = sin(lambda*(a-b)) + ... 
%     lambda*cos(lambda*(a-b))*(a-b)+c*sin(lambda*(a-b))*(a-b); 
% end 
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function w = steady_state(m,kappa,l0,lm,l,Lbnd,Rbnd) 
  
aL = Lbnd{2}; 
bL = Lbnd{3}; 
cL = Lbnd{4}; 
aR = Rbnd{2}; 
bR = Rbnd{3}; 
cR = Rbnd{4}; 
  
H = 1e16*ones(m-1,1); 
  
A = zeros(2*m,2*m); 
b = zeros(2*m,1); 
  
% Interface conditions 
for i = 1:m-1 
    A(2*i-1,2*i-1) = 1.0; 
    A(2*i-1,2*i)   = (kappa(i)/H(i)) + l(i); 
    A(2*i-1,2*i+1) = -1.0; 
    A(2*i-1,2*i+2) = -l(i); 
    b(2*i-1)       = 0.0; 
     
    A(2*i,2*i)   = kappa(i); 
    A(2*i,2*i+2) = -kappa(i+1); 
    b(2*i)       = 0.0; 
end 
  
% Right boundary condition 
A(2*m-1,2*m)   = bR+aR*lm; 
A(2*m-1,2*m-1) = aR; 
b(2*m-1)       = cR; 
  
% Left boundary condition 
A(2*m,1) = aL; 
A(2*m,2) = -bL+aL*l0; 
b(2*m)   = cL; 
  
w = A\b; 
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function wfunc = wfunc(i,Ltype,Rtype,x,m,w) 
% Form of the non-transient component of the solution  
% (steady state if it exists) 
  
% if strcmp(Ltype,'Neumann') && strcmp(Rtype,'Neumann') 
%     if i == 1 
%         wfunc = w(1)*x + w(2)*x.^2; 
%     elseif i == m 
%         wfunc = w(2*m-1)*x + w(2*m)*x.^2; 
%     else 
%         wfunc = w(2*i-1)*x + w(2*i)*x.^2; 
%     end 
% else 
    wfunc = w(2*i-1) + w(2*i)*x; 
% end 
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Matlab code to be used to input into multi-layer code: 
clear 
close all 
  
global u0 m kappa l0 lm l tspan Rbnd Lbnd interface ASDIFFCORRECTED 
  
load('AbbExp01072016.mat') % change to reflect workspace for 
experiment 
h=figure; 
hold on 
FileS = ['C403P1.tif']; % change to reflect picture relevant to data 
being analyzed 
%FileSave = 'ProCon1Loaded2'; % change to reflect test to be analyzed 
(will be file name saved for excel) 
FileSave2 = 'C403P1'; 
File = C403P1; % change to reflect test to analyze (check workspace) 
MicronPerPixel = 1.6605; % change based on picture size and pixel 
size (check in Zeiss) 
  
imshow(FileS) 
[Col, Row] = ginput(4); % go around sample picking the corners of the 
desired area in a clockwise motion, starting at the top left corner 
for k = round(min(Col)):floor(max(Col)) 
    gradLoaded(k-round(min(Col))+1) = 
sum(File(round(min(Row)):floor(max(Row)),k)); % currently sums over 
the Widths in the image to get the sume of brightness for that 
Lengthumn 
end 
  
% for k = round(min(Length)):round(max(Length)) 
%     gradLoadedaxial(k) = 
sum(File(round(min(Width)):round(max(Width), k))); % currently sums 
over the Widths in the image to get the sume of brightness for that 
Lengthumn 
% end 
  
% Old way where everything is used 
% for k = 1:round(max(Length)) - round(min(Length)) 
%     gradLoaded(k) = sum(File(:,k)); % currently sums over the 
Widths in the image to get the sume of brightness for that Lengthumn 
% end 
  
% Background_Noise_From_Negative_Loaded_Control = x; to be added 
later 
% Background_Noise_From_Negative_Unloaded_Control = x; to be added 
later 
  
while mod(length(gradLoaded),2) == 1 % checks to make sure vector is 
even numbered, adds an element if it is not 
    gradLoaded = horzcat(gradLoaded,zeros(1,1)); 
end 
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Background_Baseline = mean(mean(File(1:100,1:100))); % finds the 
background noise to be subtracted later 
XZero = find(gradLoaded == 
max(gradLoaded(1:length(gradLoaded)/2)),1); % makes y-zero the first 
brightness peak 
LoadedX1 = [([round(min(Col)):round(max(Col))]-
(XZero+round(min(Col)))) .* MicronPerPixel]; % corrects x axis to 
mean radial depth in microns 
gradLoadedscaledCol = gradLoaded./(round(max(Row)) - round(min(Row))) 
- Background_Baseline; % corrects y axis to be average brigtness 
% gradLoadedscaledY = gradLoadedaxial./(round(max(Width)) - 
round(min(Width))); 
  
while mod(length(gradLoadedscaledCol),2) == 1 && 
mod(length(LoadedX1),2) == 1 % checks to make sure vector is even 
numbered, adds an element if it is not 
    gradLoadedscaledCol = horzcat(gradLoaded,zeros(1,1)); 
    LoadedX1 = horzcat(LoadedX1,zeros(1,1)); 
end 
  
while length(gradLoadedscaledCol)>length (LoadedX1) % checks to make 
sure vector is even numbered, adds an element if it is not 
    LoadedX1 = horzcat(LoadedX1,zeros(1,1)); 
end 
  
while length(LoadedX1) > length(gradLoadedscaledCol) % checks to make 
sure vector is even numbered, adds an element if it is not 
    gradLoadedscaledCol = horzcat(gradLoadedscaledCol,zeros(1,1)); 
end 
  
CorrectedMat = [LoadedX1; gradLoadedscaledCol]; % holds the correct x 
position (microns) and corresponding average brightness values 
High1 = max(gradLoadedscaledCol(1:length(gradLoadedscaledCol)/2)); % 
brightness value of first peak (might have to change this to make it  
better);might not end in the center of sample)) 
High2 = 
max(gradLoadedscaledCol(length(gradLoadedscaledCol)/2:length(gradLoad
edscaledCol))); % brightness value of second peak (might have to 
change this to make it  better); might not end in the center of 
sample)) 
Baseline = 
mean(gradLoadedscaledCol(length(gradLoadedscaledCol)/2+XZero-
100:length(gradLoadedscaledCol)/2+XZero+100)); % brightness value in 
middle (or close to it, might want to change this later) 
Difference1 = High1 - Baseline;  
Difference2 = High2 - Baseline; 
FindHighCorrected1 = CorrectedMat(1,find(CorrectedMat(2,:) == 
High1)); % correct x position of first peak 
FindHighCorrected2 = CorrectedMat(1,find(CorrectedMat(2,:) == 
High2)); 
  
% subplot(2,1,1), imshow('Exp 3 Non Loaded 4.tif'), subplot(2,1,2), 
plot(LoadedX1, gradLoadedscaledX), axis([0 4250 0 
max(gradLoadedscaledX)*1.1]) 
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%plot(LoadedX1, gradLoadedscaledX, 'g', axis([0 
CorrectedMat(1,find(CorrectedMat(2,:) == High2)) 0 
max(gradLoadedscaledX)*1.1])); 
  
subplot(2,1,1), imshow(FileS), subplot(2,1,2), plot(LoadedX1, 
gradLoadedscaledCol), axis([0 4250 0 max(gradLoadedscaledCol)*1.1]) 
plot(LoadedX1, gradLoadedscaledCol, 'g'),axis([0 
CorrectedMat(1,find(CorrectedMat(2,:) == High2,1)) 0 
max(gradLoadedscaledCol)*1.1]); 
hold on 
  
gradLoadedscaledCol = gradLoadedscaledCol - Baseline; 
gradLoadedscaledCol = gradLoadedscaledCol(1:1000); 
Max = find(gradLoadedscaledCol == (High1 - Baseline)); 
% plot(LoadedX1(Max:1000), gradLoadedscaledCol(Max:1000)) 
ASDIFF = gradLoadedscaledCol(Max:1000)./High1; 
plot(LoadedX1(Max:1000), ASDIFF) 
  
% dlmwrite(FileSave, [(find(gradLoadedscaledCol == 
High1):find(gradLoadedscaledCol == High2))', 
(gradLoadedscaledCol(find(gradLoadedscaledCol == 
High1):find(gradLoadedscaledCol == High2)))']) 
dlmwrite(FileSave2, [LoadedX1(1:1000)', gradLoadedscaledCol']); 
  
n = numel(ASDIFF); 
  
  
%%%%%LJ%LJLKFJLD 
  
  
u0 = @(x) zeros(size(x)); 
m = 3; 
kappa = [3,10,7]; 
l0 = 0; 
lm = 1000; 
l = [100, 400]; 
tspan = 10800; 
Rbnd = {'Dirichlet',1.0,0.0,0}; 
Lbnd = {'Dirichlet',1.0,0.0,1.0}; 
interface = 'Perfect'; 
ASDIFFCORRECTED = interp1(1:n, ASDIFF, linspace(1, n, 1.66*n), 
'nearest'); 
  
[u, x] = multdiff(m,kappa,l0,lm,l,u0,Lbnd,Rbnd, tspan, interface); 
figure 
plot(x,u,LoadedX1(Max:1000),ASDIFF) 
